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GENERAL REMARKS 
 
1. Melting points were recorded by open capillary method and are uncorrected. 
2. Infrared spectra were recorded on Shimadzu FT IR-8400 (Diffuse reflectance
 attachment) using KBr. Spectra were calibrated against the polystyrene
 absorption at 1610 cm-1. 
3. 1H & 13C NMR spectra were recorded on Bruker Avance II 400 spectrometer.
 Making a solution of samples in DMSO d6 and CDCl3 solvents using
 tetramethylsilane (TMS) as the internal standard unless otherwise mentioned,
 and are given in the δ scale. The standard abbreviations s, d, t, q, m, dd, dt, br
 s refer to singlet, doublet, triplet, quartet, multiplet, doublet of a doublet,
 doublet of a triplet, AB quartet and broad singlet respectively. 
4. Mass spectra were recorded on Shimadzu GC MS-QP 2010 spectrometer
 operating at 70 eV using direct injection probe technique. 
5. Analytical thin layer chromatography (TLC) was performed on Merck
 precoated silica gel-G F254 aluminium plates. Visualization of the spots on
 TLC plates was achieved either by exposure to iodine vapor or UV light. 
6. The chemicals used for the synthesis of intermediates and end products were
 purchased from Spectrochem, Sisco Research Laboratories (SRL), Thomas
 Baker, Sd fine chemicals, Loba chemie and SU-Lab. 
7. All the reactions were carried out in Samsung MW83Y Microwave Oven
 which was locally modified for carrying out chemical reactions 
8. All evaporation of solvents was carried out under reduced pressure on
 Heidolph LABOROTA-400-efficient. 
9. % Yield reported are isolated yields of material judged homogeneous by TLC
 and before recrystallization. 
10. The structures and names of all compounds given in the experimental section
 and in physical data table were generated using ChemBio Draw Ultra 10.0. 
11. Elemental analysis was carried out on Vario EL Carlo Erba 1108. 
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ABBREVIATIONS 
 
ABC ATP Binding Cassette 
AcOH Acetic Acid 
ActD Actinomycin D 
ADHD Attention-deficit hyperactivity disorder 
AIDS Acquired Immuno Deficiency Syndrome 
AlCl3 Aluminum chloride 
Ar Aromatic 
ARC Aids Related Complex 
ATP Adenosine Triphosphate 
Av. Average 
BBB Blood-brain barrier 
BMI Body mass index 
BMS Bristol-Myers Squibb 
BP Boiling Point 
BSEP Bile salt excretory pump 
BuLi Butyllithium 
CAMP Cyclic Adenosine Mono Phosphate 
CDCl3 deuterated chloroform 
CNS Central Nervous System 
CO2 Carbon dioxide  
COD Chemical oxygen demand 
CoMFA Comparative Molecular Field Analysis 
CoMSIA Comparative Molecular Similarity Index Analysis 
Conc. Concentrated 
Cox Cyclooxygenase 
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CuI Copper(I) iodide 
D.M. Demineralized Water 
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DMAP Dimethylamino Pyridine 
Abbreviation 
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FT-IR Fourier Transform Infrared 
FVP Flash Vacuum Pyrolysis 
GABA Gama-amino butyric acid 
GC Gas Chromatography 
GC -MS Gas Chromatography Mass Spectra 
H2SO4 Sulphuric acid 
HBF4 Tetrafluoroboric acid 
HCl Hydrochloric acid 
HDL High-density lipoprotein 
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LC LiquidChromatography 
LDL Low density lipoproteins 
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1.1 INTRODUCTION 
 
Organic chemists synthesize hundreds of new heterocyclic compounds every 
week. In most cases the chemist has specific reasons for synthesizing a particular 
compound, usually based on theoretical considerations, medicinal chemistry, 
biological mechanisms or a combination of all three.  
 
The heterocyclic compounds are very widely distributed in nature and are very 
essential to living organisms. They play a vital role in the metabolism of all the living 
cells. Among large number of heterocycles found in nature, nitrogen heterocycles are 
the most abundant specially those containing oxygen or sulphur1 due to their wide 
distribution in nucleic acid illustration and their involvement in almost every 
physiological process of plants and animals. 
  
Heterocyclic compounds possess great applicability in industry as well as in 
our life in various ways. For example most of the sugars and their derivatives, 
including vitamin C2, exist largely in the form of five membered (Furanosied 
structure) or six membered (Pyranosied structure) ring containing one oxygen atom. 
Further, most members of the vitamin B group possess heterocyclic rings containing 
nitrogen. e.g., vitamin B6 (Pyridoxine),3, 4 which is a derivative of the pyridine 
essential in amino acid metabolism. 
  
The heterocyclic compounds also occupy key position in the area of drugs and 
pharmaceuticals. Almost 80% of the drugs in clinical use are based on heterocyclic 
constitution because they have specific chemical reactivity. Majority of the large 
number of drugs being introduced in pharmacopeias in recent year are heterocyclic 
compounds. A wide variety of modern drugs such as chlordiazepoxide (tranquillizer), 
5,6 imipromine (antidepressant),7 guanethidine (antihypertensive),8 indapamide 
(diuretic and antihypertensive)9, 10, etc. Many non-steroidal drugs such as ketoprofen 
11, fenoprofen and flurbiprofen12 are well known anti-inflammatory agents; these 
derivatives were found to more potent with fewer side effects. Many antibiotics 
including penicillin13, cephalosporin14, norfloxacin15, streptomycin16, 17 etc., also 
contain heterocyclic ring.  
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Many veterinary products like parental and morantel are the drug of choice as 
broad spectrum anthelmintics18. The herbicides Atrazine and Simazine are well 
known examples of heterocyclic agrochemicals19, 20. Plant pigments such as indigo21, 
hemoglobin22 and anthiocyanins23, chlorophyll24 has contributed much to color 
chemistry and all these contain heterocyclic ring. Further, many other heterocyclic 
coloring matters are in use since prehistoric times. Further, the heterocyclic tetra 
Selene fulvalene was the first ionic molecular crystal to demonstrate 
superconductivity.25 
 
1.2 MEDICINAL CHEMISTRY 
 
The art of medicinal chemistry – the science that strives to identify, create or 
modify molecules for therapeutic application has enriched greatly from developments 
in the areas of organic chemistry, biology, biophysical/biochemical methods and 
computational tools. While opportunities are enormous, advancing a drug candidate 
from bench top to clinic is associated with challenges as well and a good 
understanding on both these aspects would significantly accelerate drug discovery 
process. Really, the unprecedented increase in human life expectancy, which has 
almost doubled in a hundred years, is mainly due to drugs and to those who 
discovered them. 
 
A race has been going on between the diseases and scientific investigations. 
Most of the infectious diseases like tuberculosis, typhoid, malaria, infective hepatitis, 
tetanus, cholera, etc., which kills lacks of people every year in underdeveloped or 
developing countries, have been completely wiped off from the developed nations. 
However, these have gradually been replaced by heart disease, cancer and HIV 
infection which are now considered as the biggest killers.  
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1.2.1 HISTORY AND EVOLUTION OF MEDICINAL CHEMISTRY 26 
 
Medicinal chemistry’s roots can be found in the fertile mix of ancient folk 
medicine and early natural product chemistry and hence its name. As appreciation for 
the links between chemical structure and observed biological activity grew, medicinal 
chemistry began to emerge about 150 years ago as a distinct discipline intending to 
explore these relationships via chemical modification and structural mimicry of 
nature’s materials, particularly with an eye towards enhancing the efficacy of 
substances thought to be of therapeutic value.27 
 
Just as in all fields of science, the history of medicinal chemistry is comprised 
of the ideas, knowledge and available tools that have advanced contemporary 
knowledge. The spectacular advances in medicinal chemistry over the years are no 
exception. Burger28 stated that “the great advances of medicinal chemistry have been 
achieved by two types of investigators: those with the genius of prophetic logic, who 
have opened a new field by interpreting correctly a few well-placed experiments, 
whether they pertained to the design or the mechanism of action of drugs and those 
who have varied patiently the chemical structures of physiologically active 
compounds until a useful drug could be evolved as a tool in medicine.” 
 
1.2.2 DEVELOPMENTS LEADING TO VARIOUS DRUG CLASSES 
 
Psychiatrists have been using agents that are active in the central nervous 
system for hundreds of years. Stimulants and depressants were used to modify the 
mood and mental states of psychiatric patients. Amphetamine, sedatives and 
hypnotics were used to stimulate or depress the mental states of patients. The 
synthesis of chlorpromazine by Charpentier ultimately caused a revolution in the 
treatment of schizophrenia, but who really discovered chlorpromazine? Charpentier, 
who first synthesized the molecule in 1950 at Rhone-Poulenc’s research laboratory; 
Simon Courvoisier, who reported distinctive effects on animal behavior; Henri 
Laborit, a French military surgeon who first noticed distinctive psychotropic effects in 
man; or Pierre Deniker and Jean Delay, French psychiatrists who clearly outlined 
what has now become its accepted use in psychiatry and without whose endorsement 
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and prestige, Rhone-Poulenc might never have developed it further as an 
antipsychotic. Because of the bitter disputes over the discovery of chlorpromazine, no 
Nobel Prize was awarded for what has been the single most important breakthrough in 
psychiatric treatment. 
 
The first pure hormone to be isolated from an endocrine gland was 
epinephrine, which led to further molecular modifications in the area of 
sympathomimetic amines. Subsequently, nor epinephrine was identified from 
sympathetic nerves. The development of chromatographic techniques allowed the 
isolation and characterization of a multitude of hormones from a single gland. In 
1914, biochemist Edward Kendall isolated thyroxin (T4) from the thyroid gland. He 
subsequently won the Nobel Prize in physiology or medicine in 1950 for his 
discovery of the activity of cortisone. Less than 50 years after the discovery of 
oxytocin in 1904 by Sir Henry Dale found that an extract from the human pituitary 
gland contracted the uterus of a pregnant cat. Biochemist Du Vigneud synthesized the 
cyclic peptide hormone. His work resulted in the Nobel Prize in chemistry in 1955. 
 
Frederick G. Banting and Charles H. Best, working in the laboratory of John J. 
R. McLeod at the University of Toronto, isolated the polypeptide hormone insulin and 
began its testing in dogs. By 1922, researchers, with the help of James B. Collip and 
the pharmaceutical industry, were able to purify and produce animal-based insulin in 
large quantities. Insulin soon became a major product for Eli Lilly & Co. and Novo 
Nordisk, a Danish pharmaceutical company. In 1923, McLeod and Banting were 
awarded Nobel Prize in Medicine or Physiology and after much controversy; they 
shared the prize with Collip and Best. For the next 60 years, cattle and pigs were the 
major sources of insulin. In 1978, the biotech company Genentech and the City of 
Hope National Medical Center produced human insulin in the laboratory using 
recombinant DNA technology. By 1982, Lilly’s Humulin became the first genetically 
engineered drug to be approved by the U.S. Food and Drug Administration (FDA). 
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1.2.3 EVOLVING DRUG DISCOVERY AND DEVELOPMENT 
PROCESS 
 
Working definition for medicinal chemistry 
 
A working definition simply states that medicinal chemistry uses physical 
organic principles to understand the interaction of small molecular displays with the 
biological realm. Physical organic principles encompass overall conformational 
considerations, chemical properties and molecular electrostatic potentials, as well as 
distinctly localized stereo chemical, hydrophilic, electronic and steric parameters. 
Small molecular displays should be thought of in terms of low molecular weight 
compounds (e.g., usually less than 1 kg) that are typically of a xenobiotic origin and 
thus not in terms of biotechnologically derived polymers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
[Fig. 1: Nonlinear relationship of medicinal chemistry to basic and applied research] 
 
The technologies that can be deployed as tools to study these interactions at 
medicinal chemistry’s fundamental level of understanding are, by intent, dissociated 
from medicinal chemistry’s definition. Presently, such tools include biotechnology-
related methods such as site-directed mutagenesis, combinatorial chemistry methods, 
provided that the latter are coupled with knowledge generating structural databases 
and long-standing synthetic chemistry manipulations that can be conducted in a 
Chemistry Medicinal 
chemistry 
Medicine
Basic 
Applied 
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systematic manner on either one of the interacting species in order to explore SARs. 
Finally, it should be appreciated that this definition merges both the basic and applied 
natures of medicinal chemistry’s scientific activities into a key mix of endeavors for 
which a new research paradigm (Fig. 1) has also been recently proposed as being a 
significant trend,29 even if potentially “dangerous” in that it could compromise the 
longer-term pursuit of fundamental knowledge by bringing applied science decision 
criteria into the funding programs that have previously supported pure, basic 
science.30 
 
1.2.4 THE PROCESS OF DRUG DISCOVERY 
 
Inventing and developing a new medicine is a long, complex, costly and 
highly risky process that has few peers in the commercial world. Research and 
development (R&D) for most of the medicines available today has required 12–24 
years for a single new medicine, from starting a project to the launch of a drug 
product (Fig. 2). In addition, many expensive, long-term research projects completely 
fail to produce a marketable medicine. The cost for this overall process has escalated 
sharply to an estimated US $1.4 billion for a single new drug.31 The funds to support 
this research usually come from the income of the private pharmaceutical company 
that sponsors the work. In research (‘R’; discovery) phase, only a fraction of the 
scientific hypotheses that form the basis for a project actually yield a drug candidate 
for development. In the drug development (‘D’) phase, experience has shown that 
only approximately 1 out of 15–25 drug candidates survives the detailed safety and 
efficacy testing (in animals and humans) required for it to become a marketed 
product. And for the few drug candidates that successfully become marketed 
products, some will not recover their costs of development in the competitive 
marketplace and only approximately one in three will become a major commercial 
product. Clearly, this is a high-stake, long-term and risky activity, but the potential 
benefits to the millions of patients with serious diseases provide a constant motivating 
force. At virtually every phase-from project initiation to discovery, development and 
planning for marketing for a new drug-modern medicinal chemist can have a role. 
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Stages in the drug discovery process 
[Fig. 2: The process of new drug discovery] 
 
The drug discovery process begins with the identification of a medical need, 
including a judgment on the adequacy of existing therapies (if there are any). From 
this analysis, together with an appraisal of the current knowledge about the target 
disease, will come hypotheses on how to possibly improve therapy — that is, what 
efficacy, safety or mechanistically novel improvements will advance the method of 
drug treatment for patients with the target disease. On the basis of these hypotheses, 
specific objectives will be set for the project. Then, testing selected chemicals in 
appropriate biological tests can begin. Key subsequent steps in the process include 
detecting relevant biological activity (a ‘hit’) for a structurally novel compound in 
vitro, then finding a related compound with in vivo activity in an appropriate animal 
model, followed by maximizing this activity through the preparation of analogous 
structures and finally selecting one compound as the drug development candidate. 
This drug candidate then undergoes toxicological testing in animals, as required by 
law. If the compound passes all these tests, all the accumulated research data are 
assembled and submitted as an Investigational New Drug Application (IND) to the 
Food and Drug Administration (FDA) in the United States (or comparable agency in 
other countries) before clinical trials are initiated. In the clinic, there is sequential 
evaluation in normal human volunteers of toleration (Phase I), efficacy and dose 
range in patients (Phase II), followed by widespread trials in thousands of appropriate 
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patients to develop a broad database of efficacy and safety. For the few (4–7%) drug 
candidates that survive this series of development trials, a New Drug Application 
(NDA) that contains all the accumulated research data is filed for thorough review by 
the experts at the FDA. Only with their approval can the new drug be offered to 
doctors and their patients to treat the disease for which it was designed. 
 
1.2.5 DRUG METABOLISM 
 
The human body is an example of an exquisitely designed, extremely complex 
machine that functions day-in and day-out to allow for survival of the organism in 
response to a never-ending onslaught of external challenges. When one considers the 
enormous variety of environmental stressors to which the body is continually 
subjected, it is not surprising to anticipate the existence of a multitude of checks and 
balances associated with its physiological and biochemical systems. 
 
Humans are exposed throughout their lifetime to a large variety of drugs and 
nonessential exogenous (foreign) compounds (collectively termed “xenobiotic”) that 
may pose health hazards. Most drugs and other xenobiotic are metabolized by 
enzymes normally associated with the metabolism of endogenous constituents (e.g., 
steroids and biogenic amines). The liver is the major site of drug metabolism, 
although other xenobiotic-metabolizing enzymes are found in nervous tissue, kidney, 
lung, plasma and the gastrointestinal tract.  
 
Among the more active extra hepatic tissues capable of metabolizing drugs is 
the intestinal mucosa, kidney and lung. The ability of the liver and extra hepatic 
tissues to metabolize substances to either pharmacologically inactive or bioactive 
metabolites before reaching systemic blood levels is termed “first-pass metabolism”. 
Other metabolism reactions occurring in the gastrointestinal tract are associated with 
bacteria and other microflora of the tract. The bacterial flora can affect metabolism 
through the production of toxic metabolites, formation of carcinogens from inactive 
precursors, detoxication and exhibition of species differences in drug metabolism, 
exhibition of individual differences in drug metabolism, production of 
pharmacologically active metabolites from inactive precursors and production of 
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metabolites not formed by animal tissues. The pathways of xenobiotic metabolism are 
divided into two major categories. 
 
Phase I reactions (Biotransformation)  
This type includes oxidation, hydroxylation, reduction and hydrolysis. In these 
enzymatic reactions, a new functional group is introduced into the substrate molecule, 
an existing functional group is modified or a functional group or acceptor site for 
Phase II transfer reactions is exposed, making the xenobiotic more polar and 
therefore, more readily excreted. 
 
Phase II reactions (Conjugation) 
These reactions are enzymatic syntheses whereby a functional group, such as 
alcohol, phenol or amine, is masked by the addition of a new group, such as acetyl, 
sulfate, glucoronic acid or certain amino acids, which further increases the polarity of 
the drug or xenobiotic. Most substances undergo both Phase I and Phase II reactions 
sequentially.  
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2.1 INTRODUCTION: PYRAZOLES 
 
The chemistry of pyrazoles has been reviewed by Jarobe in 1967. Pyrazoles 
have attracted attention of medicinal chemists for both with regard to heterocyclic 
chemistry and the pharmacological activities associated with them. Pyrazole have 
been studied extensively because of ready accessibility, diverse chemical reactivity, 
broad spectrum of biological activity and varieties of industrial applications. 
 
Pyrazole has three possible tautomeric structures. But 2-pyrazole (1) consist a 
unique class of nitrogen containing five member heterocycles. 
 
N
N
H  
(1) 
As evident from the literature in recent years a significant portion of research 
work in heterocyclic chemistry has been devoted to pyrazoles containing different 
alkyl, aryl and heteroaryl groups as substituents. 
 
Pyrazoles belong to the family of azoles, i.e. five-member ring containing only 
nitrogen and carbon atoms, ranging from pyrrole to pentazole. According to Albert’s 
classification, they are π-excessive, N-hetero aromatic derivatives and according to 
Kauffmann’s arenology principle, as a substituted carbon, they are analogues of 
amines and as substituted nitrogen they are analogues of halogens, i.e. pseudo 
halogens. Synthesis of pyrazole and its N-aryl analogs has been a subject of consistent 
interest because of the wide applications of such heterocycles in pharmaceutical as 
well as in agrochemical industry.1-3 numerous compounds containing pyrazole moiety 
have been shown to exhibit anti-hyperglycemic, analgesic, anti-inflammatory, anti-
pyretic, anti-bacterial and sedative-hypnotic activities. 4-6  
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N
N
COOH
Cl
N
N
(CH2)3N(CH3)2
(1)
Lonazolac
(anti-inflammatory)
Fezolamine
(antidepressant)
(2)
N
N
N
H3C
CH3
O
O
OH
F
(3)
N
N
Ph
ORCH3
(4)
E-3710
(analgesic)
N
N
Ph
NH
H3C SH
S
(5)
Pyrazoline-4-dithiocarbamic acid
(antibacterial & antifungicidal)
N
N
CH3
HN
H3C
OH
Cl
(6)
(antipsychotic)
Pyrazole mevalonolactone
(hypocholesterolemic effect)
 
 
N
N
CH 3
O
NH
N
CH 3
(7)
Granisoton
(antagonist)
N
N
OCH 3
CH 3
(8)
N
N
CH 3
H 3CO
(9)
N
N
N
N
Cl
H 3C
H
EMD-16923
(sedative-hypnotic)
N
N
N
N
CH 3
CH 3
CH 3
F 3C
H
O
(10)
Difenamizole
(analgesic-anti-inflammatory-antipyretic)
(11)
Estrogen receptor Estrogen receptor
 
  
1-Phenylpyrazole moiety is present in several drug candidates for the 
treatment of various diseases such as cyclooxygenase-2 (Cox-2) inhibitors, IL-1 
synthesis inhibitors and protein kinas inhibitors etc.7-10 Similarly, few of the 1,5-
diarylpyrazole derivatives have been shown to exhibit non-nucleoside HIV-1 reverse 
transcriptase inhibitor activity11 along with Cox-2 inhibitor.9,10 The corresponding 
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1,3,5-triaryl-4-alkylpyrazoles have been recently identified as the efficient legends for 
estrogen receptor displaying high binding affinities and selective transcriptional 
efficacy for ERI subtype.12-16 Therefore, continuous efforts have been devoted for the 
development of more general and efficient  methods for the synthesis of this class of 
compounds. 
 
During the course of ongoing interest in development of efficient general 
synthetic routes for five and six-membered heterocycles utilizing α-ox ketene 
dithioacetals (12) as a versatile 3-carbon building blocks,17-19 it has been shown in 
these studies, that it is possible to tune the reactivity of these ambient electrophiles  
 
SMe
R2
MeS
R1
O
N
N
R2
R1
MeS
Ar
N
N
R2
SMe
R1
Ar
(12)
(13)
(14)
 
 
 
towards unsymmetrical heterobionucleophiles such as hydroxylamine by variation of 
reaction conditions to afford either 3-aryl-5-(methylthio) or 5-aryl-3-
(methylthio)isoxazoles in highly regiocontrolled  fashion.20 Recently, Junjappa  H and 
Ila H have shown in their subsequent aromatic21-23 and heteroaromatic24 annulations 
studies, the possibility of achieving regioselective addition (1,4- addition vs. 1,2- 
addition) to α-ox ketene dithioacetals (12) with various carbanionic species by 
altering their nucleophilic nature (hard/soft nucleophiles). In continuation of these 
studies, more interest was taken in probing the reaction of these α-oxoketene 
dithioacetals (12) with aryl hydrazine with a view to develop a regioselective 
synthesis of isomeric 1-aryl-3,4-substituted-5-(methylthio)- and 1-aryl-4,5-
substituted-3-(methylthio)-pyrazoles (13) and (14) by manipulating the reaction 
conditions. 
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2.1.1 SYNTHETIC STUDY OF PYRAZOLES  
 
Most of the methods for the synthesis of pyrazoles involve approaches based 
on either (i) cyclocondensation of 1,3-dicarbonyl compounds and their equivalent 1,3-
dienophilic synthons such as propargylic ketenes, dialkylamino/alkoxy/chloro ketones 
with arylhydrazines or (ii) intermolecular [2+3] cycloadditions of 1,3-dipoles to 
alkynes.25-35  
 
However, the appealing generality of these methods are somewhat vitiated due 
to the frequent formation of regioisomeric mixtures of unsymmetrical pyrazoles in 
these reactions. Therefore, several elegant methods for the synthesis of 
asymmetrically substituted pyrazoles have been reported in the literature. Before 
presenting the results of our work, a brief literature survey on some of the recent 
syntheses of pyrazoles and its derivatives has been discussed. Among these methods, 
few selected recent examples have been highlighted in the following. 
 
Essassi et al.36 have reported that 4-phenyl-1, 5-benzodiazepine-2-thione (15), 
reacts with hydrazine to give 3-N-(2-aminophenyl amino)-5-phenylpyrazole (16). The 
reaction of (16) with diethyl acetylenedicarboxylate in ethanol under stirring at room 
temperature afforded ethyl-2-(2-ethoxy-2-oxoethyl)-1-(3-phenyl-1H-pyrazol-5-yl)-
2,3-dihydro-1H-benzimidazole-2- carboxylate (18) (resulting from the attack of the 
NH2 and NH groups of (16) on the triple bond of acetylenedicarboxylate) and (17) in 
good yield. There exists a tautomeric equilibrium between the enamine form A and 
the methyleneimine form B as shown in the reaction scheme. 
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NH
N
Ph
S
NH2
NH
N
NH
Ph
N
NH
COOC2H5
H
O
N
NH
Ph
+
N
NH
N
NH
Ph
COOC2H5
H
COOC2H5
H
N
N
COOC2H5
H
O
N
NH
Ph
H
(15) (16)
(18)(17A)(17B)
N2H4
COOC2H5
COOC2H5
 
 
Mikulskiene et al.37 have synthesized some new 1-aryl-4-[(3, 5–
dimethylpyrazole-1-yl) carbonyl]-2-pyrrolidinones (21a, b) by the condensation of 
hydrazide (20a, b) with 2,4-pentanedione in 2-propanol in the presence of a catalytic 
amount of hydrochloric acid. 
 
 
N
COOCH3
O R
N2H4.H2O
N
CONHNH2
O R
CH3COCH2COCH3
N N
H3C CH3
N
O R
O
(19a,b) (20a,b) (21a,b)
R = a) 3-Cl-4-CH3-C6H3 and b) 5-Cl-2-CH3-C6H3
 
 
Elassar et al.38 have discussed the chemistry of carbofunctionally substituted 
hydrazones and reported some important methods for the synthesis of pyrazole 
derivatives. The reaction of 3-(2-phenylhydrazono) pentane-2, 4-dione (22) with 
diazomethane who afforded pyrazole (25) in addition to (23) and (24).39,40 Although 
reaction sequence looks logical, this result should be checked again and reaction 
product should be characterized spectroscopically. 
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H3C CH3
N
O O
NH
Ar
CH2N2
Et2O
H3C
N
O
NH
Ar
O
H3C
N
O
NH
Ar
N
N
H3C
O
Ar
CH3
(22) (23)
(24)
(25)
 
 
Patel et al.41 have reported successful Vilsmeier formylation of (26) followed 
by cyclization and hydrolysis to yield pyrazole (27).  
 
N
NC
NH
Ar
N
NH
Ar
POCl3
DMF N
N
N
NH2N
O
Ar
Ar
(26) (27)
 
 
The ester (28) afforded arylazopyrazoles (29) upon treatment with hydrazine 
hydrate in refluxing ethanol.42, 43 
  
N
NH
CHO
Ar
C2H5O
O
N2H4
C2H5OH, Reflux NN
N
O
H
HN
Ar
(28) (29)
 
 
Bondock et al.44 have reported the synthesis of 1-cyanoacetyl-3, 5-dimethyl 
pyrazole45 (31) by the treatment of (30) in water containing a catalytic amount of 
conc. HCl with acetyl acetone at room temperature. The reaction of (30) with alkyl-
isocyanate yields alkyl-carbamoyl derivative (32) that cyclized into pyrazole 
derivative (33) on treatment with 2N sodium hydroxide.46  
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CN
NH
NH2
O
+ H3C CH3
O O H2O/HCl
r. t. N
N CH3
O
H3C
NC
(30) (31)
CN OR
NC NH NH NH
O
O
R(32)
NaOH
N
N NH
O
RHO
NH2
(33)
Where, R= a) H
                    b) Me
                    c) Ph
 
 
Elagdi et al.47 have reported the reaction of 2-(1-phenylethylidene) 
malononitrile with (30) furnished pyrazoline derivative (34). Pyrazolidinone 
derivative (35) was obtained by treatment of (30) with ethyl 2-cyano-3-phenylbut -2-
enoate.  
 
CN
NH
NH2
O NC
NC
CH3
Ph
NH
NH
H2N
NC
H3C Ph
(30) (34)
NC CH3
Ph
OC2H5
O
NH
NH
O
NC
H3C Ph
(35)   
 
Plantier-Royon et al.48 have developed a novel method for the synthesis of 3-
trialkylsilyl pyrazoles from β-oxoacylsilanes. This methodology was further extended 
to the synthesis of silylated pyrazoles bearing a carbohydrate moiety. 
   
 
O O
H
SiMe3R
R1NHNH2
Et2O N
N
Me3Si
R
R1
+
N
NR1
R
Me3Si
Major MinorR= C4H9, R1= H, R1= OBn
(36a-d)
(37a-d) (38a-d)
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2.1.2 PHARMACOLOGICAL-SIGNIFICANCE OF PYRAZOLES 
 
Pyrazoles belong to an important class of heterocycles due to their biological 
and pharmacological activities49,50 such as anti-inflammatory,51 herbicidal,52 
fungicidal,53 bactericidal,53 plant growth inhibitory,52 antipyretic,54 and protein kinase 
inhibitory activities.55 Also, they are the key starting materials for the synthesis of 
commercial aryl/hetero-arylazopyrazolone dyes.56,57   
Many other authors have reported other biological activities.58-85 
 
 
2.2 BENZOFURANS 
 
Benzofuran is the heterocyclic compound consisting of fused benzene and 
furan rings. This colorless solid is a component of coal tar. Benzofuran is the "parent" 
of many related compounds with more complex structures. For example, psoralen is a 
benzofuran derivative that occurs in several plants. 
 
 
 
 
2.2.1 PHYSICAL PROPERTIES 
 
Benzofuran is oily liquid. Its Molecular formula is C8H6O and molecular 
weight is 118.13 g mol−1 Its Boiling-point is 173 °C, 446 K, 343 °F and Melting-point 
is -18 °C, 255 K, -0 °F it do not dissolve in water, soluble in ethanol, ethyl ether and 
benzene. With the steam can be volatile and could be chemical decomposition and 
other oxidants.  
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2.2 INTRODUCTION 
 
In nature’s collection of biologically active heterocycles, benzo[b]furan 
derivatives86-89 constitutes a major group. They are usually important constituents of 
plant extracts used in traditional medicine,87 and some of them also play an important 
role in the natural defense mechanisms of their plants. These compounds include 
hydroxylated benzofurans such as Euparin90 (1, Figure 1.), Coumestrol91 (2), 
dehydrotremetone92 (3), or Cicerfuran93 (4). Due to this effect, a synthetic route-  
-leading to hydroxylated benzofurans would be of general interest. 
 
OHO
O
O
O
HO
O
O
O
O
O
MeO
OHO
1 2
3 4
OH
 
(Fig.-1) 
 
An obvious approach would utilize the cross-coupling of the benzofuran and 
C2-substituent moieties as demonstrated for analogous systems by Timári.94 
Unfortunately, extension of this procedure would require the selective preparation of 
differently substituted benzofurans, a task that has not been solved generally yet. An 
alternate approach would achieve the formation of the benzofuran moiety through the 
ring closure of an o-alknylphenol, 95-100 available through the coupling of an aryl 
halide and the appropriate aryl acetylene.  
 
In spite of the large number of publications describing the conversion of 2-
halophenols to benzo[b]furans,95-100 the preparation of hydroxylated benzofurans has 
received only limited attention so far.97,99,100 By analogy, such a process would start 
from a halogenated dihydroxybenzene. These compounds usually fail to undergo 
Sonogashira coupling  and the successful procedures on similar systems usually 
utilize the selective protection of the different hydroxyl groups or an equimolar 
amount of preformed organo copper reagent.100 A recent publication described the use 
of acetyl protecting groups that allowed for the efficient, ‘one-pot’ conversion of 
bromorezorcine (5, Figure 2.) to Cicerfuran (4).101 
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HO OH
Br
1. AcCl,TEA
        THF
MeO
O
O2.
Pd/PtBu3/Cu
AcO OAc
O
O
OMe KOH
aq. MeOH
OHO
O
O
MeO
4
5
(Fig.-2) 
 
After the discovery of disodium cromoglycate (DSCG), an efficient drug 
which is useful in treatment of human asthma, several isosteric or structurally related 
bisheterocyclic systems have been synthesized.102-104 DSCG-like and bisbenzofuran 
containing structures have been synthesized and characterized by Sunder and Peet.105 
The condensation products of quinine that incorporate the structures of the 2,8-
dimethoxydibenzofuran dimer, the trimer, 2,11-dimethoxybenzo-[1,2-b;3,4- 
b’]bis(benzofuran),106 and the open tetramer dibenzo[b,b’]furo[3,2-e;4,5-
e’]bis(benzofuran) derivatives107 have been synthesized and their X-ray crystal 
structures have been clarified, but overall there is limited literature on bisbenzofuran 
itself and bisbenzofuran containing compounds. According to our literature survey, no 
reports concerning oxime ether containing bisbenzofuran rings have been published 
since 1970. On the other hand, limited biological activity studies on bis- benzofuran 
containing compounds were found. 104, 106and 108 As it is known that, oxime ethers have 
found many uses in recent years as nonsteroidal anti-inflammatory drugs, 109 beta-
adrenergic, 110 mold inhibitory active compound in poultry science,111 anti-
protozoan,112 and insect growth regulator 113 and as various materials with steroidal 
effects.114 
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2.2.2 SYNTHESIS OF BENZOFURANS 
 
O
Toluene, 900C h OR R
5% Catalyst N NMes Mes
Ru
Ph
Cl
Cl
Catalyst:
Pcy3  
 
Substituted benzofurans were synthesized from their corresponding substituted 1-
allyl-2-allyloxybenzenes using ruthenium-catalyzed C- and O-allyl isomerization 
followed by ring-closingmetathesis.115 
 
Br
OHR'' R'
R
O 5% Pd (OAC)2
2.7 eq NaOtBu,
800C, 17-24 h or
MW, 800C, 30 min
R'
O
R
OHR''
1.5eq TFA
00C, 2-3 h O
R'
R
R''
 
A one-pot synthesis of benzofurans which utilizes a palladium-catalyzed enolate 
arylation demonstrates broad substrate scope and provides differentially substituted  
Benzofurans in moderate yields. The utility of the method is further demonstrated by  
the synthesis of the natural product eupomatenoid 6 in three steps.116 
 
R OH
O
N
N
N
Cl
ClCl
1eq NEt3
PPh2Br
OH
MW, 1100C, 60 min
O
R
 
 
An effective and mild microwave-assisted route to 2-substituted benzofurans directly 
from carboxylic acids allows the preparation of α-alkyl-2-benzofuranmethanamines 
from N-protected α-amino acids without racemization in good yields.117 
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O
N
R''
R'
R F3C
O
O
S
OO
CF3
(TFAT)
5eq
2eq DMAP
CH2Cl2, rt, 22h
O
R'
R''R
 
 
TFAA induces a [3,3]-sigmatropic rearrangement of N-trifluoroacetyl-ene-hydroxyl 
amines for the synthesis of dihydrobenzofurans, whereas reactions with TFAT-DMAP 
gives benzofurans. The synthetic utility is demonstrated by the short synthesis of 
natural benzofurans without protection of the hydroxyl group.118 
 
O
R
Br
R'
8.5 mol %CuI
3.5eq TMEDA
H2O, 1200C
O
R R'
 
 
Copper-TMEDA catalyzes the transformation of readily available ketone derivatives 
into the corresponding benzo[b]furans in good to excellent yields. The sustainable 
protocol uses water as the solvent without organic co-solvents and one example of 
catalyst reutilization is also presented.119 
 
X
R
R'
O
0.1eq CuI
1.5eq K3PO4
DMF, 1050C
12-16h O
R
R'
X:I, Br  
 
An efficient CuI-catalyzed ring closure of 2-haloaromatic ketones gives a wide 
variety of benzo[b] furans.120 
 
X
R
R'
O
0.1eq CuI
1.5eq K3PO4
DMF, 1050C
22h
O
R'
X:Cl, Br
R
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An efficient, indirect anti-Markovnikov hydration of asymmetrically substituted 
terminal and internal alkynes is based on TiCl4-catalyzed hydroamination reactions. 
Its application to ortho-alkynylhaloarenes, followed by a copper-catalyzed O-
arylation, provides substituted benzo[b]furans.121 
 
OH
R I
I
R' 1mol-%Pd(OAc)25 mol-%CuI
THF/Et3N (4:1)
reflux, 18-36h
O
R'R
R'=alkyl, Ar, CO2Et
 
 
In the presence of palladium (II) acetate and copper (I) iodide, unsymmetrical buta-
1,3-diynes were selectively obtained from the reaction of (E)-1,2-diiodoalkenes with 
terminal alkynes in moderate to good yields at room temperature. Using the same 
conditions, the coupling of 2-ethynylphenol with (E)-1, 2-diiodoalkenes followed by a 
cyclization at 100°C gives ethynylbenzofurans.122 
 
HO
Ar
HO R'
R''
0.1eq. Zn(OTf)2
toluene
1000C, 16-20h
O
Ar
R'
R''
 
 
Zn(OTf)2 catalyzed the cyclization of propargyl alcohols with anilines and phenols in 
toluene at 100°C without additive and gave various indole and benzofuran products 
with different structures. The cyclization of propargyl alcohols and amides gave 
oxazoles. Mechanisms for the different substitution patterns are discussed.123 
  
CHO
OH
R N2 OEt
O
1.6 eq
1) 0.1eq HBF4.OEt2(54%)
    CH2Cl2, rt
2) removal of volatiles
3) H2SO4, 5-10 min
O
CO2Et
R
 
 
A convenient high-yielding, efficient, selective and simple one-pot procedure for the  
synthesis of 3-ethoxycarbonylbenzofurans from commercially available salisaldehyde 
and ethyl diazoacetate has been developed.124 
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I
Br
R
CO2R''
OR
0.1eq CuI
3eq K2CO3
THF 24-30h
1000C(Sealed tube)
CO2R''
O-
R'
Br
R O
CO2R''
R'R
R',R''=alkyl
 
CuI-catalyzed coupling of 1-bromo-2-iodobenzenes with β-keto esters in THF at 
100°C provides 2,3-disubstituted benzofurans. This domino transformation involves 
an intermolecular -C-C- bond formation and a subsequent intramolecular –C=O bond 
formation process.125 
 
O O
R' R''
R
2-20 mol-%, Ptcl2
8-80 mol-%, COD
toluene
300C, 1h-4h
O
R'
O R''
R
 
 
The Pt-catalyzed cyclization of o-alkynylphenyl acetals produces3-(-alkoxyalkyl) 
benzofurans in good to high yields. The mechanism is discussed.126 
 
Cl
C6H17
3.75eq. KOH
0.1eq.ligand Pd2(dba)3
H2O/dioxane(3:5)
1000C, 8h
O
C6H17
83%
PtBu2
ligand
 
 
A one-pot method for the preparation of alkyl aryl ethers from aryl halides and the  
Preparation of substituted benzofurans via a Pd-catalyzed phenol formation/cycli- 
-zation protocols starting from 2-chloroaryl alkynes are described.127 
 
OMe
R
2 eq. E-X
CH2Cl2
250C, 3h
O
E
R
E, X: I2, PhSeCl
p-O2NC6H4SCl  
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2,3-Disubstituted benzo[b]furans are readily prepared under very mild reaction 
conditions by the Sonogashira coupling of various o-iodoanisoles and terminal 
alkynes, followed by an electrophilic cyclization. Aryl- and vinylic-substituted 
alkynes give cyclization products in excellent yields.128 
 
2.2.3 BIOLOGICALLY RELEVANT 2-SUBSTITUTED BENZOFURANS 
  
Khellin (Fig. 1) is one of several furochromones that can be isolated from 
Ammi visnaga L., a perennial herbaceous plant that grows wild in many Eastern 
Mediterranean countries. Recently, khellin, along with several analogues, was found 
to possess desirable lipid-altering activity and is a coronary vasodilator: i.e., lowering 
the atherogenic VLDL + LDL-cholesterol fraction and elevating the anti-atherogenic 
(i.e., protective against atherosclerosis) HDL-cholesterol fraction, in animal models 
129 as well as in man. 
 
O
OMe
Me
O
OH
OMe
O
OMe
OMe
O
OH
Me
 
(Fig-1.) 
 
Cloridarol (Fig. 2) was used in for treatment of lipidemia and as an 
anticoagulant.130 Race mates of 2- benzofuranyl carbinols like have been shown to 
display antifungal and aromatase inhibiting activities. These carbinols were prepared 
in racemic form in good yields and recently synthesis of aryl 2-benzofuranyl in high 
enantiomeric purity was reported.131 
 
O OH
Cl
O OH
R
R=4-Cl, 4-F,3-Me  
(Fig-2.) 
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Other benzofuran drugs have similar structures: compound promotes the 
excretion of uric acid and is useful for treating gout.132 Thiophene (Fig. 3) has 
analgesic activity.133 
 
O
O
Cl
Et
O
COOH
O O
S
COOHMe
Me
 
(Fig-3.) 
 
Furaprofen (-methyl-3-phenyl-7-benzofuranacetic acid)134 has a similar 
activity than the well-known Ibuprofen (2- [4-(2-methylpropyl) phenyl] 
propanoicacid). Trioxsalen135 (Fig. 4) is a synthetic psoralen136 that offers skin 
protection against UVB erythema and is an orally active tanning and pigmentation 
agent useful in the treatment of vitiligo. 
 
OO
Me
O
Me
Me
 
(Fig-4.) 
 
A variety of polycyclic benzofurans have anticancer activity: indole (Fig. 5) 
has antitumor and antiviral activity.137 
 
N
H
O
Me  
(Fig-5.) 
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A chiral optically active benzofuran derivative was isolated from the sponge 
Dysidea frondosa together with other derivatives such as Frondosin A-D, each of 
them inhibiting the binding of IL-8 to its receptor in the low micromolar range.138 
Frondosin B (Fig. 6) is recovered in nature in an enantiomeric form. A more recent 
paper reported the total synthesis and determination of the absolute configuration of 
Frondosin B.139 
 
O
HO
Me
Me
Me
 
(Fig-6.) 
 
Chapter – 2                                                                               Synthesis of Benzofuran-2-yl….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                       29 
2.3 AIM OF CURRENT WORK 
 
The literature survey revealed that some extensive work has been done on 
pyrozole and pyrazolone type of the compounds. Also, due to the usefulness of 
traditional medicines like Coumestrol, Dehydrotremetone and Cicerfuran, the 
benzofuran moiety has been selected for the research criteria. 
 
Browsing through the literature of organomedicinal chemistry the most useful 
moiety found was substituted 4, 5-dihydro pyrazolonone derivatives. Because of the 
less toxicological properties and good to moderate activities, several compounds have 
been synthesized by our team in the laboratory. The work encompassed in this chapter 
is an extension of the aforesaid research activity. 
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2.4 REACTION SCHEMES 
 
2.4.1 PREPARATION OF BENZOFURAN-2-CARBOHYDRAZIDE  
 
O
R
CHO
Base
RT CH
O
HC
R
R1
R1
where R=H, 4-Cl, 4-F.
         R1=H,4-CH3,4-NO2 etc.
 
 
2.4.2 PREPARATION OF BENZOFURAN-2-YL (4, 5- DIHYDRO-3, 5-
SUBSTITUTED DIPHENYLPYRAZOL-1- YL) METHANONE 
 
O
NH2NH2.H2O
O
C
H
O
HC
O
OC2H5
O
NH NH2
O
O
NH NH2
N
N
O
O
R1
R
R
R1
where R=H, 4-Cl, 4-F.
         R1=H,4-CH3,4-NO2 etc.
Glacial acetic acid
Br
O O CHO
OH
K2CO3, DMF
reflux, 1.5hr O
O
OC2H5
Step-1
Step-2
Step-3
0-50C
reflux, 12hr.
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2.5 PLAUSIBLE REACTION MECHANISM 
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2.6 EXPERIMENTAL 
 
2.6.1. MATERIALS AND METHODS 
 
Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. Formation of all 
compounds was purified by using flash chromatography. IR spectra were recorded 
in Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass spectra were 
recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection Probe 
technique. 1H NMR was determined in DMSO-d6/CDCl3 solution on a Bruker Ac 
400 MHz spectrometer. Elemental analysis of the all the synthesized compounds 
was carried out on Elemental Vario EL III Carlo Erba 1108 model and the results 
are in agreements with the structures assigned. 
 
2.6.2. GENERAL PROCEDURE FOR PREPARATION OF SUBSTITUTED 
CHALCONES 
 
Substituted aldehydes (0.01 mole) was charged into 250 ml flat bottom flask. 
15 ml of methanol was added into above flask to dissolve it under stirring. And add 
into Substituted acetophenones (0.01mole) to stirr it for RT. 3-4 drops of saturated 
sodium hydroxide solution was added as a catalyst. The reaction mixture was stirred 
for 24 hours at RT. As a solid product comes. The progress and the completion of the 
reaction were checked by silica gel-G F254 thin layer chromatography using hexane : 
ethyl acetate (4 : 6) as a mobile phase. After the reaction to be completed, filtered 
under reduced pressure.  
Similarly other compounds are also prepared. 
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2.6.2a. PHYSICAL DATA OF SUBSTITUTED CHALCONES140: 
 
O
RR1
 
TABLE-2.1 
Sr. 
No. 
Code 
Name & 
No. 
Substitutions 
Molecular 
Formula 
Molecular 
Weight 
M.P. 
0C 
Rf 
Value R R1 
1 SC-01 H H C15H12O 208 55-57 0.46 
2 SC-02 H 4-CH3 C16H14O 222 110-112 0.48 
3 SC-03 H 4-NO2 C15H11NO3 253 158-164 0.52 
4 SC-04 H 3,4-di-OCH3 C17H16O3 268 87-89 0.46 
5 SC-05 H 4-F C15H11FO 226 85-87 0.50 
6 SC-06 H 4-Cl C15H11ClO 243 114-116 0.44 
7 SC-07 H 2-Cl C15H11ClO 243 50-52 0.46 
8 SC-08 H 4-OCH3 C16H14O2 238 75-77 0.50 
9 SC-09 4-Cl H C15H11ClO 243 97-101 0.48 
10 SC-10 4-Cl 4-Cl C15H10Cl2O 277 157-159 0.52 
11 SC-11 4-Cl 4-OCH3 C16H13ClO2 273 126-128 0.44 
12 SC-12 4-Cl 4-NO2 C15H10ClNO3 288 162-164 0.48 
13 SC-13 4-Cl 2-Cl C15H10Cl2O 277 82-84 0.38 
14 SC-14 4-Cl 3,4-di-OCH3 C17H15ClO3 303 106-107 0.42 
15 SC-15 4-Cl 4-CH3 C16H13ClO 257 162-164 0.48 
16 SC-16 4-Cl 4-F C15H10ClFO 261 112-114 0.52 
17 SC-17 4-F H C15H11FO 226 79-80 0.40 
18 SC-18 4-F 4-Cl C15H10ClFO 261 131-134 0.44 
19 SC-19 4-F 4-OCH3 C16H13FO2 256 107-108 0.48 
20 SC-20 4-F 4-N02 C15H10FNO3 271 135-137 0.42 
21 SC-21 4-F 2-Cl C15H10ClFO 261 88-90 0.40 
22 SC-22 4-F 3,4-di-OCH3 C17H15FO3 286 91-93 0.48 
23 SC-23 4-F 4-CH3 C16H13FO 240 122-124 0.44 
24 SC-24 4-F 4-F C15H10F2O 244 117-119 0.46 
TLC solvent system Rf, Hexane: Ethyl acetate - 4:6 
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2.6.3. GENERAL PROCEDURE OF BENZOFURAN-2-YL (4, 5- DIHYDRO-
3, 5-SUBSTITUTED DIPHENYLPYRAZOL-1- YL) METHANONES 
 
Step-1 PREPARATION OF ETHYL BENZOFURAN-2-CARBOXYLATE 
 
Salisaldehyde (0.01 mole) was charged into 250 ml round bottom flask. 30 ml 
of dimethyl formamide was added into above flask. Then added 0.01 mole of 
ethylbromo acetate and K2CO3 (0.03 mole) was added. The reaction mixture was 
refluxed for 1.5 hours at 1000C on oil bath. The progress and the completion of the 
reaction were checked by silica gel-G F254 thin layer chromatography using hexane : 
ethyl acetate (9 : 1) as a mobile phase. After the reaction to be completed, reaction 
mixture was poured into ice. Then product was extracted using ethyl acetate (50 ml × 
3), the combined organic layer was washed using brine solution (20 ml × 2). The 
organic layer was dried on anhydrous sodium sulphate and the solvent was removed 
under reduced pressure to acquire the product in a viscous liquid form. Yield –77 %, 
B. P. – 276°C.a 
 
Step-2 PREPARATION OF BENZOFURAN-2-CARBOHYDRAZIDES :  
 
Ethyl benzofuran-2-carboxylate (0.01 mole) was charged into 250 ml round 
bottom flask. Add drop wise into 15 ml of hydrazine hydrate at 0-50C above flask. 
The progress and the completion of the reaction were checked by silica gel-G F254 thin 
layer chromatography using hexane: ethyl acetate (4: 6) as a mobile phase. After the 
reaction to be completed, the mixture was stirred at room temperature to give 
benzofuran-2-carbohydrazide as a white colored shining product. M.P. – 190–1940C.b  
 
 
 
 
 
                                                 
a Bioorganic & Medicinal Chemistry Letters 18 (2008) 5591–5593. 
b Halli, M.B.; Oriental Journal of Chemistry 2001, V17(3), P441-444. 
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Step-3 SYNTHESIS OF BENZOFURAN-2-YL (4, 5- DIHYDRO-3, 5-
SUBSTITUTED DIPHENYLPYRAZOL-1- YL) METHANONE 
 
Benzofuran hydrazide (0.01 mole) was charged into 250 ml round bottom 
flask. 10 ml of Glacial acetic acid was added to dissolve it. Then add into substituted 
chalcones (0.01 mole). The reaction mixture was refluxed on oil bath for 12hours. The 
progress and the completion of the reaction were checked by silica gel-G F254 thin 
layer chromatography using hexane: ethyl acetate (4: 6) as a mobile phase. After the 
complete reaction the mixture was poured into crushed ice to give solid product then 
filtered it under reduced pressure. Finally, it was purified by flash chromatography 
using hexane and ethyl acetate as eluents.  
Similarly other compounds are also prepared. 
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2.7 PHYSICAL DATA 
 
PHYSICAL DATA OF BENZOFURAN-2-YL (4, 5- DIHYDRO-3, 5-SUBSTITUTED 
DIPHENYLPYRAZOL-1- YL) METHANONES (SBF-01 TO SBF-28) 
 
N
N
O
O
R1
R
 
 
TABLE-2.2 
Sr. 
No. 
Code 
Name & 
No. 
Substitutions 
Molecular 
Formula 
Molecular 
Weight 
M.P. 
0C 
Rf 
Value 
R R1 
1 SBF-01 H H C24H18N2O2 366 210-212 0.44 
2 SBF-02 H 4-CH3 C25H20N2O2 380 180-182 0.51 
3 SBF-03 H 4-NO2 C24H17N3O4 411 170-172 0.42 
4 SBF-04 H 3,4-di-OCH3 C26H22N2O4 426 150-154 0.46 
5 SBF-05 H 4-F C24H17FN2O2 384 220-224 0.41 
6 SBF-06 H 4-Cl C24H17ClN2O2 401 240-242 0.44 
7 SBF-07 H 2-Cl C24H17ClN2O2 401 178-182 0.52 
8 SBF-08 H 4-OCH3 C25H20N2O3 396 168-170 0.42 
9 SBF-11 4-Cl H C24H17ClN2O2 401 154-156 0.45 
10 SBF-12 4-Cl 4-Cl C24H16Cl2N2O2 435 176-178 0.48 
11 SBF-13 4-Cl 4-OCH3 C25H19ClN2O3 431 188-190 0.51 
12 SBF-14 4-Cl 4-NO2 C24H16ClN3O4 446 192-194 0.40 
13 SBF-15 4-Cl 2-Cl C24H16Cl2N2O2 435 160-162 0.44 
14 SBF-16 4-Cl 3,4-di-OCH3 C26H21ClN2O4 461 188-190 0.40 
15 SBF-17 4-Cl 4-CH3 C25H19ClN2O2 415 178-182 0.50 
16 SBF-18 4-Cl 4-F C24H16ClFN2O2 419 220-222 0.44 
17 SBF-21 4-F H C24H17FN2O2 384 244-246 0.48 
18 SBF-22 4-F 4-Cl C24H16ClFN2O2 419 210-212 0.41 
19 SBF-23 4-F 4-OCH3 C25H19FN2O3 414 220-222 0.48 
20 SBF-24 4-F 4-N02 C24H16FN3O4 429 240-244 0.44 
21 SBF-25 4-F 2-Cl C24H16ClFN2O2 419 176-178 0.46 
22 SBF-26 4-F 3,4-di-OCH3 C26H21FN2O4 444 164-166 0.44 
23 SBF-27 4-F 4-CH3 C25H19FN2O2 398 174-176 0.42 
24 SBF-28 4-F 4-F C24H16F2N2O2 402 184-186 0.48 
TLC solvent system for Rf, Hexane : Ethyl acetate - 4:6 
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2.8 SPECTRAL DISCUSSION 
 
2.8.1. MASS SPECTRA 
  
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. SBF-01 and SBF-02 of Mass 
spectra are given on page no. 49 and 52. 
 
2.8.2. IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT IR 
8400 spectrophotometer using Diffused Reflectance Attachment (DRA) System using 
Potassium Bromide. 
  
In case of SBF-01 to SBF-24 aromatic C-H stretching frequencies were found 
near 3050 cm-1 C-H stretching frequencies for methylene group were obtained near 
2950 cm-1. –C=O Stretching vibrations were found near 1690 cm-1. –C=N vibrations 
were found in the region of 1640 cm-1. -C-O-C- furan ring vibration was found 1040 
cm-1. Along with all the frequencies obtained in above compounds, additionally -C-Cl 
frequency was found between 780 cm-1 to 700 cm-1 in SBF-11 to SBF-18. and –C-F 
frequency was found between 1100 cm-1 to 1000 cm-1 in SBF-21 to SBF-28 
Compounds. SBF-01 and SBF-02 of IR spectra are given on page no. 49 and 52. 
 
2.8.3. 1H NMR SPECTRA 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer. Sample solutions were made in DMSO/CDCl3 solvent 
using tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons identified from H NMR spectrum and their chemical shift (δ 
ppm) were in the agreement of the structure of the molecule. J values were calculated 
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to identify o, m and p coupling. In some cases, aromatic protons were obtained as 
multiplet. 1H NMR spectral interpretation can be discussed as under.  
 
1H NMR OF (BENZOFURAN-2-YL)(4,5-DIHYDRO-3,5-DIPHENYLPYRAZOL-
1-YL)METHANONE (SBF-01): 
 
N
N
O
O
HHH
H
H
HH
H
H
H
H
H
H
H
HH
H
H
123
4
5 6
7
8
9
10
11 12
13
14 15
16
17
18
 
 
1. The one proton no. 1 and proton no. 2 of the methylene group gave a multiplet 
at 3.11 δ ppm-3.88 δ ppm.  It bit a down field due to the nitrogen atom. And 
its two protons are divided in 1H and 1H it shows in spectra. 
2. The deshielded proton no. 3 of pyrazole ring it gave a multiplet and it shows 
on down field at 5.80 δ ppm-5.84 δ ppm due to the effect of nitrogen atom of 
pyrazole ring. 
3. The aromatic ring of the two phenyl ring attached with pyrazole, in two phenyl 
ring proton no. 10, 11, 12, 15, 16 and 17 are on same atmosphere so these six 
protons gave a multiplet at 7.24 δ ppm-7.31 δ ppm it shows in spectra. 
4. The proton no. 8 of Benzofuran ring gave a characteristic singlet at 8.12 δ 
ppm. 
5. The aromatic ring of proton no. 6, 9 and 13 of three protons gave a multiplet at 
7.49 δ ppm. 
6. The aromatic ring of proton no. 7, 14 and 18 of three proton gave a multiplet 
at 7.78 δ ppm-7.84 δ ppm. 
7. The aromatic ring of proton no. 4 gave a multiplet at 7.54 δ ppm -7.59 δ ppm. 
8. The aromatic ring of proton no. 5 gave a multiplet at 7.39 δ ppm-7.43 δ ppm. 
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Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound SBF-01 has been confirmed. Spectrum is given on page no. 50.  
 
1H NMR OF (BENZOFURAN-2-YL) (4,5-DIHYDRO-3-PHENYL-5-P-
TOLYLPYRAZOL-1-YL) METHANONE (SBF-02): 
 
N
N
O
O
HHH
H
H
HH
H
H
H
H
H
H
H
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1. The proton no. 11 of methyl group gave a characteristic singlet at 2.28 δ ppm. 
2. The proton no. 1 and 2 of the methylene group gave a multiplate at 3.20 δ 
ppm-3.82 δ ppm.  It bit a down field due to the nitrogen atom. And its 2 
protons are divided in 1H and 1H it shows in spectra. 
3. The deshielded proton no. 3 of pyrazole it gave a multiplet and it shows on 
down field at 5.79 δ ppm-5.83 δ ppm due to the effect of nitrogen atom of 
pyrazole ring. 
4. The proton no. 8 of Benzofuran ring gave a characteristic singlet at 8.03 δ 
ppm. 
5. The proton no. 4 gave a doublet at 7.57 δ ppm. - 7.59 δ ppm. And J value for 
this proton calculated and found to be 8.0 Hz, suggesting it is ortho coupled. 
6. The proton no. 7 gave a doublet at 7.74 δ ppm. - 7.76 δ ppm. And J value for 
this proton calculated and found to be 8.0 Hz, suggesting it is ortho coupled. 
7. The proton no. 14 and 18 of two proton gave a triplet at 7.27 δ ppm-7.42 δ 
ppm it shown on expanded spectra. 
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8. The proton no. 9 and 13 of two proton gave a doublet at 7.10 δ ppm-7.12 δ 
ppm and J value is 8.0 Hz, it suggests an ortho coupling. 
9. The proton no. 10 and 12 of two proton gave a doublet at 7.19 δ ppm-7.21 δ 
ppm and J value is 8.0 Hz, it suggests an ortho coupling. 
10. The proton no. 5 and 6 gave a double doublet at 7.82 δ ppm - 7.84 δ ppm it 
shown on expanded spectra. and J value is 8.0 Hz, it suggests ortho coupling. 
11. The proton no. 15, 16 and 17 of three protons gave a multiplet at 7.46 δ ppm -
7.51 δ ppm shown on expanded region. 
 
Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound SBF-02 has been confirmed. Spectrum is given on page no. 53. 
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2.8.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds. The spectral and elemental analysis data are given for individual 
compounds. 
  
2.9     ANALYTICAL DATA 
 
(Benzofuran-2-yl)(4,5-dihydro-3,5-diphenylpyrazol-1-yl)methanone  (SBF-01):   
Yield: 72%,  IR (KBr, cm-1): 3059 (Ar. C-H stretching), 2920 (Aliphatic–CH2 
stretching), 1691 (C=O stretching), 1641 (-C=N of pyrazole ring), 1545 (Ar. -C-C- 
stretching), 1186 (-C-N of pyrazole ring), 1109 (-C-O-C- furan ring), 962 (Ar. -C-H 
i.p. deformation); 1H NMR (400Hz-DMSO-d6 ) δ (ppm) : 3.25 (1H, m), 3.88 (1H, m), 
5.84 (1H, m), 7.31 (6H, m), 7.43 (1H, m), 7.49 (3H, m), 7.59 (1H, m), 7.84 (3H, m), 
8.12 (1H, s);  MS m/z = 366 (M+); Anal. Calcd. for C24H18N2O2: C, 78.67; H, 4.95; N, 
7.65; O, 8.73. Found: C, 78.64; H, 4.92; N, 7.61; O, 8.70%. 
 
(Benzofuran-2-yl)(4,5-dihydro-3-phenyl-5-p-tolylpyrazol-1-yl)methanone(SBF-02): 
Yield: 76%, IR (KBr, cm-1): 3059 (Ar. -C-H stretching), 2941 (Aliphatic -CH2 
stretching), 1695 (-C=O stretching), 1637 (-C=N of pyrazole ring), 1546 (Ar. -C-C- 
stretching), 1184 (-C-N of pyrazole ring), 1109 (-C-O-C- furan ring), 960 (Ar. -C-H 
i.p. deformation); 1H NMR (400Hz-CDCl3 ) δ (ppm): 2.28 (3H, s), 3.26 (1H, m), 3.82 
(1H, m), 5.83 (1H, m), 7.12 (2H, d, J=8.0 Hz), 7.21 (2H, d, J=8.0 Hz), 7.30 (1H, t), 
7.42 (1H, t), 7.51 (3H, m), 7.59 (1H, d, J=8.0 Hz), 7.76 (1H, d, J=8.0 Hz), 7.84 (2H, 
m), 8.03 (1H, s); MS m/z = 380 (M+); Anal. Calcd. for C25H20N2O2: C, 78.93; H, 5.30; 
N, 7.36; O, 8.41. Found: C, 78.91; H, 5.26; N, 7.30; O, 8.40%. 
 
(Benzofuran-2-yl)(4,5-dihydro-5-(4-nitrophenyl)-3-phenylpyrazol-1yl)methanone(SBF-
03):  
Yield: 70%, IR (KBr, cm-1): 3032 (Ar. -C-H stretching), 2935 (Aliphatic -CH2 
stretching), 1697 (-C=O stretching), 1600 (-C=N of pyrazole ring), 1518 (Ar. -C-C- 
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stretching), 1184 (-C-N of pyrazole ring), 1109 (-C-O-C- furan ring), 964 (Ar. -C-H 
i.p. deformation);  MS m/z = 411 (M+); Anal. Calcd. for C24H17N3O4: C, 70.07; H, 
4.16; N, 10.21; O, 15.56. Found: C, 70.04; H, 4.12; N, 10.20; O, 15.51%. 
 
(Benzofuran-2-yl)(4,5-dihydro-5-(3,4-dimethoxyphenyl)-3-phenylpyrazol-1-yl) 
methanone  (SBF-04):  
Yield: 74%, IR (KBr, cm-1): 3044 (Ar. -C-H stretching), 2922 (Aliphatic -CH2 
stretching), 1690 (-C=O stretching), 1638 (-C=N of pyrazole ring), 1543 (Ar. -C-C- 
stretching), 1180 (-C-N of pyrazole ring), 1112 (-C-O-C- furan ring), 962 (Ar. -C-H 
i.p. deformation); MS m/z = 426 (M+); Anal. Calcd. for C26H22N2O4: C, 73.23; H, 
5.20; N, 6.57; O, 15.01. Found: C, 73.22; H, 5.20; N, 6.51; O, 15.00%. 
 
(Benzofuran-2-yl)(5-(4-fluorophenyl)-4,5-dihydro-3-phenylpyrazol-1-yl)methanone 
(SBF-05):   
Yield: 72%, IR (KBr, cm-1): 3055 (Ar. -C-H stretching), 2922 (Aliphatic -CH2 
stretching), 1694 (-C=O stretching), 1646 (-C=N of pyrazole ring), 1540 (Ar. -C-C- 
stretching), 1188 (-C-N of pyrazole ring), 1114 (-C-O-C- furan ring), 966 (Ar. -C-H 
i.p. deformation), 1018 (-C-F stretching);  MS m/z = 384 (M+), 386 (M+2 ); Anal. 
Calcd. for C24H17FN2O2: C, 74.99; H, 4.46; N, 7.29; O, 8.32. Found: C, 74.96; H, 
4.42; N, 7.22; O, 8.31%. 
 
 (Benzofuran-2-yl)(5-(4-chlorophenyl)-4,5-dihydro-3-phenylpyrazol-1-yl)methanone 
(SBF-06):   
Yield: 78%, IR (KBr, cm-1): 3062 (Ar. -C-H stretching), 2926 (Aliphatic -CH2 str.),  
1688 (-C=O stretching), 1641 (-C=N of pyrazole ring), 1547 (Ar. -C-C- stretching),  
1182 (-C-N of pyrazole ring), 1104 (-C-O-C- furan ring), 966 (Ar. -C-H i.p. 
deformation), 743 (-C-Cl stretching); MS m/z = 401 (M+), 403 (M+2 ); Anal. Calcd. for 
C24H17ClN2O2: C, 71.91; H, 4.27; N, 6.99; O, 7.98. Found: C, 71.88; H, 4.24; N, 6.92; 
O, 7.91%. 
 
(Benzofuran-2-yl)(5-(2-chlorophenyl)-4,5-dihydro-3-phenylpyrazol-1-yl)methanone 
(SBF-07):   
Yield: 70%, IR (KBr, cm-1): 3044 (Ar. -C-H stretching), 2930 (Aliphatic -CH2 
stretching), 1694 (-C=O stretching), 1643 (-C=N of pyrazole ring), 1548 (Ar. -C-C- 
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stretching), 1183 (-C-N of pyrazole ring), 1110 (-C-O-C- furan ring), 961 (Ar. -C-H 
i.p. deformation), 745 (-C-Cl stretching); MS m/z = 401 (M+), 403 (M+2 ); Anal. 
Calcd. for C24H17ClN2O2: C, 71.91; H, 4.27; N, 6.99; O, 7.98. Found: C, 71.90; H, 
4.22; N, 6.92; O, 7.96%. 
 
(Benzofuran-2-yl)(4,5-dihydro-5-(4-methoxyphenyl)-3-phenylpyrazol-1-yl)methanone 
(SBF-08):   
Yield: 76%, IR (KBr, cm-1): 3052 (Ar. -C-H stretching), 2928 (Aliphatic -CH2 
stretching), 1692 (-C=O stretching), 1648 (-C=N of pyrazole ring), 1539 (Ar. -C-C- 
stretching), 1184 (-C-N of pyrazole ring), 1112 (-C-O-C- furan ring), 961 (Ar. -C-H 
i.p. deformation); MS m/z = 396 (M+); Anal. Calcd. for C25H20N2O3: C, 75.74; H, 
5.08; N, 7.07; O, 12.11. Found: C, 75.71; H, 5.02; N, 7.01; O, 12.10%. 
 
(Benzofuran-2-yl)(3-(4-chlorophenyl)-4,5-dihydro-5-phenylpyrazol-1-yl)methanone 
(SBF-11):   
Yield: 70%, IR (KBr, cm-1): 3064 (Ar. -C-H stretching), 2962 (Aliphatic -CH2 
stretching), 1695 (-C=O stretching), 1641 (-C=N of pyrazole ring), 1548 (Ar. -C-C- 
stretching), 1186 (-C-N of pyrazole ring), 1114 (-C-O-C- furan ring), 964 (Ar. -C-H 
i.p. deformation); 756 (-C-Cl stretching);  MS m/z = 401 (M+), 403 (M+2 ); Anal. 
Calcd. for C24H17ClN2O2: C, 71.91; H, 4.27; N, 6.99; O, 7.98. Found: C, 71.87; H, 
4.24; N, 6.96; O, 7.97%. 
 
(3,5-bis(4-chlorophenyl)-4,5-dihydropyrazol-1-yl)(Benzofuran-2-yl)methanone  
(SBF-12):   
Yield: 76%, IR (KBr, cm-1): 3061 (Ar. -C-H stretching), 2924 (Aliphatic -CH2 
stretching), 1691 (-C=O stretching), 1643 (-C=N of pyrazole ring), 1550 (Ar. -C-C- 
stretching), 1180 (-C-N of pyrazole ring), 1116 (-C-O-C- furan ring), 963 (Ar. -C-H 
i.p. deformation), 744 (-C-Cl stretching);  MS m/z =  435 (M+), 437 (M+2 ); Anal. 
Calcd. for C24H16Cl2N2O2: C, 66.22; H, 3.70; N, 6.44; O, 7.35. Found: C, 66.21; H, 
3.66; N, 6.44; O, 7.31%. 
 
(Benzofuran-2-yl)(3-(4-chlorophenyl)-4,5-dihydro-5-(4-methoxyphenyl)pyrazol-1-
yl)methanone  (SBF-13):   
Yield: 68%, IR (KBr, cm-1): 3052 (Ar. -C-H stretching), 2921 (Aliphatic -CH2-  
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stretching), 1691 (-C=O stretching), 1646 (-C=N of pyrazole ring), 1547 (Ar. -C-C- 
stretching), 1181 (-C-N of pyrazole ring), 1109 (-C-O-C- furan ring), 968 (Ar. -C-H 
i.p. deformation), 748 (-C-Cl stretching);  MS m/z =  431 (M+), 433 (M+2 ); Anal. 
Calcd. for C25H19ClN2O3: C, 69.69; H, 4.44; N, 6.50; O, 11.14. Found: C, 69.65; H, 
4.46; N, 6.44; O, 11.12%. 
 
(Benzofuran-2-yl)(3-(4-chlorophenyl)-4,5-dihydro-5-(4-nitrophenyl)pyrazol-1-
yl)methanone  (SBF-14):   
Yield: 74%, IR (KBr, cm-1): 3050 (Ar. -C-H stretching), 2930 (Aliphatic -CH2 
stretching), 1688 (-C=O stretching), 1640 (-C=N of pyrazole ring), 1546 (Ar. -C-C- 
stretching), 1181 (-C-N of pyrazole ring), 1115 (-C-O-C- furan ring), 963 (Ar. -C-H 
i.p. deformation), 745 (-C-Cl stretching);  MS m/z = 446 (M+), 448 (M+2 ); Anal. 
Calcd. for C24H16ClN3O4: C, 64.65; H, 3.62; N, 9.42; O, 14.35. Found: C, 64.62; H, 
3.60; N, 9.40; O, 14.31%. 
 
(Benzofuran-2-yl)(5-(2-chlorophenyl)-3-(4-chlorophenyl)-4,5-dihydropyrazol-
1-yl)methanone  (SBF-15):   
Yield: 70%, IR (KBr, cm-1): 3064 (Ar. -C-H stretching), 2926 (Aliphatic -CH2 str.), 
1696 (-C=O stretching), 1641 (-C=N of pyrazole ring), 1540 (Ar. -C-C- stretching),  
1186 (-C-N of pyrazole ring), 1109 (-C-O-C- furan ring), 957 (Ar. -C-H i.p. 
deformation), 748 (-C-Cl stretching);  MS m/z = 435 (M+), 437 (M+2 ); Anal. Calcd. 
for C24H16Cl2N2O2: C, 66.22; H, 3.70; N, 6.44; O, 7.35. Found: C, 66.20; H, 3.71; N, 
6.43; O, 7.30%. 
 
(Benzofuran-2-yl)(3-(4-chlorophenyl)-4,5-dihydro-5-(3,4-dimethoxyphenyl)pyrazol-1-
yl) methanone  (SBF-16):  
Yield: 72%, IR (KBr, cm-1): 3063 (Ar. -C-H stretching), 2928 (Aliphatic -CH2 
stretching), 1694 (-C=O stretching), 1638 (-C=N of pyrazole ring), 1541 (Ar. -C-C- 
stretching), 1182 (-C-N of pyrazole ring), 1109 (-C-O-C- furan ring), 958 (Ar. -C-H 
i.p. deformation), 742 (-C-Cl stretching); MS m/z =  461 (M+), 463 (M+2 ); Anal. 
Calcd. for C26H21ClN2O4: C, 67.75; H, 4.59; N, 6.08; O, 13.89. Found: C, 67.71; H,  
4.55; N, 6.09; O, 13.80%. 
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(Benzofuran-2-yl)(3-(4-chlorophenyl)-4,5-dihydro-5-p-tolylpyrazol-1-yl)methanone 
(SBF-17):   
Yield: 78%, IR (KBr, cm-1): 3061 (Ar. -C-H stretching), 2925 (Aliphatic -CH2 
stretching), 1696 (-C=O stretching), 1648 (-C=N of pyrazole ring), 1541 (Ar. -C-C- 
stretching), 1180 (-C-N of pyrazole ring), 1111 (-C-O-C- furan ring), 967 (Ar. -C-H 
i.p. deformation), 750 (-C-Cl stretching);  MS m/z = 415 (M+), 417 (M+2 ); Anal. 
Calcd. for C25H19ClN2O2: C, 72.37; H, 4.62; N, 6.75; O, 7.71. Found: C, 72.32; H, 
4.60; N, 6.70; O, 7.70%. 
 
(Benzofuran-2-yl)(3-(4-chlorophenyl)-5-(4-fluorophenyl)-4,5-dihydropyrazol-1-yl) 
methanone  (SBF-18):   
Yield: 68%, IR (KBr, cm-1): 3048 (Ar. -C-H stretching), 2927 (Aliphatic -CH2 
stretching), 1695 (-C=O stretching), 1650 (-C=N of pyrazole ring), 1541 (Ar. -C-C- 
stretching), 1190 (-C-N of pyrazole ring), 1115 (-C-O-C- furan ring), 968 (Ar. -C-H 
i.p. deformation), 746 (-C-Cl stretching), 1020 (-C-F stretching);  MS m/z = 419 (M+), 
421 (M+2 ); Anal. Calcd. for C24H16ClFN2O2: C, 68.82; H, 3.85; N, 6.69; O, 7.64. 
Found: C, 68.80; H, 3.81; N, 6.62; O, 7.61%. 
 
(Benzofuran-2-yl)(3-(4-fluorophenyl)-4,5-dihydro-5-phenylpyrazol-1-yl)methanone 
(SBF-21):   
Yield: 72%, IR (KBr, cm-1): 3051 (Ar. -C-H stretching), 2927 (Aliphatic -CH2 
stretching), 1694 (-C=O stretching), 1648 (-C=N of pyrazole ring), 1536 (Ar. -C-C- 
stretching), 1186 (-C-N of pyrazole ring), 1109 (-C-O-C- furan ring), 955 (Ar. -C-H 
i.p. deformation), 1018 (-C-F stretching); MS m/z = 384 (M+), 386 (M+2 ); Anal. 
Calcd. for C24H17FN2O2: C, 74.99; H, 4.46; N, 7.29; O, 8.32. Found: C, 74.96; H, 
4.40; N, 7.25; O, 8.30%. 
 
(Benzofuran-2-yl)(5-(4-chlorophenyl)-3-(4-fluorophenyl)-4,5-dihydropyrazol-1-yl) 
methanone  (SBF-22):   
Yield: 76%, IR (KBr, cm-1): 3036 (Ar. -C-H stretching), 2922 (Aliphatic -CH2 
stretching), 1686 (-C=O stretching), 1643 (-C=N of pyrazole ring), 1548 (Ar. -C-C- 
stretching), 1182 (-C-N of pyrazole ring), 1112 (-C-O-C- furan ring), 954 (Ar. -C-H 
i.p. deformation), 740 (-C-Cl stretching), 1020 (-C-F stretching);  MS m/z = 419 (M+), 
421(M+2 ); Anal. Calcd. for C24H16ClFN2O2: C, 68.82; H, 3.85; N, 6.69; O, 7.64.  
Chapter – 2                                                                               Synthesis of Benzofuran-2-yl….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                       46 
Found: C, 68.80; H, 3.81; N, 6.65; O, 7.60%. 
 
(Benzofuran-2-yl)(3-(4-fluorophenyl)-4,5-dihydro-5-(4-methoxyphenyl)pyrazol-1-yl) 
methanone  (SBF-23):   
Yield: 74%, IR (KBr, cm-1): 3050 (Ar. -C-H stretching), 2918 (Aliphatic -CH2 
stretching), 1696 (-C=O stretching), 1644 (-C=N of pyrazole ring), 1546 (Ar. -C-C- 
stretching), 1196 (-C-N of pyrazole ring), 1115 (-C-O-C- furan ring), 964 (Ar. -C-H 
i.p. deformation), 1020 (-C-F stretching); MS m/z =  414 (M+), 416 (M+2 ); Anal. 
Calcd. for C25H19FN2O3: C, 72.45; H, 4.62; N, 6.76; O, 11.58. Found: C, 72.42; H, 
4.60; N, 6.70; O, 11.51%. 
 
(Benzofuran-2-yl)(3-(4-fluorophenyl)-4,5-dihydro-5-(4-nitrophenyl)pyrazol-1-yl) 
methanone  (SBF-24):   
Yield: 76%, IR (KBr, cm-1): 3063 (Ar. -C-H stretching), 2921 (Aliphatic -CH2 
stretching), 1694 (-C=O stretching), 1641 (-C=N of pyrazole ring), 1547 (Ar. -C-C- 
stretching), 1190 (-C-N of pyrazole ring), 1114 (-C-O-C- furan ring), 964 (Ar. -C-H 
i.p. deformation), 1028 (-C-F stretching); MS m/z = 429 (M+), 431 (M+2 ); Anal. 
Calcd. for C24H16FN3O4: C, 67.13; H, 3.76; N, 9.79; O, 14.90. Found: C, 67.10; H, 
3.71; N, 9.77; O, 14.88%. 
 
(Benzofuran-2-yl)(5-(2-chlorophenyl)-3-(4-fluorophenyl)-4,5-dihydropyrazol-1-yl) 
methanone  (SBF-25):  
Yield: 66%, IR (KBr, cm-1): 3048 (Ar. -C-H stretching), 2926 (Aliphatic -CH2 str.),  
1697 (-C=O stretching), 1641 (-C=N of pyrazole ring), 1541 (Ar. -C-C- stretching),  
1188 (-C-N of pyrazole ring), 1112 (-C-O-C- furan ring), 960 (Ar. -C-H i.p. def.),  
744 (-C-Cl stretching), 1022 (-C-F stretching);  MS m/z = 419 (M+), 421 (M+2 ); Anal. 
Calcd. for C24H16ClFN2O2: C, 68.82; H, 3.85; N, 6.69; O, 7.64. Found: C, 68.80; H, 
3.81; N, 6.66; O, 7.61%. 
 
(Benzofuran-2-yl)(3-(4-fluorophenyl)-4,5-dihydro-5-(3,4-dimethoxyphenyl)pyrazol-1-
yl) methanone  (SBF-26):   
Yield: 76%, IR (KBr, cm-1): 3038 (Ar -C-H stretching), 2938 (Aliphatic -CH2 -  
stretching), 1690 (-C=O stretching), 1655 (-C=N of pyrazole ring), 1544(Ar. -C-C-  
stretching), 1184 (-C-N of pyrazole ring), 1112 (-C-O-C- furan ring), 960 (Ar. -C-H  
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i.p. deformation); 1021 (-C-F stretching);  MS m/z =  444 (M+), 446 (M+2 ); Anal. 
Calcd. for C26H21FN2O4: C, 70.26; H, 4.76; N, 6.30; O, 14.40. Found: C, 70.22; H, 
4.70; N, 6.31; O, 14.38%. 
 
(Benzofuran-2-yl)(3-(4-fluorophenyl)-4,5-dihydro-5-p-tolylpyrazol-1-yl)methanone 
(SBF-27):   
Yield: 78%, IR (KBr, cm-1): 3044 (Ar -C-H stretching), 2936 (Aliphatic -CH2 
stretching), 1689 (-C=O stretching), 1651 (-C=N of pyrazole ring), 1548 (Ar. -C-C- 
stretching), 1180 (-C-N of pyrazole ring), 1112 (-C-O-C- furan ring), 966 (Ar. -C-H 
i.p. deformation), 1024(-C-F stretching);  MS m/z = 398 (M+), 400 (M+2 ); Anal. 
Calcd. for C25H19FN2O2: C, 75.36; H, 4.81; N, 7.03; O, 8.03. Found: C, 75.30; H, 
4.81; N, 7.00; O, 8.01%. 
 
(3,5-bis(4-fluorophenyl)-4,5-dihydropyrazol-1-yl)(Benzofuran-2-yl)methanone (SBF-
28):   
Yield: 74%, IR (KBr, cm-1): 3042 (Ar -C-H stretching), 2935 (Aliphatic -CH2 str.), 
1696 (-C=O stretching), 1656 (-C=N of pyrazole ring), 1542(Ar. -C-C- stretching), 
1180 (-C-N of pyrazole ring), 1115 (-C-O-C- furan ring), 966 (Ar. -C-H i.p. 
deformation), 1022 (-C-F stretching);  MS m/z = 402 (M+), 404 (M+2 ); Anal. Calcd. 
for C24H16F2N2O2: C, 71.64; H, 4.01; N, 6.96; O, 7.95. Found: C, 71.60; H, 4.01; N, 
6.92; O, 7.90%. 
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2.10    RESULTS AND DISCUSSION      
 
Most of the methods for the synthesis of pyrazoles involve approaches based 
on either cyclocondensation of 1,3-dicarbonyl compounds and their equivalent 1,3-
dienophilic synthons such as propargylic ketones, dialkylamino/alkoxy/chloro ketones 
with arylhydrazines or intermolecular cycloadditions of 1,3-dipoles to alkynes.  
 
In this chapter, known methods were adopted. for the preparation of 
benzofuran-2-yl (4, 5- dihydro-3, 5-substituted diphenylpyrazol-1- yl) methanone 
from Benzofuran hydrazide and substituted chalcones by using glacial acetic acid.  
 
2.11    CONCLUSION 
 
Pyrazoles belong to an important class of heterocycles due to their biological 
and pharmacological activities49,50 such as anti-inflammatory,51 herbicidal,52 
fungicidal,53 bactericidal,53 plant growth inhibitory,52 antipyretic,54 and protein kinase 
inhibitory activities.55 Also, they are the key starting materials for the synthesis of 
commercial aryl/ hetero-arylazopyrazolone dyes.56,57 
 
This chapter involves some interesting chemical aspects as far as organic 
chemical synthesis is concerned. The New chemical entities synthesized in this 
chapter were screened for MDR (Multidrug Resistance) study. The results of which 
are discussed separately in Chapter-7. 
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2.12    REPRESENTATIVE SPECTRA 
 
2.12.1 Mass Spectrum of SBF-01 
 
 
 
2.12.2 IR Spectrum of SBF-01 
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2.12.3 1H NMR Spectrum of SBF-01 
 
 
 
  Expanded 1H-NMR Spectrum of SBF-01 
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  Expanded 1H-NMR Spectrum of SBF-01 
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2.12.4 Mass Spectrum of SBF-02 
 
 
2.12.5 IR Spectrum of SBF-02 
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2.12.6        1H NMR Spectrum of SBF-02 
 
 
    Expanded 1H-NMR Spectrum of SBF-02 
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  Expanded 1H-NMR Spectrum of SBF-02 
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3.1 INTRODUCTION 
 
Valproic acid is simple branched chain carboxylic acid used in epilepsy. 
Valproic acid increases GABA (γ-amino butyric acid) synthesis and release and 
potentiates by this mechanism GABA ergic transmission in specific brain regions. 
Valproic acid also reduces the release of excitatory amino acid β-hydroxy butyric acid 
and to attenuate neuronal excitation mediated by activation of N-methyl-D- 
aspartames glutamate receptors. Valproic acid is a broad-spectrum antiepileptic drug 
effective against all seizure types. 
 
Valproic acid (by its official name 2-propylvaleric acid) was first synthesized 
in 1882 by Burton as an analogue of valeric acid, found naturally in valerian. A clear 
liquid fatty acid at room temperature, for many decades its only use was in 
laboratories as a "metabolically inert" solvent for organic compounds. In 1962, the 
French researcher Pierre Eymard serendipitously discovered the anticonvulsant 
properties of Valproic acid while using it as a vehicle for a number of other 
compounds that were being screened for anti-seizure activity. He found that it 
prevented pentylenetetrazol-induced convulsions in rodents. Since then it has also 
been used for migraine and bipolar disorder.  
 
3.2 VALPROATE: PAST, PRESENT, AND FUTURE   
 
Preclinical studies have been carried out during the past four decades to 
investigate the different mechanisms of action of valproate (VPA). The mechanisms 
of VPA which seem to be of clinical importance include increased GABA ergic 
activity, reduction in excitatory neurotransmission, and modification of monoamines. 
These mechanisms are discussed in relation to the various clinical uses of the drug. 
VPA is widely used as an antiepileptic drug with a broad spectrum of activity. In 
patients, VPA possesses efficacy in the treatment of various epileptic seizures such as 
absence, myoclonic, and generalized tonic-clonic seizures. It is also effective in the 
treatment of partial seizures with or without secondary generalization and acutely in 
status epileptics. The pharmacokinetic aspects of VPA and the frequent drug 
interactions between VPA and other drugs are discussed. The available methods for 
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the determination of VPA in body fluids are briefly evaluated. At present, 
investigations and clinical trials are carried out and evaluated to explore the new 
indications for VPA in other conditions such as in psychiatric disorders, migraine and 
neuropathic pain. Furthermore, the toxicity of VPA, both regarding commonly 
occurring side effects and potential idiosyncratic reactions are described. Derivatives 
of VPA with improved efficacy and tolerability are in development.  
 
 
3.3 CHEMICAL STRUCTURE OF VALPROIC ACID THEIR 
DERIVATIVES 
  
 Valproic acid Molecular formula is C8H16O2 and molecular weight is 144.2 
and other derivatives of Valproic acid are Sodium Valproate molecular formula is 
C8H15NaO2 and molecular weight is 166.2, Semi sodium Valproate molecular formula 
is C16H31NaO4 and molecular weight is 310.4, Valproate Pivoxil molecular formula is 
C14H26O4 and molecular weight is 258.4, Valpromide molecular formula is C8H17NO 
and molecular weight is 143.2. 
 
Chemical names of Valproic acid: 
2-Propylpentanoic acid, 2-Propylvaleric acid, Di-n-dipropylacetic acid 
Chemical names of Sodium Valproate: 
Sodium 2-propylvalerate, Sodium 2-propylpentanoate 
Chemical names of Semi sodium Valproate: 
2-Propylvaleric acid-sodium 2-propylvalerate, Sodium hydrogen bis(2-propylvalerate) 
Chemical names of Valproate Pivoxil: 
Hydroxymethyl 2-propylvalerate pivalate 
Chemical names of Valpromide: 
Dipropylacetamide, 2-propylvaleramide 
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3.4 PHYSICAL PROPERTIES OF VALPROIC ACID 
  
 Valproic acid is Colorless to pale yellow viscous liquid. It is It is slightly 
soluble in water (1.2 mg/mL); fully soluble in acetone, chloroform, ether and methyl 
alcohol. Valproic acid is Store in airtight containers and protect from light. Valproic 
acid capsules should be stored at 15 to 30°C and freezing should be avoided. 
 
3.5 USES OF VALPROIC ACID 
  
 Valproic acid is used solely or in combination with other anticonvulsants in 
the treatment of simple (petit mal) and complex absence seizures. Valproate may be 
effective against myoclonic and atonics seizures in young children and considered. 
 
 
3.6 SYNTHESIS OF VALPROIC ACID 
 
 
CN
OO
2CH3ONa
CN
OO
Na
Na
H3C
Br
2
KOC4H9t
-2NaBr
CN
OO
Acid 
HydrolysisNaOH
CN
COOH
Hydrolysis
alkaline
COOH
COOH
De-carboxylation
-CO2
O
OH
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3.7 ACTION ON MECHANISM OF VALPROIC ACID   
 
 VALPROIC ACID (VPA) is indicated for the treatment of epilepsy and 
bipolar disorder and in the prevention of migraine headaches. VPA has also become 
more widely prescribed due to several off-label indications such as in the treatment of 
neuropathic pain and cancer.1,2 Despite VPA being well tolerated and having a low 
incidence of serious side effects, one concern with VPA therapy is weight gain. A 
prospective study identified that 37% of female patients with epilepsy developed 
obesity, as defined as a body mass index (BMI) greater than 25, after 1 yr of treatment 
with VPA.3 Numerous retrospective and cross-sectional analyses also report that 
treatment with VPA is associated with a significant increase in weight ranging from 5 
to 49 kg.4, 5, 6, 7 Studies examining VPA-induced weight gain have been conducted 
predominantly in adult women because VPA can induce a number of reproductive 
endocrine abnormalities that include hyperandrogenism, menstrual disturbances, 
weight gain, and/or polycystic ovaries.8, 9,10 Fifty-two percent of males treated with 
VPA, however, also have BMI scores within the obesity category,11 and youth and 
adolescents treated with VPA are reported to have BMI scores over expected age 
norms.12,13,14 Similarly, a prospective double-blind comparison of the incidence and 
magnitude of weight gain in patients receiving VPA vs. lamotrigine monotherapy 
demonstrated that weight gain was greater for those patients treated with VPA and 
was significant within 10 wk of treatment onset.15,16 Weight gain associated with VPA 
treatment is of great concern due to its physical and psychological consequences.17 
Notably, obesity leads to increase risk for numerous other diseases, such as diabetes 
mellitus, coronary heart disease,18 and increased noncompliance with 
pharmacotherapy in psychiatric patients.19  
 
The mechanism underlying VPA-induced weight gain has not been elucidated. 
Age, gender, medical condition, dose and serum concentrations of VPA and family 
history of body weight problems are not significantly correlated with the gain in 
weight associated with VPA treatment.20, 21 In attempts to generate animal models of 
VPA-induced weight gain, VPA has been shown to induce a significant increase in 
body weight in female rhesus monkeys 22; however, we and others have demonstrated 
that VPA does not cause weight gain in rodents.23, 24, 25 The etiology of VPA-induced 
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mechanism independent of new protein synthesis. These results show that VPA can 
have direct effects on adiposities that may contribute to altered energy balance in 
patients treated with VPA. 
 
 
3.8 ANTI-CANCER ACTIVITY OF VALPROIC ACID  
 
The short chain fatty acid valproic acid (VPA, 2-propylpetanoic acid) is 
approved for the treatment of epilepsia, bipolar disorders and migraine and clinically 
used for schizophrenia. In 1999, the first clinical anti-cancer trial using VPA was 
initiated. Currently, VPA is examined in numerous clinical trials for different 
leukemia’s and solid tumor entities. In addition to clinical assessment, the 
experimental examination of VPA as anti-cancer drug is ongoing and many questions 
remain unanswered. Although other mechanisms may also contribute to VPA-induced 
anti-cancer effects, inhibition of histone deacetylase appears to play a central role. 
This review focuses on recent developments regarding the anti-cancer activity of 
VPA. 
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3.A.1    AIM OF CURRENT WORK 
 
Over and above, the known antiepileptic properties of Valproic acids and its 
salt, renewed interest of these molecules in anticancera and antiviralb therapy has led 
wide interest in newer derivatives of these molecules. 
 
In the current chapter, the Valproic ‘Core’ structure was used as a starting 
material to arrive at many molecules with different pharmacophores which obeys 
Lipinski’s rule. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
a Current Pharmaceutical Design, Volume 13, Number 33, November 2007, pp. 3378-3393(16). 
b Clin Pharmacokinet. 1996 May;30(5):385-401. 
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3.A.2    REACTION SCHEMES 
 
3.A.2.1 PREPARATION OF METHYL-2-PROPYL PENTANOATE 
 
O
OH CH3OH
Glacial acetic acid
600-700C
O
OCH3
 
 
3.A.2.2 PREPARATION OF 2-PROPYL PENTANOHYDRAZIDE 
 
NH2NH2.H2O
1100C
O
N
H
NH2O
OCH3
 
 
3.A.2.3 PREPARATION OF N'-(2-CHLOROACETYL)-2-PROPYL PENTANEHYDRAZIDE 
 
Cl
O
Cl
Base
DMF
0-50C
O
N
H
NH
O
Cl
O
N
H
NH2
 
 
3.A.2.4 PREPARATION OF N’-(2-(SUBSTITUTED AMINO)-ACETYL)-2-
PROPYL PENTANEHYDRAZIDE 
 
NH
R2
R1
RT
O
N
H
NH
O
N
O
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H
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Cl R2
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3.A.3    PLAUSIBLE REACTION MECHANISM 
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3.A.4    EXPERIMENTAL 
 
3.A.4.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. Formation of all 
compounds was purified by using flash chromatography. IR spectra were recorded 
in Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass spectra were 
recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection Probe 
technique. 1H NMR was determined in CDCl3 solution on a Bruker Ac 400 MHz 
spectrometer. Elemental analysis of the all the synthesized compounds was carried 
out on Elemental Vario EL III Carlo Erba 1108 model and the results are in 
agreements with the structures assigned. 
 
3.A.4.2 PREPARATION OF METHYL 2-PROPYL PENTANOATE 
 
2-propyl pentanoic acid (0.01 mole) was charged into 250 ml round bottom 
flask. 15 ml of methanol was added into above flask. 3-4 drops of Con. Sulphuric acid 
was added as a catalyst. The reaction mixture was refluxed for 12-14 hours on water 
bath. The progress and the completion of the reaction were checked by silica gel-G 
F254 thin layer chromatography using hexane : ethyl acetate (4 : 6) as a mobile phase. 
After the reaction to be completed excess of methanol was removed under reduced 
pressure. The separated product was extracted using ethyl acetate (30 ml × 3), the 
combined organic layer was washed using 5% sodium bicarbonate solution (20 ml × 
2) followed by water (20 ml × 2). The organic layer was dried on anhydrous sodium 
sulphate and the solvent was removed under reduced pressure to acquire the product 
in a viscous liquid form. Yield - 90 %, B. P. – 170-172°C.c 
 
 
 
                                                 
c Dostovalova, V. I. ; Organic Magnetic Resonance 1983, V21(1), P111-19. 
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3.A.4.3 PREPARATION OF 2-PROPYL PENTANOHYDRAZIDE 
 
Methyl 2-propylpentanoate (0.01 mole) was charged into 250 ml round bottom 
flask. 15 ml of hydrazine hydrate was added into above flask. The reaction mixture 
was refluxed on water bath for 12-14 hours. The progress and the completion of the 
reaction were checked by silica gel-G F254 thin layer chromatography using hexane: 
ethyl acetate (4: 6) as a mobile phase. After the reaction to be completed, the mixture 
was cooled to room temperature to give 2-propylpentanohydrazide as a white colored 
shining fluffy product. Yield - 60 %, M. P. – 124–126°Cd.  
 
3.A.4.4 PREPARATION OF N'-(2-CHLOROACETYL)-2-PROPYL 
PENTANEHYDRAZIDE 
  
2-propylpentanohydrazide (0.01 mole) was charged into 250 ml round bottom 
flask. 10 ml of tetrahydrofuran was added to dissolve it. Then add 0.015 mole of 
triethylamine as a catalyst. And add into 0.01 mole of chloroacetyl chloride at 0-50 C. 
the reaction mixture was stirred at RT overnight. The progress and the completion of 
the reaction were checked by silica gel-G F254 thin layer chromatography using 
toluene : ethyl acetate (4: 6) as a mobile phase. After the reaction is completed, 
mixture poured into crushed ice. N'-(2-chloroacetyl)-2-propylpentanehydrazide a 
brown colored solid product.  
Similarly other compounds are also prepared. 
 
3.A.4.5 PREPARATION OF N’-(2-(SUBSTITUTED AMINO)-ACETYL)-
2-PROPYL PENTANE HYDRAZIDES 
  
N'-(2-chloroacetyl)-2-propylpentanehydrazide (0.01 mole) was charged into 
250 ml round bottom flask. 10 ml of dimethylformamide was added to dissolve it. 
Then add in to 0.03 mole of potassium carbonate as a catalyst. And add into 0.01 
mole of different secondary amines at RT. the reaction mixture was stirred at RT 
overnight. The progress and the completion of the reaction were checked by silica gel-
G F254 thin layer chromatography using hexane: ethyl acetate (3: 7) as a mobile phase.  
                                                 
d  Benoit-Guyod, Jean L. ; Chemica Therapeutica 1968, V3(5), P336-42. 
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After the reaction to completed mixture poured into crushed ice, a solid product-
comes. Finally, it was purified by Flash chromatography using hexane and ethyl- 
acetate as eluents.  
Similarly other compounds are also prepared. 
 
 
3.A.5    PHYSICAL DATA 
 
PHYSICAL DATA OF N’-(2-(SUBSTITUTED AMINO)-ACETYL)-2-
PROPYLPENTANE HYDRAZIDE (SPSC-01 TO SPSC-12) 
  
O
N
H
NH
O
N
R1
R2
 
TABLE-3.A.1 
Sr. 
No. 
Code 
Name & 
No. 
Substitutions
Molecular 
Formula 
M.W. 
MP 
0C 
Rf 
Value
01 SPSC-01 
N
H
N
 
C15H30N4O2 298 160-162 0.52 
02 SPSC-02 
N
H
N
 
C16H32N4O2 312 178-180 0.48 
03 SPSC-03 
O
H
N
 
C14H27N3O3 285 204-206 0.42 
04 SPSC-04 N
H
N
 
C20H32N4O2 360 168-170 0.50 
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05 SPSC-05 N
H
N
 
C21H34N4O2 375 172-174 0.44 
06 SPSC-06 
NH
CH3
CH3
CH3
CH3
 
C16H33N3O2 299 174-176 0.42 
07 SPSC-07 
NH
NH  
C14H28N4O2 284 150-152 0.46 
08 SPSC-08 
NH
CH3
CH3
 
C16H33N3O2 299 166-168 0.52 
09 SPSC-09 
NH
CH3
 
C17H27N3O2 305 170-172 0.38 
10 SPSC-10 
NH
 
C15H29N3O2 283 168-170 0.42 
11 SPSC-11 
NH
CH3
CH3
 
C14H29N3O2 271 178-180 0.44 
12 SPSC-12 
NH
 
C14H27N3O2 269 184-186 0.46 
 
Rf value was calculated using solvent system, Hexane : Ethyl Acetate (3: 7) 
 
 
 
 
 
 
Chapter – 3 Section-A                                                           Synthesis of N’-(2-(substituted ..... 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     77 
3.A.6    SPECTRAL DISCUSSION 
 
3.A.6.1    MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. SPSC-01 
and SPSC-02 of Mass spectra are given on page no. 83 and 85. 
 
3.A.6.2 IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT IR 
8400 spectrophotometer using Diffused Reflectance Attachment (DRA) System using 
Potassium Bromide.  
 
-N-H stretching frequency was observed near 3400 cm-1 in case of SPSC-01 to 
SPSC-12. There are two carbonyl groups present in all the compounds but due to the 
same environment, the peaks are merged in the region of 1680 cm-1. C-H stretching 
frequencies were observed between 2810 cm-1 and 3000 cm-1, N-H bending frequency 
were observed near 1600 cm-1. SPSC-01 and SPSC-02 of IR spectra are given on page 
no. 83 and 85. 
 
3.A.6.3 1H NMR SPECTRA 
 
1H spectra of the synthesized compounds were recorded on Bruker Avance II 
400 spectrometer. Sample solutions were made in DMSO-d6/CDCl3 solvent using 
tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons identified from proton NMR spectrum and their chemical shift (δ 
ppm) were in the agreement of the structure of the molecule. J values were calculated 
to identify o, m and p coupling. 1H NMR spectral interpretation can be discussed as 
under. 
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1H NMR OF N'-(2-(4-METHYLPIPERAZIN-1-YL) ACETYL)-2-
PROPYLPENTANEHYDRAZIDE (SPSC-01) 
 
O
N
H
NH
O
N N CH3
1
23
45
6
7
8
9
10
11
12
1314
15
 
 
1. The Proton no.1 of methyl group gave a characteristic singlet at 2.30 δ ppm. 
2. Another four protons of piprazine methylene groups of proton no. 2 and 3 
gave multiplet at 2.47 δ ppm. Due to the nitrogen atmosphere, four protons of 
methylene groups flipped individually and peaks got merged. 
3. Another four protons of piprazine methylene groups of proton no. 4 and 5 
gave multiplet at 2.63 δ ppm. Due to the nitrogen atmosphere, four protons of 
methylene groups flipped individually and peaks got merged. 
4. Two protons of methylene group of proton no.6 attached with N atom of 
piprazine ring gave a characteristic singlet at 3.14 δ ppm. 
5. Proton no. 9 and 10 of proppyl chain of two methyl group of six protons gave 
a multiplet at 0.87 δ ppm - 0.91 δ ppm. 
6. Proton no. 11, 12, 13 and 14 of dipropyl chain gave a multiplet at 1.25 δ ppm - 
1.68 δ ppm.  It showed expanded spectra. 
7. Proton no. 15 of dipropyl chain gave a multiplet at 2.21 δ ppm-2.27 δ ppm. 
8. Two most deshielded proton no.7 and 8 of secondary amine in hydrazide 
linkage of two (-NH) groups gave two separable singlet in the down field at 
9.07 δ ppm and 9.53 δ ppm respectively. 
 
Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound SPSC-01 has been confirmed. Spectrum is given on page no. 84. 
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1H NMR OF N'-(2-(4-ETHYLPIPERAZIN-1-YL) ACETYL)-2-
PROPYLPENTANEHYDRAZIDE (SPSC-02) 
 
O
N
H
NH
O
N N CH2
1
2
34
56
7
8
9
10
11
12
13
14 15
CH316
 
 
1. The Proton no.1 of methyl group gave a Triplet at 1.05 δ ppm -1.08 δ ppm. 
2. The Proton no. 2 of two protons gave a quartet at 2.32 δ ppm -2.44 δ ppm. 
3. Another four protons of piprazine methylene groups of proton no. 3 and 4 
gave multiplet at 2.59 δ ppm. Due to the nitrogen atmosphere, four protons of 
methylene groups flipped individually and peaks got merged. 
4. Another four protons of piprazine methylene groups of proton no. 5 and 6 
gave multiplet at 2.62 δ ppm. Due to the nitrogen atmosphere, four protons of 
methylene groups flipped individually and peaks got merged. 
5. Two protons of methylene group of proton no.7 attached with N atom of 
piprazine ring gave a characteristic singlet at 3.08 δ ppm. The assignment of 
this proton is the most important for the structure elucidation and as it is 
evident here the successful assignment of this singlet has confirmed our 
structure. 
6. Proton no. 10 and 11 of proppyl chain of two methyl group of six proton gave 
a multiplet at 0.85 δ ppm-0.90 δ ppm. 
7. Proton no. 12, 13, 14 and 15 of dipropyl chain gave a multiplet at 1.25 δ ppm- 
1.61 δ ppm. it shown an expanded spectra. 
8. Proton no. 16 of dipropyl chain of a proton gave a quartet at 2.27 δ ppm-2.30 δ 
ppm. 
9. Two most deshielded proton no.7 and 8 of secondary amine in hydrazide 
linkage of two (-NH) group gave two separable singlet in the down field at 
9.30 δ ppm and 9.99 δ ppm respectively. 
 
 Thus, by observing and assigning the peaks in the NMR spectrum and by the    
Calculation of the J values for each of the above proton, the proposed structure for  
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Compound SPSC-02 has been confirmed. Spectrum is given on page no. 86. 
 
3.A.6.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds. The spectral and elemental analysis data are given for individual 
compounds. 
 
3.A.7   ANALYTICAL DATA 
 
N'-(2-(4-methylpiperazin-1-yl) acetyl)-2-propylpentanehydrazide (SPSC-01):  
Yield: 76%, IR (KBr, cm-1): 3446 (N-H stretching), 2956 (-CH3 asym. str.), 2931 (-
CH2 asym. str.), 2874 (-CH3 sym. Str.), 2841 (-CH2 sym. Str.), 1672 (-C=O str.), 1608 
(N-H bending), 1452 (-CH3 asym. bending deformation), 1367 (-CH3 sym bending 
deformation),;  1H NMR (400 MHz, CDCl3): δ (ppm) 0.91 (6H, m), 1.46 (6H, m), 
1.68 (2H, m), 2.27 (1H, m), 2.30 (3H, s), 2.52 (4H, m), 2.63 (4H, m), 3.14 (2H, s), 
9.07 (1H, s), 9.53 (1H, s), MS m/z = 298 (M+); Anal. Calcd. for C15H30N4O2: C, 
60.37; H, 10.13; N, 18.77; O, 10.72. Found: C, 60.35; H, 10.11; N, 18.71; O, 10.70%. 
 
N'-(2-(4-ethylpiperazin-1-ylacetyl)-2-propylpentanehydrazide (SPSC-02): 
Yield: 78%, IR (KBr, cm-1): 3448 (N-H stretching), 2956 (-CH3 asym. str.), 2928 (-
CH2 asym. str.), 2812 (-CH2 sym. Str.), 1676 (-C=O str.), 1614 (N-H bending), 1456 
(-CH3 asym. bending deformation), 1375 (-CH3 sym bending deformation);  1H NMR 
(400 MHz, CDCl3): δ (ppm) 0.90 (6H, m), 1.08 (3H, t), 1.39 (6H, m), 1.61 (2H, m), 
2.30 (1H, m), 2.44 (2H, q), 2.59 (4H, m), 2.62 (4H, m), 3.08 (2H, s), 9.30 (1H, s), 
9.99 (1H, s) MS m/z = 312 (M+); Anal. Calcd. for C16H32N4O2: C, 61.50; H, 10.32; N, 
17.93; O, 10.24. Found: C, 61.48; H, 10.30; N, 17.91; O, 10.24%. 
 
N'-(2-morpholinoacetyl)-2-propylpentanehydrazide  (SPSC-03):  
Yield: 74%, IR (KBr, cm-1): 3444 (N-H stretching), 2954 (-CH3 asym. str.), 2926 (-
CH2 asym. str.), 2878 (-CH3 sym. Str.), 2838 (-CH2 sym. Str.), 1670 (-C=O str.), 1610 
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(N-H bending), 1450 (-CH3 asym. bending deformation), 1366 (-CH3 sym bending 
deformation);  MS m/z = 285 (M+); Anal. Calcd. for C14H27N3O3: C, 58.92; H, 9.54; 
N, 14.72; O, 16.82. Found: C, 58.88; H, 9.50; N, 14.70; O, 16.81%. 
 
N'-(2-(4-phenylpiperazin-1-yl)acetyl)-2-propylpentanehydrazide (SPSC-04):  
Yield: 72%, IR (KBr, cm-1): 3452 (N-H stretching), 2955 (-CH3 asym. str.), 2929 (-
CH2 asym. str.), 2874 (-CH3 sym. Str.), 2823 (-CH2 sym. Str.), 1683 (-C=O str.), 1608 
(N-H bending), 1485 (-CH3 asym. bending deformation), 1377 (-CH3 sym bending 
deformation);   MS m/z = 360 (M+); Anal. Calcd. for C20H32N4O2: C, 66.63; H, 8.95; 
N, 15.54; O, 8.88. Found: C, 66.60; H, 8.91; N, 15.51; O, 8.84%. 
 
N'-(2-(4-benzylpiperazin-1-yl)acetyl)-2-propylpentanehydrazide (SPSC-05):  
Yield: 78%, IR (KBr, cm-1): 3454 (N-H stretching), 2944 (-CH3 asym. str.), 2938 (-
CH2 asym. str.), 2870 (-CH3 sym. Str.), 2833 (-CH2 sym. Str.), 1672 (-C=O str.), 1612 
(N-H bending), 1450 (-CH3 asym. bending deformation), 1378 (-CH3 sym bending 
deformation); MS m/z = 375 (M+); Anal. Calcd. for C21H34N4O2: C, 67.35; H, 9.15; N, 
14.96; O, 8.54. Found: C, 67.32; H, 9.10; N, 14.91; O, 8.52%. 
 
N'-(2-(diisopropylamino)acetyl)-2-propylpentanehydrazide (SPSC-06):  
Yield: 72%, IR (KBr, cm-1): 3440 (N-H stretching), 2950 (-CH3 asym. str.), 2931 (-
CH2 asym. str.), 2879 (-CH3 sym. Str.), 2840 (-CH2 sym. Str.), 1680 (-C=O str.), 1610 
(N-H bending), 1456 (-CH3 asym. bending deformation), 1361 (-CH3 sym bending 
deformation); MS m/z = 299 (M+); Anal. Calcd. for C16H33N3O2: C, 64.17; H, 11.11; 
N, 14.03; O, 10.69. Found: C, 64.12; H, 11.10; N, 14.01; O, 10.66%. 
 
N'-(2-(piperazin-1-yl)acetyl)-2-propylpentanehydrazide (SPSC-07):  
Yield: 82%, IR (KBr, cm-1): 3438 (N-H stretching), 2953 (-CH3 asym. str.), 293 (-CH2 
asym. str.), 2874 (CH3 sym. Str.), 2836 (CH2 sym. Str.), 1668 (-C=O str.), 1616 (N-H 
bending), 1450 (-CH3 asym. bending deformation), 1362 (-CH3 sym bending 
deformation);  MS m/z = 284 (M+); Anal. Calcd. for C14H28N4O2: C, 59.12; H, 9.92; 
N, 19.70; O, 11.25. Found: C, 59.10; H, 9.90; N, 19.68; O, 11.22%. 
 
N'-(2-(dipropylamino)acetyl)-2-propylpentanehydrazide (SPSC-08):  
Yield: 78%, IR (KBr, cm-1): 3446 (N-H stretching), 2951 (-CH3 asym. str.), 2941 (- 
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CH2 asym. str.), 2870 (-CH3 sym. Str.), 2840 (-CH2 sym. Str.), 1678 (-C=O str.), 1608 
(N-H bending), 1444 (-CH3 asym. bending deformation), 1361 (-CH3 sym bending 
deformation); MS m/z = 299 (M+); Anal. Calcd. for C16H33N3O2: C, 64.17; H, 11.11; 
N, 14.03; O, 10.69. Found: C, 64.17; H, 11.12; N, 14.02; O, 10.70%. 
 
N'-(2-(N-methyl-N-phenylamino)acetyl)-2-propylpentanehydrazide  (SPSC-09):  
Yield: 72%, IR (KBr, cm-1): 3440 (N-H stretching), 2952 (-CH3 asym. str.), 2930 (-
CH2 asym. str.), 2868 (-CH3 sym. Str.), 2838 (-CH2 sym. Str.), 1670 (-C=O str.), 1608 
(N-H bending), 1450 (-CH3 asym. bending deformation), 1378 (-CH3 sym bending 
deformation); MS m/z = 305 (M+); Anal. Calcd. for C17H27N3O2: C, 66.85; H, 8.91; N, 
13.76; O, 10.48. Found: C, 66.81; H, 8.92; N, 13.70; O, 10.46%. 
 
N'-(2-(piperidin-1-yl)acetyl)-2-propylpentanehydrazide (SPSC-10):   
Yield:76%, IR (KBr, cm-1): 3440 (N-H stretching), 2952 (-CH3 asym. str.), 2930 (-
CH2 asym. str.), 2868 (-CH3 sym. Str.), 2846 (-CH2 sym. Str.), 1670 (-C=O str.), 1614 
(N-H bending), 1458 (-CH3 asym. bending deformation), 1361 (-CH3 sym bending 
deformation);  MS m/z = 283 (M+); Anal. Calcd. for C15H29N3O2: C, 63.57; H, 10.31; 
N, 14.83; O, 11.29. Found: C, 63.51; H, 10.22; N, 14.77; O, 11.23%. 
 
N'-(2-(diethylamino)acetyl)-2-propylpentanehydrazide (SPSC-11):  
Yield: 72%, IR (KBr, cm-1): 3452 (N-H stretching), 2958 (-CH3 asym. str.), 2928 (-
CH2 asym. str.), 2872 (-CH3 sym. Str.), 2838 (-CH2 sym. Str.), 1678 (-C=O str.), 1611 
(N-H bending), 1450 (-CH3 asym. bending deformation), 1361 (-CH3 sym bending 
deformation);  MS m/z = 271 (M+); Anal. Calcd. for C14H29N3O2: C, 61.96; H, 10.77; 
N, 15.48; O, 11.79. Found: C, 61.95; H, 10.76; N, 15.47; O, 11.78%. 
 
2-propyl-N'-(2-(pyrrolidin-1-yl)acetyl)pentanehydrazide (SPSC-12):  
Yield: 76%, IR (KBr, cm-1): 3444 (N-H stretching), 2951 (-CH3 asym. str.), 2928 (-
CH2 asym. str.), 2875 (-CH3 sym. Str.), 2834 (-CH2 sym. Str.), 1670 (-C=O str.), 1608 
(N-H bending), 1450 (-CH3 asym. bending deformation), 1361 (-CH3 sym bending 
deformation); MS m/z = 269 (M+); Anal. Calcd. for C14H27N3O2: C, 62.42; H, 10.10; 
N, 15.60; O, 11.88. Found: C, 62.41; H, 10.10; N, 15.61; O, 11.86%. 
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3.A.8   REPRESENTATIVE SPECTRA 
 
3.A.8.1 Mass Spectrum of SPSC-01 
 
3.A.8.2 IR Spectrum of SPSC-01 
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3.A.8.3      1H NMR Spectrum of SPSC-01 
  
EXPANDED 1H-NMR SPECTRUM OF SPSC-01 
 
O
N
H
NH
O
N N CH3
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3.A.8.4 Mass Spectrum of SPSC-02 
 
 
3.A.8.5 IR Spectrum of SPSC-02 
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3.A.8.6 1H NMR Spectrum of SPSC-02 
 
 
 
  EXPANDED 1H-NMR SPECTRUM OF SPSC-02 
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3.B.1    AIM OF CURRENT WORK 
 
In recent years, environmentally benign synthetic methods have received 
considerable attention and some solvent-free protocols have been developed. In 
present work is a multistep synthesis in which the final step is performed by using 
microwave synthesizer for rapid synthesis. 
 
In this sub chapter, Valproic acid is used as a starting product and converted 
into respective ester to obtain a hydrazide by using hydrazine hydrate which further 
treated with substituted acetophenone to obtain a series of novel compounds having 
structural moiety of Valproic acid and hydrazide linker with extended systems, using 
microwave synthesizer.  
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3.B.2    REACTION SCHEMES 
 
3.B.2.1 PREPARATION OF METHYL-2-PROPYL PENTANOATE 
 
O
OH CH3OH
Glacial acetic acid
600-700C
O
OCH3
 
 
3.B.2.2 PREPARATION OF 2-PROPYL PENTANOHYDRAZIDE 
 
NH2NH2.H2O
1100C
O
N
H
NH2
O
OCH3
 
 
3.B.2.3 PREPARATION OF (Z) – N’-(1-(SUBSTITUTED PHENYL) 
ETHYLIDENE) 2-PROPYL PENTANEHYDRAZIDE 
 
O
R
Glacial acetic acid
MW 450Watt
8-10min
O
N
H
N
O
N
H
NH2
R
Where R=H, 4-Cl etc.
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3.B.3    PLAUSIBLE REACTION MECHANISM 
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3.B.4    EXPERIMENTAL 
  
3.B.4.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. All the reactions were 
carried out in Samsung MW83Y Microwave Oven which was locally modified for 
carrying out chemical reactions. IR spectra were recorded in Shimadzu FT-IR-8400 
instrument using KBr pellet method. Mass spectra were recorded on Shimadzu GC-
MS-QP-2010 model using Direct Injection Probe technique. 1H NMR was determined 
in CDCl3 solution on a Bruker Ac 400 MHz spectrometer. Elemental analysis of the 
all the synthesized compounds was carried out on Elemental Vario EL III Carlo 
Erba 1108 model and the results are in agreements with the structures assigned. 
 
3.B.4.2 PREPARATION OF METHYL 2-PROPYL PENTANOATE 
 
2-propyl pentanoic acid (0.01 mole) was charged into 250 ml round bottom 
flask. 15 ml of methanol was added into above flask. 3-4 drops of Con. Sulphuric acid 
was added as a catalyst. The reaction mixture was refluxed for 12-14 hours on water 
bath. The progress and the completion of the reaction were checked by silica gel-G 
F254 thin layer chromatography using hexane: ethyl acetate (4: 6) as a mobile phase. 
After the reaction to be completed excess of methanol was removed under reduced 
pressure. The separated product was extracted using ethyl acetate (30 ml × 3), the 
combined organic layer was washed using 5% sodium bicarbonate solution (20 ml × 
2) followed by water (20 ml × 2). The organic layer was dried on anhydrous sodium 
sulphate and the solvent was removed under reduced pressure to acquire the product 
in a viscous liquid form. Yield - 90 %, B. P. – 170–172°C.a 
 
 
 
                                                 
a Dostovalova, V. I. ; Organic Magnetic Resonance 1983, V21(1), P111-19. 
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3.B.4.3  PREPARATION OF 2-PROPYL PENTANOHYDRAZIDE 
 
Methyl 2-propylpentanoate (0.01 mole) was taken into 250 ml round bottom 
flask. 15 ml of hydrazine hydrate was added into above flask. The reaction mixture 
was refluxed on water bath for 12-14 hours. The progress and the completion of the 
reaction were checked by silica gel-G F254 thin layer chromatography using hexane: 
ethyl acetate (4 : 6) as a mobile phase. After the reaction to be completed, the mixture 
was cooled to room temperature to give 2-propylpentanohydrazide as a white colored 
shining fluffy product. Yield - 60 %, M. P. – 124–126°C.b 
 
3.B.4.4 GENERAL PROCEDURE OF (Z) – N’-(1-(SUBSTITUTED 
PHENYL) ETHYLIDENE) 2-PROPYL PENTANEHYDRAZIDE 
 
2-propylpentanohydrazide (0.01 mole) was added into 250 ml round bottom 
flask. 15 ml of Methanol was added into above flask. 0.01 mole of substituted 
acetophenones were added and add into 2-3 drops of glacial acetic acid as a catalyst. 
The reaction mixture the reaction mixture carried out under microwave irradiation at 
450 Watt. for 8-10 minutes. The progress and the completion of the reaction were 
checked by silica gel-G F254 thin layer chromatography using toluene: ethyl acetate (7: 
3) as a mobile phase. After the reaction to be completed, the mixture was cooled to 
room temperature to give solid product. Finally it recrystallized from methanol. 
Similarly other compounds are also prepared. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
b Benoit-Guyod, Jean L.; Chemica Therapeutica 1968, V3(5), P336-42. 
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3.B.5    PHYSICAL DATA 
 
PHYSICAL DATA OF (Z) – N’-(1-(SUBSTITUTED PHENYL) ETHYLIDENE) 
PROPYL PENTANEHYDRAZIDES (SPA-01 TO SPA-10) 
  
O
N
H
N
R
 
TABLE-3.B.1 
Sr. 
No. 
Code 
Name & No. Substitutions 
Molecular 
Formula 
Molecular 
Weight 
MP 
0C Rf Value 
01 SPA-01 H C16H24N2O 260 188-190 0.44 
02 SPA-02 4-Cl C16H23ClN2O 295 208-210 0.48 
03 SPA-03 4-CH3 C17H26N2O 274 222-224 0.50 
04 SPA-04 2-OH C16H24N2O2 276 238-240 0.42 
05 SPA-05 4-OCH3 C17H26N2O2 290 192-194 0.44 
06 SPA-06 4-NO2 C16H23N3O3 305 188-190 0.48 
07 SPA-07 4-F C16H23FN2O 278 198-200 0.54 
08 SPA-08 2- OCH3 C17H26N2O2 290 220-222 0.46 
09 SPA-09 3-NO2 C16H23N3O3 305 238-240 0.42 
10 SPA-10 2-Cl C16H23ClN2O 295 202-204 0.52 
 
Rf value was calculated using solvent system, Toluene: Ethyl Acetate (7: 3) 
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3.B.6    SPECTRAL DISCUSSION 
 
3.B.6.1 MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. SPA-01 and SPA-02 of Mass 
spectra are given on page no. 99 and 101. 
 
3.B.6.2 IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT IR 
8400 spectrophotometer using Diffused Reflectance Attachment (DRA) System using 
Potassium Bromide.  
 
NH stretching vibration observed near 3440 cm-1, C-H stretching frequencies 
of aromatic were observed between 3100 cm-1 and 3000 cm-1, C-H asym. stretching 
frequencies were observed between 2975 cm-1 and 2920 cm-1, C-H sym. stretching 
frequencies were observed between 2880 cm-1 and 2860 cm-1, Azomethine frequency 
were observed between 1650 cm-1 and 1580 cm-1, N-H bending vibration observed 
near 1550 cm-1, There are two carbonyl groups present in all the compounds but due 
to the same environment, the peaks merged in the region of 1660 cm-1. CN stretching 
frequency was observed near 1250 cm-1 in all the compounds. SPA-01 and SPA-02 of 
IR spectra are given on page no. 99 and 101. 
  
3.B.6.3 1H NMR SPECTRA 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer. Sample solutions were made in CDCl3 solvent using 
tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons identified from proton NMR spectrum and their chemical shift (δ 
ppm) were in the agreement of the structure of the molecule. J values were calculated 
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to identify o, m and p coupling. 1H NMR spectral interpretation can be discussed as 
under. 
 
1H NMR OF (Z)-N'-(1-PHENYLETHYLIDENE)-2-PROPYLPENTANEHYDRAZIDE 
(SPA-01) 
 
O
N
H
N CH3
1
2
3
4
5
6
7
8
9
10
13
14
11
12
 
 
1. The Proton no.1 of methyl group gave a characteristic singlet at 2.25 δ ppm. 
2. The Proton no. 2 and 6 of aromatic phenyl ring of two proton gave a multiplet 
at 7.74 δ ppm-7.77 δ ppm. 
3. The Proton no. 3, 4 and 5 of phenyl ring of three proton gave a multiplet at 
7.35 δ ppm-7.42 δ ppm. 
4. The Proton no. 8 and 9 of propyl chain of five proton gave a multiplet at 0.90 
δ ppm-0.94 δ ppm. 
5. Proton no. 13 and 14 of propyl chain of five proton gave a multiplet at 1.28 δ 
ppm-1.41 δ ppm. 
6. Proton no. 10 of propyl chain of proton gave a multiplet at 1.45 δ ppm- 1.53 δ 
ppm.  
7. Proton no. 12 of propyl chain of proton gave a multiplet at 1.69 δ ppm-1.78 δ 
ppm. 
8. Proton no. 11 of di propyl chain gave a multiplet at 3.57 δ ppm- 3.62 δ ppm. 
9. Most deshielded proton no. 7 of secondary amine in hydrazide (amide linkage 
CO-NH) gave singlet in the down field at 9.32 δ ppm. 
 
Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound no. SPA-01 has been confirmed. Spectrum is given on page no. 100. 
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1H NMR OF (Z)-N'-(1-(4-CHLOROPHENYL) ETHYLIDENE)-2-
PROPYLPENTANEHYDRAZIDE (SPA-02) 
 
O
N
H
N CH3
1
2
34
5
6
7
8
9
11
13
10
Cl
12
 
 
1. The Proton no.1 of methyl group gave a characteristic singlet at 2.26 δ ppm. 
2. The Proton no. 3 and 4 of aromatic phenyl ring of two proton gave a doublet at 
7.34 δ ppm-7.36 δ ppm. And J value of this proton is 8.0 Hz. that suggests a 
ortho coupled. 
3. The Proton no. 2 and 5 of phenyl ring of two proton gave a doublet at 7.68 δ 
ppm-7.70 δ ppm. And J value of this proton is 8.0 Hz. that suggests a ortho 
coupled. 
4. The Proton no. 7 and 8 of propyl chain of five protons gave a multiplet at 0.93 
δ ppm.  
5. Proton no. 12 and 13 of propyl chain of five proton gave a multiplet at 1.29 δ 
ppm-1.39 δ ppm. 
6. Proton no. 9 of propyl chain of two protons gave a multiplet at 1.44 δ ppm- 
1.53 δ ppm. 
7. Proton no. 11 of propyl chain of two protons gave a multiplet at 1.68 δ ppm- 
1.75δ ppm. 
8. Proton no. 10 of dipropyl chain gave a multiplet at 3.55 δ ppm - 3.59 δ ppm. 
9. Most deshielded proton no. 6 of secondary amine in hydrazide (amide linkage 
CO-NH) gave singlet in the down field at 9.71 δ ppm. 
 
Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound no. SPA-02 has been confirmed. Spectrum is given on page no. 102. 
 
 
Chapter – 3 Section-B                                                                A Rapid Microwave asisted….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     96 
3.B.6.4    ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds. The spectral and elemental analysis data are given for individual 
compounds. 
 
3.B.7    ANALYTICAL DATA 
 
(Z)-N'-(1-phenylethylidene)-2-propylpentanehydrazide (SPA-01):  
Yield:76%, IR (KBr, cm-1): 3443 (-NH str. Vib.), 3034 (Ar. –C-H str.), 2951 (-C-H 
asym. str.), 2868 (-C-H sym. Str.), 1658 (-C=O str.), 1600 (-N=C str.), 1546 (-NH 
bending), 1444 (-C-H deformation asym. str.), 1377 (-C-H deformation sym. Str.), 
1303 (CN str. Vib.), 1111 (-C-H i.p. deformation), 877 (-C-H oop bending);  1H NMR 
(400 MHz, CDCl3): δ (ppm) 0.94 (5H, m), 1.41 (5H, m), 1.53 (2H, m), 1.78 (2H, m), 
2.25 (3H, s), 3.62 (1H, m), 7.42 (3H, m), 7.77 (2H, m), 9.32 (1H, s); MS m/z = 260 
(M+); Anal. Calcd. for C16H24N2O: C, 73.81; H, 9.29; N, 10.76; O, 6.14. Found: C, 
73.80; H, 9.26; N, 10.70; O, 6.12%.  
 
(Z)-N'-(1-(4-chlorophenyl) ethylidene)-2-propylpentanehydrazide (SPA-02): 
Yield: 78%, IR (KBr, cm-1): 3448 (-NH str. Vib.), 3014 (Ar. –C-H str.), 2953 (-C-H 
asym. str.), 2868 (-C-H sym. Str.), 1660 (-C=O str.), 1604 (-N=C str.), 1543 (-NH 
bending), 1460 (-C-H deformation asym. str.), 1398 (-C-H deformation sym. Str.), 
1307, 1246 (CN str. Vib.),  1095 (-C-H i.p. deformation), 827 (-C-H oop bending); 1H 
NMR (400 MHz, CDCl3): δ (ppm) 0.93 (5H, m), 1.39 (5H, m), 1.53 (2H, m), 1.75 
(2H, m), 2.26 (3H, s), 3.59 (1H, m), 7.36 (2H, m), 7.70 (2H, m), 9.71 (1H, s); MS m/z 
=295 (M+), 296 (M+1); Anal. Calcd. for C16H23ClN2O: C, 65.18; H, 7.86; N, 9.50; O, 
5.43. Found: C, 65.12; H, 7.81; N, 9.50; O, 5.38%. 
 
(Z)-2-propyl-N'-(1-p-tolylethylidene)pentanehydrazide (SPA-03):  
Yield: 72%, IR (KBr, cm-1): 3450 (-NH str. vib.), 3032 (Ar. -C-H str.), 2953 (-C-H 
asym. str.), 2866 (-C-H sym. Str.), 1662 (-C=O str.), 1612 (-N=C str.), 1550 (-NH  
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bending), 1460 (-C-H deformation asym. str.), 1375 (-C-H deformation sym. Str.), 
1303, 1244 (CN str. Vib.), 1120 (-C-H i.p. deformation), 815 (-C-H oop bending); MS 
m/z = 274 (M+); Anal. Calcd. for C17H26N2O: C, 74.41; H, 9.55; N, 10.21; O, 5.83. 
Found: C, 74.41; H, 9.52; N, 10.21; O, 5.82%. 
 
(Z)-N'-(1-(2-hydroxyphenyl)ethylidene)-2-propylpentanehydrazide (SPA-04): 
Yield:78%, IR (KBr, cm-1): 3446 (-NH str. vib.), 3046 (Ar. –C-H str.), 2946 (-C-H 
asym. str.), 2860 (-C-H sym. Str.), 1672 (-C=O str.), 1612 (-N=C str.), 1580 (-NH 
bending), 1462 (-C-H deformation asym. str.), 1370 (-C-H deformation sym. Str.), 
1304, 1255 (CN str. Vib.), 1116 (-C-H i.p. deformation), 831 (-C-H oop bending); MS 
m/z = 276 (M+); Anal. Calcd. for C16H24N2O2: C, 69.53; H, 8.75; N, 10.14; O, 11.58. 
Found: C, 69.51; H, 8.70; N, 10.11; O, 11.52%. 
 
(Z)-N'-(1-(4-methoxyphenyl)ethylidene)-2-propylpentanehydrazide (SPA-05): 
Yield:78%, IR (KBr, cm-1): 3440 (-NH str. vib.), 3052 (Ar. –C-H str.), 2951 (-C-H 
asym. str.), 2862 (-C-H sym. Str.), 1670 (-C=O str.), 1616 (-N=C str.), 1583 (-NH 
bending), 1458 (-C-H deformation asym. str.), 1372 (-C-H deformation sym. Str.), 
1307, 1250 (CN str. Vib.), 1124 (-C-H i.p. deformation), 826 (-C-H oop bending); MS 
m/z =  290 (M+); Anal. Calcd. for C17H26N2O2: C, 70.31; H, 9.02; N, 9.65; O, 11.02. 
Found: C, 70.28; H, 9.00; N, 9.62; O, 11.01%. 
 
(Z)-N'-(1-(4-nitrophenyl)ethylidene)-2-propylpentanehydrazide (SPA-06): 
Yield:74%, IR (KBr, cm-1): 3430 (-NH str. vib.), 3048 (Ar. –C-H str.), 2948 (-C-H 
asym. str.), 2860 (-C-H sym. Str.), 1668 (-C=O str.), 1610 (-N=C str.), 1582 (-NH 
bending), 1462 (-C-H deformation asym. str.), 1374 (-C-H deformation sym. Str.), 
1312, 1250 (CN str. Vib.), 1112 (-C-H i.p. deformation), 824 (-C-H oop bending); MS 
m/z = 305 (M+); Anal. Calcd. for C16H23N3O3: C, 62.93; H, 7.59; N, 13.76; O, 15.72. 
Found: C, 62.91; H, 7.52; N, 13.70; O, 15.71%. 
 
(Z)-N'-(1-(4-fluorophenyl)ethylidene)-2-propylpentanehydrazide (SPA-07): 
Yield:72%, IR (KBr, cm-1): 3456 (-NH str. vib.), 3050 (Ar. –C-H str.), 2960 (-C-H 
asym. str.), 2861 (-C-H sym. Str.), 1672 (-C=O str.), 1622 (-N=C str.), 1583 (-NH 
bending), 1456 (-C-H deformation asym. str.), 1370 (-C-H deformation sym. Str.), 
1307, 1248 (CN str. Vib.), 1124 (-C-H i.p. deformation), 820 (-C-H oop bending); MS 
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m/z = 278 (M+), 280 (M+2); Anal. Calcd. for C16H23FN2O: C, 69.04; H, 8.33; N, 
10.06; O, 5.75. Found: C, 69.01; H, 8.32; N, 10.04; O, 5.71%. 
 
(Z)-N'-(1-(2-methoxyphenyl)ethylidene)-2-propylpentanehydrazide (SPA-08): 
Yield:80%, IR (KBr, cm-1): 3448 (-NH str. vib.), 3048 (Ar. –C-H str.), 2956 (-C-H 
asym. str.), 2860 (-C-H sym. Str.), 1670 (-C=O str.), 1612 (-N=C str.), 1580 (-NH 
bending), 1458 (-C-H deformation asym. str.), 1372 (-C-H deformation sym. Str.), 
1314, 1256 (CN str. vib.), 1130 (-C-H i.p. deformation), 827 (-C-H oop bending),; 
MS m/z = 290 (M+); Anal. Calcd. for C17H26N2O2: C, 70.31; H, 9.02; N, 9.65; O, 
11.02. Found: C, 70.26; H, 9.02; N, 9.61; O, 11.04%. 
 
(Z)-N'-(1-(3-nitrophenyl)ethylidene)-2-propylpentanehydrazide (SPA-09): 
Yield:76%, IR (KBr, cm-1): 3450 (-NH str. vib.), 3054 (Ar. –C-H str.), 2945 (-C-H 
asym. str.), 2866 (-C-H sym. Str.), 1676 (-C=O str.), 1610 (-N=C str.), 1582 (-NH 
bending), 1462 (-C-H deformation asym. str.), 1374 (-C-H deformation sym. Str.), 
1310, 1254 (CN str. vib.), 1122 (-C-H i.p. deformation), 826 (-C-H oop bending); MS 
m/z = 305 (M+); Anal. Calcd. for C16H23N3O3: C, 62.93; H, 7.59; N, 13.76; O, 15.72. 
Found: C, 62.92; H, 7.52; N, 13.71; O, 15.73%. 
 
(Z)-N'-(1-(2-chlorophenyl)ethylidene)-2-propylpentanehydrazide (SPA-10): 
Yield:80%, IR (KBr, cm-1): 3438 (-NH str. vib.), 3053 (Ar. –C-H str.), 2958 (-C-H 
asym. str.), 2864 (-C-H sym. Str.), 1674 (-C=O str.), 1612 (-N=C str.), 1583 (-NH 
bending), 1460 (-C-H deformation asym. str.), 1378 (-C-H deformation sym. Str.), 
1310, 1251 (CN str. Vib.), 1124 (-C-H i.p. deformation), 838 (-C-H oop bending); MS 
m/z = 295 (M+), 296 (M+1); Anal. Calcd. for C16H23ClN2O: C, 65.18; H, 7.86; N, 9.50; 
O, 5.43. Found: C, 65.11; H, 7.80; N, 9.50; O, 5.41%. 
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3.B.8     REPRESENTATIVE SPECTRA  
 
3.B.8.1    Mass Spectrum of SPA-01 
 
3.B.8.2 IR Spectrum of SPA-01 
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3.B.8.3 1H NMR Spectrum of SPA-01 
 
 
 
EXPANDED 1H-NMR SPECTRUM OF SPA-01 
 
O
N
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N
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3.B.8.4 Mass Spectrum of SPA-02 
 
 
 
3.B.8.5 IR Spectrum of SPA-02 
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3.B.8.6  1H NMR Spectrum of SPA-02 
 
 
 
  EXPANDED 1H-NMR SPECTRUM OF SPA-02 
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3.C.1    AIM OF CURRENT WORK 
 
The XC(CO)NHY linkage, under the assumption Y=H called the amide 
linkage, or referred to as the peptide linkage, is generally assumed to have a planar 
structure . 
 
 
 
Several molecules containing the CONH linkage seem to have pyramidal 
nitrogen at equilibrium and a double-minimum inversion potential with a very small 
inversion barrier allowing for an effective planar ground-state structure. Various 
studies were conducted on development of various prodrugs and derivatives of 
Valproic acid. In continuations to the current research work that has been discussed in 
section-A. and section-B, an aryl amide linkage is created by using Valproic acid 
hydrazide to prepare several new derivatives. 
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3.C.2    REACTION SCHEMES 
 
3.C.2.1 PREPARATION OF METHYL-2-PROPYL PENTANOATE 
 
O
OH CH3OH
Glacial acetic acid
600-700C
O
OCH3
 
 
3.C.2.2 PREPARATION OF 2-PROPYL PENTANOHYDRAZIDE 
 
O
OCH3
NH2NH2.H2O
1100C
O
N
H
NH2
 
 
3.C.2.3 PREPARATION OF N’-SUBSTITUTED BENZOYL-2-PROPYL 
PENTANEHYDRAZIDE 
 
O
N
H
NH2
O Cl
R
O
N
H
H
N O
R
Base
0-50C
Where R=H, 4-Cl, 4-OCH3 etc.
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3.C.3    PLAUSIBLE REACTION MECHANISM 
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3.C.4    EXPERIMENTAL 
 
3.C.4.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. Formation of all 
compounds was purified by using flash chromatography. IR spectra were recorded 
in Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass spectra were 
recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection Probe 
technique. 1H NMR was determined in DMSO-d6 solution on a Bruker Ac 400 MHz 
spectrometer. Elemental analysis of the all the synthesized compounds was carried 
out on Elemental Vario EL III Carlo Erba 1108 model and the results are in 
agreements with the structures assigned. 
 
3.C.4.2 PREPARATION OF METHYL 2-PROPYL PENTANOATE 
 
2-propyl pentanoic acid (0.01 mole) was charged into 250 ml round bottom 
flask. 15 ml of methanol was added into above flask. 3-4 drops of Con. Sulphuric acid 
was added as a catalyst. The reaction mixture was refluxed for 12-14 hours on water 
bath. The progress and the completion of the reaction were checked by silica gel-G 
F254 thin layer chromatography using hexane : ethyl acetate (4: 6) as a mobile phase. 
After the reaction to be completed excess of methanol was removed under reduced 
pressure. The separated product was extracted using ethyl acetate (30 ml × 3), the 
combined organic layer was washed using 5% sodium bicarbonate solution (20 ml × 
2) followed by water (20 ml × 2). The organic layer was dried on anhydrous sodium 
sulphate and the solvent was removed under reduced pressure to acquire the product 
in a viscous liquid form. B. P. - 170-172°Ca. 
 
 
                                                 
a Dostovalova, V. I. ; Organic Magnetic Resonance 1983, V21(1), P111-19. 
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3.C.4.3 PREPARATION OF 2-PROPYL PENTANOHYDRAZIDE 
 
Methyl 2-propylpentanoate (0.01 mole) was charged into 250 ml round bottom 
flask. 15 ml of hydrazine hydrate was added into above flask. The reaction mixture 
was refluxed on water bath for 12-14 hours. The progress and the completion of the 
reaction were checked by silica gel-G F254 thin layer chromatography using hexane : 
ethyl acetate (4 : 6) as a mobile phase. After the reaction to be completed, the mixture 
was cooled to room temperature to give 2-propylpentanohydrazide as a white colored 
shining fluffy product. Yield - 60 %, M. P. - 124-126°C.b 
 
3.C.4.4 GENERAL PROCEDURE OF N’-SUBSTITUTED BENZOYL-2-
PROPYL PENTANEHYDRAZIDE 
 
2-Propylpentanehydrazide (0.01 mole) dissolve it in 10-12 ml of 
Dichloromethane then add into of triethylamine (0.03 mole) as a catalyst and add into 
Substituted benzoyl chloride (0.01 mole) in MDC. at 0-50 C for 4-5 hrs under stirring. 
The progress and the completion of the reaction were checked by silica gel-G F254 thin 
layer chromatography using hexane : ethyl acetate (7 : 3) as a mobile phase. After the 
reaction to be completed, the mixture was cooled to room temperature and poured into 
crushed ice. A solid product comes. Finally, it was purified by flash chromatography 
using hexane and ethyl acetate as eluents.  
Similarly other compounds are also prepared. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
b Benoit-Guyod, Jean L. ; Chemica Therapeutica 1968, V3(5), P336-42. 
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3.C.5    PHYSICAL DATA 
 
PHYSICAL DATA OF N’-SUBSTITUTEDBENZOYL-2-PROPYL PENTANE -
HYDRAZIDES (SPAM-01 TO SPAM-10) 
  
O
NH
HN O
R
 
TABLE-3.C.1 
Sr. 
No. 
Code 
Name & 
No. 
Substitutions Molecular Formula 
Molecular 
Weight 
MP 
0C 
Rf 
Value 
01 SPAM-01 4-Cl C15H21ClN2O2 296 180-182 0.46 
02 SPAM-02 H C15H22N2O2 262 224-226 0.52 
03 SPAM-03 4-OCH3 C16H24N2O3 292 192-194 0.44 
04 SPAM-04 4-CH3 C16H24N2O2 276 244-246 0.48 
05 SPAM-05 4-NO2 C15H21N3O4 307 198-200 0.40 
06 SPAM-06 3-NO2 C15H21N3O4 307 202-204 0.54 
07 SPAM-07 2-NO2 C15H21N3O4 307 188-190 0.50 
08 SPAM-08 2-CH3 C16H24N2O2 276 224-226 0.52 
09 SPAM-09 3-Cl C15H21ClN2O2 296 212-214 0.42 
10 SPAM-10 2-Cl C15H21ClN2O2 296 200-202 0.44 
  
Rf value was calculated using solvent system, Hexane : Ethyl Acetate (7: 3) 
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3.C.6    SPECTRAL DISCUSSION 
 
3.C.6.1 MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. SPAM-01 and SPAM-02 of 
Mass spectra are given on page no. 116 and 118. 
 
3.C.6.2 IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT IR 
8400 spectrophotometer using Diffused Reflectance Attachment (DRA) System using 
Potassium Bromide.  
 
N-H stretching vibrations were observed near 3440 cm-1, There are two 
carbonyl groups present in all the compounds but due to the same environment, the 
peaks merged in the region of 1680 cm-1, N-H bending vibrations were observed near 
1600 cm-1, C-H stretching frequencies were observed between 2810 cm-1 to 3000   
cm-1, while ring skeleton frequencies were observed near 1460 cm-1 in all the 
compounds. SPAM-01 and SPAM-02 of IR spectra are given on page no. 116 and 
118. 
 
3.C.6.3 1H  NMR SPECTRA 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer. Sample solutions were made in DMSO-d6/CDCl3 
solvent using tetramethylsilane (TMS) as the internal standard unless otherwise 
mentioned. Numbers of protons identified from proton NMR spectrum and their 
chemical shift (δ ppm) were in the agreement of the structure of the molecule. J 
values were calculated to identify o, m and p coupling.  
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1H NMR spectral interpretation can be discussed as under. 
 
1H NMR OF N’-4-CHLOROBENZOYL-2-PROPYL PENTANEHYDRAZIDE 
(SPAM-01) 
 
O
NH
HN O
Cl
1
2
3
4
5
6
7
8
9 10
11
12
13
 
 
1. The Proton no.1 and 3 of aromatic ring of two proton gave a characteristic 
doublet at 7.35 δ ppm-7.37 δ ppm. and J value of this proton is 8.0 Hz. It 
suggests ortho coupling. 
2. The Proton no. 2 and 4 of aromatic ring of two proton gave a characteristic 
doublet at 7.85 δ ppm-7.87 δ ppm. and J value of this proton is 8.0 Hz. It 
suggests a para coupled. 
3. The Proton no. 7 and 13 of two propyl chain of six proton gave a multiplet at 
0.86 δ ppm -0.92 δ ppm. 
4. Proton no. 8, 9, and 11 of two propyl chain gave a multiplet at 1.25 δ ppm -
1.47 δ ppm. 
5. Proton no. 12 of propyl chain gave a multiplet at 1.55 δ ppm- 1.66 δ ppm. 
6. Proton no. 10 of propyl chain gave a multiplet at 2.33 δ ppm -2.38 δ ppm. 
7 Two most deshielded proton no. 5 and 6 of secondary amine in hydrazide 
linkage (-NH) gave two separable singlet in the down field at 9.72 δ ppm. and 
10.37 δ ppm. Respectively. 
 
Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound no. SPAM-01 has been confirmed. Spectrum is given on page no. 117. 
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1H NMR OF N’-BENZOYL-2-PROPYLPENTANEHYDRAZIDE (SPAM-02) 
 
1
2
3
4
5
6
7
89
10
11
12
13
O
NH
HN O
14
 
 
1. The Proton no. 2 and 4 of aromatic ring gave a triplet at 7.27 δ ppm -7.34 δ 
ppm. 
2. The Proton no. 1 and 5 of aromatic ring gave a doublet at 7.79 δ ppm -7.81 δ 
ppm. and J value of this proton is 8.0 Hz. It suggests a para coupled. 
3. Proton no. 3 of aromatic ring gave a multiplet at 7.44 δ ppm -7.48 δ ppm. 
4. The Proton no. 8 and 14 of two propyl chain gave a multiplet at 0.80 δ ppm- 
0.88 δ ppm. 
4. Proton no. 9, 10 and 12 of two propyl chain gave a multiplet at 1.25 δ ppm -
1.44 δ ppm. 
5. Proton no. 13 of propyl chain gave a multiplet at 1.57 δ ppm-1.66 δ ppm. 
6. Proton no. 11 of propyl chain gave a multiplet at 2.38 δ ppm -2.42 δ ppm. 
7 Two most deshielded proton no. 6 and 7 of secondary amine in hydrazide 
linkage of two (-NH) group gave two separable singlet in the down field at 
9.90 δ ppm. and 10.66 δ ppm. Respectively. 
 
Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound no. SPAM-02 has been confirmed. Spectrum is given on page no. 119. 
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3.C.6.4    ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds. The spectral and elemental analysis data are given for individual 
compounds. 
 
 
3.C.7    ANALYTICAL DATA 
 
N’-4-chlorobenzoyl-2-propyl pentanehydrazide (SPAM-01):  
Yield: 78%, IR (KBr, cm-1):  3444 (-NH stretching vib.), 3030 (-CH3), 2868 (-CH2), 
1670 (-C=O), 1604 (-NH bending vib.), 1498, 1467 (aromatic ring skleton); 1H NMR 
(400 MHz, DMSO-d6): δ (ppm) 0.92 (6H, m), 1.47 (6H, m), 1.66 (2H, m), 2.38 (1H, 
m), 7.37 (2H, d, J=8.0 Hz), 7.87 (2H, d, J=8.0 Hz), 9.72 (1H, d), 10.37 (1H, d), MS 
m/z = 296 (M+), 298 (M+2); Anal. Calcd. for C15H21ClN2O2: C, 60.70; H, 7.13; N, 
9.44; O, 10.78. Found: C, 60.66; H, 7.11; N, 9.41; O, 10.73%. 
 
N’-benzoyl-2-propylpentanehydrazide (SPAM-02):  
Yield: 76%, IR (KBr, cm-1): 3439  (-NH stretching vib.), 3026, 2953 (-CH3), 2868 (-
CH2), 1670 (-C=O), 1602 (-NH bending vib.), 1500, 1469 (aromatic ring skleton); 1H 
NMR (400 MHz, DMSO-d6): δ (ppm) 0.88 (6H, m), 1.44 (6H, m), 1.66 (2H, m), 2.42 
(1H, m), 7.34 (2H, m), 7.48 (1H, m), 7.81 (2H, m), 9.90 (1H, d), 10.66 (1H, d); MS 
m/z =  262 (M+); Anal. Calcd. for C15H22N2O2: C, 68.67; H, 8.45; N, 10.68; O, 12.20. 
Found: C, 68.61; H, 8.42; N, 10.63; O, 12.17%. 
 
N’-4-methoxybenzoyl-2-propylpentanehydrazide (SPAM-03):  
Yield: 74%, IR (KBr, cm-1): 3448 (-NH stretching vib.), 3046, 2958 (-CH3), 2846 (-
CH2), 1672 (-C=O), 1602 (-NH bending vib.), 1494, 1456 (aromatic ring skleton); MS 
m/z = 292 (M+); Anal. Calcd. for C16H24N2O3: C, 65.73; H, 8.27; N, 9.58; O, 16.42. 
Found: C, 65.70; H, 8.24; N, 9.53; O, 16.41%. 
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N’-4-methylbenzoyl-2-propylpentanehydrazide (SPAM-04):  
Yield: 78%, IR (KBr, cm-1): 3438 (-NH stretching vib.), 3054, 2958 (-CH3), 2852 (-
CH2), 1666 (-C=O), 1600 (-NH bending vib.), 1500, 1454 (aromatic ring skleton); MS 
m/z = 276 (M+); Anal. Calcd. for C16H24N2O2: C, 69.53; H, 8.75; N, 10.14; O, 11.58. 
Found: C, 69.51; H, 8.72; N, 10.11; O, 11.52%. 
 
N’-4-nitrobenzoyl-2-propyl pentanehydrazide (SPAM-05):   
Yield: 70%, IR (KBr, cm-1): 3458 (-NH stretching vib.), 3040, 2958 (-CH3), 2838 (-
CH2), 1672 (-C=O), 1608 (-NH bending vib.), 1488, 1450 (aromatic ring skleton); MS 
m/z = 307 (M+); Anal. Calcd. for C15H21N3O4: C, 58.62; H, 6.89; N, 13.67; O, 20.82. 
Found: C, 58.60; H, 6.82; N, 13.63; O, 20.78%. 
 
N’-3-nitrobenzoyl-2-propyl pentanehydrazide (SPAM-06):  
Yield: 82%, IR (KBr, cm-1):  3446 (-NH stretching vib.), 3046, 2944 (-CH3), 2842 (-
CH2), 1666 (-C=O), 1608 (-NH bending vib.), 1494, 1438 (aromatic ring skleton); MS 
m/z = 307 (M+); Anal. Calcd. for C15H21N3O4: C, 58.62; H, 6.89; N, 13.67; O, 20.82. 
Found: C, 58.61; H, 6.85; N, 13.61; O, 20.81%. 
 
N’-2-nitrobenzoyl-2-propyl pentanehydrazide (SPAM-07):  
Yield: 80%, IR (KBr, cm-1):  3448 (-NH stretching vib.), 3028, 2950 (-CH3), 2846 (-
CH2), 1670 (-C=O), 1602 (-NH bending vib.), 1502, 1444 (aromatic ring skleton); MS 
m/z = 307 (M+); Anal. Calcd. for C15H21N3O4: C, 58.62; H, 6.89; N, 13.67; O, 20.82. 
Found: C, 58.60; H, 6.84; N, 13.63; O, 20.80%. 
 
N’-2-methylbenzoyl-2-propylpentanehydrazide (SPAM-08):  
Yield: 82%, IR (KBr, cm-1): 3456 (-NH stretching vib.), 3042, 2956 (-CH3), 2838 (-
CH2), 1674 (-C=O), 1604 (-NH bending vib.), 1490, 1456 (aromatic ring skleton); MS 
m/z = 276 (M+); Anal. Calcd. for C16H24N2O2: C, 69.53; H, 8.75; N, 10.14; O, 11.58. 
Found: C, 69.51; H, 8.71; N, 10.12; O, 11.52%. 
 
N’-3-chlorobenzoyl-2-propyl pentanehydrazide (SPAM-09):  
Yield: 74%, IR (KBr, cm-1): 3448 (-NH stretching vib.), 3038, 2954 (-CH3), 2822 (-
CH2), 1670 (-C=O), 1600 (-NH bending vib.), 1474, 1456 (aromatic ring skleton); MS  
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m/z = 296 (M+), 298 (M+2); Anal. Calcd. for C15H21ClN2O2: C, 60.70; H, 7.13; N,9.44; 
O, 10.78. Found: C, 60.68; H, 7.10; Cl, 11.92; N, 9.42; O, 10.71%. 
 
N’-2-chlorobenzoyl-2-propyl pentanehydrazide (SPAM-10):  
Yield: 72%, IR (KBr, cm-1): 3458 (-NH stretching vib.), 3020, 2946 (-CH3), 2832 (-
CH2), 1658 (-C=O), 1608 (-NH bending vib.), 1488, 1454 (aromatic ring skleton); MS 
m/z = 296 (M+), 298 (M+2); Anal. Calcd. for C15H21ClN2O2: C, 60.70; H, 7.13; N, 
9.44; O, 10.78. Found: C, 60.66; H, 7.10; N, 9.43; O, 10.74%. 
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3.C.8    RESULTS AND DISCUSSION      
 
 Several 2-propylpentanohydrazide were prepared by reacting hydrazine 
hydrate with Methyl-2-propylpentanoate. Methyl-2-propylpentanoate was prepared by 
the esterification of 2-propylpentanoic acid which is also known as Valproic acid. 
 In Section-A the targeted compounds such as N’-(2-(substituted amino)-
acetyl)-2-propylpentanehydrazide were synthesized from N'-(2-chloroacetyl)-2-
propylpentanehydrazide by using base catalyst. These types of the compounds were 
synthesized at room temperature.  
 In Section-B the targeted compounds such as N’-(1-(substituted phenyl) 
ethylidene) 2-propylpentanehydrazide were synthesized from 2-
propylpentanohydrazide by using glacial acetic acid as a catalyst. These types of the 
compounds were synthesized using Microwave assisted method which was found to 
be much faster than the conventional and the % yield was found to be higher than  
conventional methods. 
 In Section-C the targeted compounds such as N’-substituted benzoyl-2-propyl 
pentanehydrazide were synthesized from 2-propylpentanohydrazide by using base 
catalyst. These types of the compounds were synthesized at room temperature.  
 
3.C.9    CONCLUSION 
 
In conclusion, the compounds enlisted in this chapter are novel bioactive 
compounds for various biological activities. 
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3.C.10     REPRESENTATIVE SPECTRA 
 
3.C.10.1 Mass Spectrum of SPAM-01 
 
3.C.10.2 IR Spectrum of SPAM-01 
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3.C.10.3 1H NMR Spectrums of SPAM-01 
 
 
 
   EXPANDED 1H-NMR SPECTRUM OF SPAM-01 
 
 
O
NH
HN O
Cl
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3.C.10.4 Mass Spectrum of SPAM-02 
 
3.C.10.5 IR Spectrum of SPAM-02 
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3.C.10.6 1H NMR Spectrum of SPAM-02 
 
 
 
 EXPANDED 1H-NMR SPECTRUM OF SPAM-02 
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EXPANDED 1H-NMR SPECTRUM OF SPAM-02 
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CHAPTER - 4
SECTION - A
A RAPID MICROWAVE ASSISTED
SYNTHESIS OF 1-METHYL-3-
((1, 3 (SUBSTITUTED)-DIPHENYL-
1H-PYRAZOL-4-YL)METHYLENE)
QUINOLINE -2,4-(1H,3H)-DIONE
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4.A.1      PYRAZOLES : A VERSATILE SYNTHON 
 
Pyrazole refers both to the class of simple aromatic ring organic compounds of 
the heterocyclic series characterized by a five-membered ring structure composed of 
three carbon atoms and two nitrogen atoms in adjacent positions and to the 
unsubstituted parent compound. Being so composed and having pharmacological 
effects on humans, they are classified as alkaloids, although they are rare in nature. 
 
N
N
H
pyrazole
 
 
The synthesis of pyrazoles remains of great interest owing to the wide 
applications in pharmaceutical and agrochemical industry due to their herbicidal, 
fungicidal, insecticidal, analgesic, antipyretic and anti-inflammatory properties.1, 2 
Some methods have been developed in recent years, though the most important 
method is the reaction between hydrazines and β-dicarbonyl compounds.3 This 
reaction involves the double condensation of 1, 3-diketones or α, β-unsaturated 
ketones with hydrazine or its derivatives.4, 5 However, the appealing generality of this 
method is somewhat vitiated by the severe reaction conditions or the multistep 
sequences usually required to access the starting materials.6 Thus, continuous efforts 
have been devoted to the development of more general and versatile synthetic 
methodologies for this class of compounds.7 
 
N N
O
1,3-diphenyl-1H-pyrazole-4-carbaldehyde
 
 
The application of Vilsmeier–Haack (VH) reagent (POCl3 / DMF) for 
formylation of a variety of both aromatic and heteroaromatic substrates is well 
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documented.8 Besides this, the reagent has also been extensively used for effecting 
various chemical transformations from other classes of compounds. Many of these 
reactions have led to novel and convenient routes for the synthesis of various 
heterocyclic compounds.9 A notable example that finds significant application in 
heterocyclic chemistry is the synthesis of 4-formylpyrazoles from the double 
formylation of hydrazones with Vilsmeier-Haack (VH) reagent.10,11 These 
observations, coupled with the recent developments on the simple synthesis of 
pyrazole derivatives,1,2 especially 4-functionalized 1, 3-diphenylpyrazoles as 
antibacterial,12 anti-inflammatory,13,14 antiparasitic,15 and antidiabetic16 drugs, 
prompted chemistry research to undertake the synthesis of pyrazole-4-carboxldehyde 
derivatives using Vilsmeier-Haack (VH).17-19 The study is particularly aimed at 
developing a one-pot synthesis of pyrazole-4-carboxaldehyde oximes starting from 
acetophenone phenylhydrazones. 
The subsequent details are regarding several approaches related to quinolone 
nucleus, its modification and synthetic methods reported. 
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4.A.2 METHODS FOR PREPARATION : 2-QUINOLONES 
 
2-quinolones were prepared by various routes. However, we are discussing a few:- 
Following methods are used as most common and recent preparation 
strategies. 
Cyclization of o-benzamide cinnamic acid was discussed using HCl involving steps of 
condensation and deacylation.20 
 
H
N
O
O
OH
H
N OHCl, H2O
1600C, 2h
80%(E)-3-(2-(benzamido)phenyl)acrylic acid
quinolin-2(1H)-one
 
 
Cyclization of N-phenylcinnamamide in presence of AlCl321 
 
H
N O
quinolin-2(1H)-one
H
N
AlCl3
O
(84%)(E)-N-phenylcinnamamide
 
 
Hiroshi et al22 discuss ortho vinylation of aromatic anilines in presence of HCl 
via mechanism of cyclopalldation to prepare various nitrogen heterocycles including 
2-quinolones 
 
H
N
HClO
CH3
O
OMe
(E)-3-(2-(benzamido)phenyl)acrylic acid 54%
H
N O
quinolin-2(1H)-one
 
Chapter – 4 Section-A                                                            A Rapid Microwave Assisted ….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     126 
McCord et al23 discuss synthesis of 2-quinolones and substituted quinolones 
and other heterocycles by using 2-nitro aniline and substituted 1-propionic acid in 
presence of HCl and Na2CO3  
 
H
N O
quinolin-2(1H)-one
NO2
NH2
O
OH HCl, NaNO2
CuCl2
NO2
COOH
Cl
HCl, Na2CO3
2-nitrobenzenamine acrylic acid
 
2-quinolones can also be prepared by iodination of 2,2-dimethyl-N-phenyl 
propanamide in presence of iodine and butyl lithium and N,N,N’,N’-tetramethyl 
ethylene diamine. The product obtained was further cyclised using 2-Propenoic acid, 
methyl ester in presence of triethylamine and palladium acetate24 
 
H
N O
quinolin-2(1H)-one
H
N I2, BuLi
TMEDA, THF
NEt3, Pd (OAc)2
DMSOO
C4H9
N-phenylpentanamide
I
H
N
O
N-(2-iodophenyl)pivalamide
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter – 4 Section-A                                                            A Rapid Microwave Assisted ….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     127 
 4.A.3 METHODS FOR PREPARATION : N-METHYL-2-
QUINOLONES  
 
Several methods are reported for the preparation of 4-methyl quinolone. Many 
of these are synthesized bellow. 
 
1) It was prepared by cyclisation of N-methyl-N-phenylcinnamamide in presence of 
AlCl325 
 
N O
Me
(93%)
N
O
(E)-N-methyl-N-phenylcinnamamide
AlCl3
 
 
2) Oxidation of quinoline in presence of KMnO4 and Methyl Iodide results in 50% of 
N-methyl-2-quinolone.26 
 
N O
CH3
(50%)
KMnO4, MeCN
N
+MeI
quinoline
 
 
3) Chemoselective methylation of amides and heterocycles using 
chloromethyldimethylsilyl chloride in presence of other nucleophiles selectively 
yielded 77% of N-methyl-2-quinolone.27 
 
N O
CH3
(77%)
1-methylquinolin-2(1H)-one
(Me2Si)2NH, MeCN
H
N
+
CsF, (MeOCH2CH2)2O
Si
Cl
Cl
O
quinolin-2(1H)-onechloro(chloromethyl)dimethylsilane
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4) A rearrangement reaction of 2-methoxypyridine under Flash Vacuum Pyrolysis 
(FVP) conditions involving high temperature, low pressure and gas phase conditions 
to yield 50% of N-methyl-2-quinolone28 
 
N O
CH3
(50%)
1-methylquinolin-2(1H)-one
MeOH, 6 h
N
+
Cl
NaOMe
2-chloroquinoline
Reflux
N OMe
6000C, 0.1mmHg
Gas Phase
2-methoxyquinoline
 
5) Cyclisation reaction of N-aryl cinnamamides in presence of AlCl3 yielded desired 
products in 67% yield. Use of Bismuth Chloride gives selective cyclization29 
 
(67%)
N O
CH3
1-methylquinolin-2(1H)-one
N
O
(E)-N-methyl-N-phenylcinnamamide
AlCl3, PhCl
2 hrs, 900C
 
 
6) Similarly, cyclization reaction yielding N-methyl-2quinolones by 2-
Nitrobenzaldehydes. It involved the first step of reduction of 2-Nitrobenzaldehydes to 
2-aminobenzaldehyde, which was reacted immediately with acylchlorides to give 2-
carboxyamidobenzaldehydes. Subsequent reaction with a base yielded 3-substituted 
quinolinones. Further, treatment with Iodine in Methyl Iodide in basic medium gave 
3-substituted 1-methyl 2-quinolone.30 
 
N O
CH3
1-methylquinolin-2(1H)-one
Cs2CO3, DMF
400C, 1-48 hrs, 600C
H
N
CHO
OMeI
N-(2-formylphenyl)acetamide
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4.A.4 METHODS FOR PREPARATION : 4-HYDROXY-N-
METHYL-2-QUINOLONES  
 
1) Condensation of methylaniline and malonic acid diethyl ester yielded 19% of 4-
Hydroxy-N-methyl-2-quinolone31  
 
HN
CH3
O O
O
Et
O
Et
diethyl malonate
N-methylbenzenamine
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
(19%)
 
 
2) Cyclization reaction of N-acetyl-N-methyl anthranilic acid methyl ester in presence 
of LDA and THF gave the desired compound32 
 
N O
CH3
LiN(PrLi)2
OH
OMe
O
N
O
methyl 2-(N-methylacetamido)benzoate 4-hydroxy-1-methylquinolin-2(1H)-one
THF
 
 
3) Another cyclization reaction of compound ethyl 3(2-(methylamino) phenyl)-3-
oxopropanoete in toluene yields 4-hydroxy-N-methyl-2-quinolone.33  
 
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
Toluene
O
N
H
O
O
Et
ethyl 3-(2-(methylamino)phenyl)-3-oxopropanoate
 
 
4) Some authors used mushroom tyrosinase as catalyst to synthesize coumestans, 
benzofurans and other heterocyclic compounds. Similarly, they used N-
methylanthranilic acid and acetic acid in presence of mushroom tyrosinase34 
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N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
R=AcOH
O
N
H
OH
(35%)
2-(methylamino)benzoic acid
 
 
5) Deacetylation under acidic conditions under MicroWave irradiation for 2 mins 
resulted in 95% if 4-hydroxy-N-methyl-2-quinolone.35 
 
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
H2SO4, H2O
(95%)
2 min, MW
N O
OH
CH3
O
3-acetyl-4-hydroxy-1-methylquinolin-2(1H)-one
 
 
6) A convenient one-pot synthesis of 2,4-quinolone by condensation of malonyl 
chloride with N-methylaniline in presence of benzene under 2 hours reflux resulted in 
85 % of 4-hydroxy-N-methyl-2-quinolone36  
 
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
Benzene
(85%)
2 h, Reflux
N
CH3
Cl
OO
Cl
malonyl dichloride
1,2-dihydro-1-methylpyridine
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4.A.5 REACTIONS OF 4-HYDROXY-N-METHYL-2-QUINOLONES  
 
1) Reaction of 4-hydroxy-2-quinolone with 3-bromopropyne in presence of 
K2CO3 and dimethylketone resulted in mixture of three products as shown 
below37 
 
N O
CH3
O
N O
CH3
OH
CH3
Br
4-hydroxy-1-methylquinolin-2(1H)-one (52%)
H2
C C CH
N O
CH3
O
H2
C C CH
H2C C CH
(23%)
N O
CH3
O
H2C C CH
H2
C C CH
(20%)
 
 
2) Reaction of 4-hydroxy-2-quinolone with 2,3-dichloropropene in presence of 
potassium carbonate resulted in a mixture of 4-((2-chloro-2-propenyl)oxy)-1-methyl -
2,4-quinolinedione and 3,3-bis-((-2-chloro-2-propenyl)oxy)-1-methyl-2,4-
quinolinediones.38 
 
N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
(42%)
CH2
Cl
Cl
CH2
Cl N O
CH3
O
C
CH2
Cl
C
CH2
Cl
 
 
3) 4-hydroxy-2-quinolone reacts with Apple’s salt in presence of pyridine in 
Methylene dichloride to gave (3Z)-3-(4-chloro-5H-1, 2, 3-dithiazole-5-ylidene)1-
methylquinoline-2,4(1H,3H)-dione.39 
 
Chapter – 4 Section-A                                                            A Rapid Microwave Assisted ….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     132 
N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
N
S S
Cl
Cl
Cl
MDC
Pyridine
(Apple's Salt)
N
S
S
Cl
(3Z)-3-(4-chloro-5H-1,2,3-dithiazol-5-yli
dene)-1-methylquinoline-2,4(1H,3H)-dione
 
4) The preparation of 3-methylurea derivatives of 4-hydroxy-2-quinolone in presence 
of urea and triethylorthoformate in dioxan is reported.40  
 
N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
CH(OMe)3 NH2CONH2
Reflux
5 hrs
H
N NH2
O
(76%)
 
 
5) Reaction of 4-hydroxy-N-methyl-2-quinolone with substituted ureas in presence of 
triethyl orthoformate and using dioxane as solvent were also afforded 67-96% yield 
(4-5 reactions to be compiled in one)41 
 
N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
CH(OHMe)3 NH2CONH
Reflux
5 hrs, Dioxane
H
N
H
N
O
R
R= CH3, n-Bu, 1-Propene, Ph
R
 
6) One-pot, microwave assisted synthesis of 3-substututed-N-Methyl-2, 4-
Quinolinedione in solution phase using 1,2-dimethoxytrimethylamine were 
investigated.42  
N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
5 min N
MeO
CH
MeO
N
1500C
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Similarly, using the above scheme, dimethoxy triethylamine with 4-hydroxy-1-
methylquinoline-2(1H)-one gave 58% of 3-substituted product as shown below  
 
N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
5 min
NHMeO
CH
MeO
N
1500C
OMe
O
CN
OMe
4-(4-methoxyphenyl)
-3-oxobutanenitrile
(58%)
 
 
7) Knoevanagel condensation of 4-hydroxy-N-methyl-2-quinolone in presence of 
aldehyde and pyridine was (refluxed for 3 hours) yielded 78% of N-methyl-3(-1-
phenylmethylene)-2, 4-quinolinedione.43 
 
N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methyl
quinolin-2(1H)-one
OH
benzaldehyde
Py, 3 hrs
Reflux
 
 
8) 4-hydroxy-N-methyl-2-quinolone in presence of o-aminopyridine and 1,1-
dimethoxytrimethylamine in toluene under reflux conditions yielded 83% of N-
methyl-3-[-2-pyridynylamino)methylene)-2,4-quinolinedione44 
 
N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methyl
quinolin-2(1H)-one
2 h, Reflux
H
N
MeO
CH
MeO
N TolueneN
NH2
pyrimidin-2-amine
N
(83%)
 
 
Similarly, using 3-aminopyridine and 2-aminopyrimidine gave corresponding 
products in 83-86% yield.  
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N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methylquinolin-2(1H)-one
2 h, Reflux
H
N
MeO
CH
MeO
N
Toluene
N N
NH2
pyrimidin-2-amine N
N
(86%)
 
 
9) Reimer-Tiemann reaction reported between 4-hydroxy-N-methyl-2-quinolone and 
4-amino antypyrine two were refluxed under alkaline conditions followed by 
overnight reflux in AcOH yielded 90% of 3-substituted product45 
 
N O
CH3
O
N O
CH3
OH
4-hydroxy-1-methyl
quinolin-2(1H)-one
H
N
N
N
H2N
O
4-amino-1,2-dihydro-1,5-di
methyl-2-phenylpyrazol-3-one
NaOH2H2O, 6h, Reflux
AcOH, 2h, Reflux
N
N
O
Ph
(90%)
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4.A.6 3-DIAZO ANALOGUES OF 4-HYDROXY-N-METHYL-2-
QUINOLONES 
 
1) The authors reported two sublimation fast polyester dyes prepared from 
diazotization reaction of (1) with 4-hydroxy-N-methyl-2-quinolone at pH >8 for 
polyester and polyamide fibers.46 Similarly, diazotization of 3-amino-
C6H3SO2CH=CHCl2 with 4-hydroxy-N-methyl-2-quinolone at pH 9-10 resulted in 
monoazo dyes.  
 
N
R
N
N
OH
R1
S
O
O
Cl
Cl
R= CH3, H
R1= H, OCH3
 
 
2) Sato et al have reported that halogenation of 3-phenylazo-4-hydroxy-2-quinolone 
yielded a better quality of dyes for polyesters fiber.47  
 
N
R
O
OH
N
N
X
R= Alkyl or Substituted alyl,
X= CN, NO2, alkoxy, hlogen
 
 
3) Some authors used standard diazotization techniques using HCl and NaNO2 as 
below48 
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N
Me
O
OH
HN S
O
O
N
O
N-(3-((E)-2-(dimethylamino)
vinylsulfonyl)phenyl)acetamide
HCl, NaNO2
N
Me
O
OH
N
N
SO O
N
4-hydroxy-1-methyl
quinolin-2(1H)-one
 
4) Synthesis and dying performance of mono and bis-azo 4-hydrxy-N-methyl-2-
quinolones of structures I, II, III are well documented49 
 
N
CH3
O
OH
N
H
R1 N
N
R
N
R2
R3
N
N
N
CH3
O
R1 OH
N
N
R
(I)
(II)
R=p-Me-C6H4, p-MeOC6H4, p-NO2-C6H4
R1=H, -COCH3
R= p-Me-C6H4, 1-naphthyl, p-NO2-C6H4
R2=R3=Me, CH2Cl2, CN, CH2CH2OH
R4= H, Cl
N
CH3
O
OH
N
NR3 N
N R2
N
R
R1
(III) R= R1=Me, CH2CH2CN, CH2CH2OH
R2= H, Cl
R3= H, NO2  
 
5) The inventors of patent claim preparation and uses of sulphonated quinolone dyes 
and it’s use as fiber reactive dyes as per scheme shown below50 
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N
CH3
O
OH
S
OO
O
SO3H
H2N
OH
4-hydroxy-1-methyl
quinolin-2(1H)-one
2-(3,4-dimethylphenylsulf
onyl)ethyl hydrogen sulfate
N
CH3
O
OH
N N
(3E)-3-(2-phenyldiazenyl)-4-hy
droxy-1-methylquinolin-2(1H)-one
NaNO2/HCl, H2O
NaNO3, CuSO4, Na2CO3
 
6) Preparation of various bis-azo disperse dyes for polyester by reaction of n-(4-
aminophenyl)-acetamide with N-methyl-4-hydroxy-2-quinolone in dimethylketone in 
basic medium is reported51 
 
N
CH3
O
OH
H2N
NHAc
N
CH2
O
OH
4-hydroxy-1-methyl
quinolin-2(1H)-one
N-(4-aminophenyl)
acetamide
N
N
N
H
NaOH, CH3COCH3, H2O
AcOH, H2O O
 
 
7) These authors specifically prepared 12 3-(arylazo)-4-hydroxy-1-methyl-2-(1H)-
Quinolone dyes by coupling reaction between 4-hydroxy-1-methyl-2(1H)-Quinolone 
with 12 different diazo compounds as depicted below52 
 
N
CH3
O
OH
H2N
N
CH3
O
OH4-hydroxy-1-methyl
quinolin-2(1H)-one
N
N
NaOH, CH3COCH3, H2O
AcOH, H2O
R
R
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4.A.7 BIOLOGICAL IMPORTANCE  
 
4.A.7a QUINOLONE AND ITS DERIVATIVES: 
 
Quinolones act as Local anesthetic,53 Quinolone substituted by pipirazine can 
act as cardiotonic agents54 also useful in treatment like Peptic Ulcer treatment55 
Anticoagulants56 Thrombosis and Phosphodiesterase inhibitors57 Antidiabetic58  
Somatostatin decreasing inhibitor59 Oxytocin antagonists60 Antipsorasis61 
Antiinfective62 Inhibitors of necrosis factor as well as interleukin 6 production63 
Neutrophil induced inflammation inhibitor64 Rejection inhibitor for transplants65 
Hepatocyte growth factor enhancers66 Virus replication inhibitor67 Cardiac Fibroblast 
inhibitors68 Anti multiple sclorosis69 For mood disorders in addition to serotponin 
uptake inhibitors70 For accelerating salivation,71 It is also discussed to have B-
adrenoreceptor agonist properties.72 
 
US 3493464 disclose the use of metallic quinolinolate complex formed in-situ 
to have fungus static activity. They prepared Ferrous, Manganese, Copper, Nickel and 
Zinc Complexes73 
 
Co
N
N
OO 2+ --
 
 
Mutagenicity of quinolines and various quinolones were studied in Salmonella 
Typhurium.74 Quinolones are also known to bind to RNA, DNA and pol nucleotides 
in presence of NADPH and rat liver microsomes and it metabolises into various 
substituted quinolones incl 2-quinolone.75 
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Similarly, 4-hydroxy-2-quinolone were also reported to have many biological 
activities. Shah A et al discussed antimicrobial/antitubercular screening of substituted 
2,4-dihydroxyquinolones.76 Naturally occurring 4-hydroxy-2-quinolones were isolated 
from Haplophyllum A. Juss. and were checked for cytotoxic activity of 2,4-quinolone on 
human cancer cell line77 
 
It was found that 4–hydroxy-2-quinolone having trimethyl flouro or flouro 
substituent are important for  pharmacological and synthetic targets and also act as 
basic synthon for number of antibacterial fluoroquinolones and are promising potent 
and selective glycine site NMDA receptors. A simple one step MW assisted synthesis 
was described and it’s phytotoxicity as well as cytotoxicity was evaluated against 
Leukemia and adrenocarcinome derived cell line.78  
 
H
N O
OH
R R = 7CF3, 8CF3, 6F, 7F, 8F
 
 
4.A.7b N-METHYL 2-QUINOLONES: 
 
1) N-methyl-2-quinolone and was reported as fungistats and also posseses 
fungicidal properties79, 2) In 1981, N-methyl-2-quinolone was reported as the bitter 
constituent of heamolymph in aposematic beetle80. 3) In some of the antifungal 
studies it was found that N-methyl-2-quinolone were non-toxic to the mycelial growth 
of Pyrucularia Oryzae which causes rice blast disease in vitro and they did not inhibit 
conodial formations too. However, the studies indicated that it did block melanization 
of appresoria and prevented the penetration of infected hyphae through the epidermal 
wall. The reason was that these compounds blocked pathway of melanin synthesis 
between scylactone and vermelone81. 4)  N-methyl-2-quinolone was reported to 
covert into 2,4-dione analogue in presence of  milk xanthine oxidase and hence acts as 
competitive inhibitor of the same enzyme82. 5) It is found out that N-methyl-2-
quinolone inhibits 1,8-dihydroxynaphthalene-melanin biosynthesis and in turn 
melanin synthesis in the conodia of Penicillium and Aspergillus species.83  6) In 1999, 
it was extracted from Galipea Officianallis (This species is the only known species 
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which contains tetrahydroquinoline alkaloids) The ethnolic extract was found to be 
active against Mycobacterium Tuberculosis84 7) The alkaloids from Galipea 
Officianallis were analysed using GC-MS and five new tetrahydroquinolines were 
identified85 
 
H
N
O
O
(1)
H
N
OH
OH
(2)
4-(2-(1,2,3,4-tetrahydroquinolin-
2-yl)ethyl)benzene-1,2-diol2-(2-(benzo[d][1,3]dioxol-7-yl)
ethyl)-1,2,3,4-tetrahydroquinoline
H
N
OMe
OMe
2-(3,4-dimethoxyphenethyl)-1,2,3,4-tetrahydroquinoline
(3)
H
N
1,2,3,4-tetrahydro-2-pentylquinoline
(4)
N
CH3
1,2,3,4-tetrahydro-1-methyl-2-propylquinoline
(5)  
 
 
4.A.7c 4-HYDROXY N-METHYL 2-QUINOLONES: 
 
1) Biotransformation of alkaloids through intermediate stage of 4-hydroxy-quinolones 
by aid of cell suspension cultures of  Ruta Graveolens was reported86 
2) It was reported as hair dye coupler and similar applications87-89 
3) It was isolated from fermentation broth of Dactylosporangium species and it acted 
as Chymase inhibitor.88 
5) Benzalacetone synthase enzyme derived from Rheum Palmatum efficiently 
catalysed the condensation of anthraninoyl-COA with Malonyl-COA to produce 4-
hydroxy-quinolones – an alkaloid scaffold normally produced by type III polyketide90 
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4.A.8    AIM OF CURRENT WORK 
 
4-hydroxy 2-quinolones and aromatic aldehydes are known to produce 2, 4-
chromane diones (arylidine at C3 position) and coumarin dimers under reflux, with or 
without base. Thus, few new chromane diones were prepared using pyrazole 
aldehydes. 
 
Though the chemistry of the synthesized compounds is known, the compounds 
are reported herein for the first time. Biological importance of such important 
compounds is the rational behind the current work done in chapter-7. 
The current chapter is related to preparation of small molecules based on 
Quinolones and Pyrazoles together.  
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4.A.9      REACTION SCHEMES 
 
 
4.A.9.1 PREPARATION OF PYRAZOLE ALDEHYDES 
 
STEP – 1 
 
 
H
N
NH2
H3C
O
R
H
N
N
R
CH3
Gla. acetic acid
ethanol,     5-6 hrs.
where R=H,4-NO2,4-Cl, etc.
∆
 
 
 
STEP – 2 
 
 
H
N
N
R
CH3
N
N
O
R
DMF-POCl3
 70-800C 5-6 hrs.
where R=H,4-NO2,4-Cl, etc.
∆
 
 
 
4.A.9.2 PREPARATION OF (E)-1-METHYL-3-((1, 3 (SUBSTITUTED)-
DIPHENYL-1H-PYRAZOL-4-YL)METHYLENE) QUINOLINE -
2,4-(1H,3H)-DIONES 
 
 
N
CH3
O
OH
N
N
O
R
N
CH3
O
N N
R
O
where R=H,4-NO2,4-Cl, etc.
Base
MW-450watt
10-12mins.
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4.A.10    PLAUSIBLE REACTION MECHANISM 
 
 
N
N
O
H
R
H++ N
N
OH+
H
R
N
N C+
OH
H
R
+
N
CH3
O
OH..
N
N
OH
N
CH3
O
OH+
H
R
H+- N
N
OH
N
CH3
O
OH
R
H++ N
N
OH2
+
N
CH3
O
OH
R
..
..
OH2- N
N
N
CH3
O
O+ H
R
H+- N
N
N
CH3
O
O
R
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4.A.11     EXPERIMENTAL 
 
4.A.11.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. All the reactions were 
carried out in Samsung MW83Y Microwave Oven which was locally modified for 
carrying out chemical reactions. IR spectra were recorded in Shimadzu FT-IR-8400 
instrument using KBr pellet method. Mass spectra were recorded on Shimadzu GC-
MS-QP-2010 model using Direct Injection Probe technique. 1H NMR was determined 
in CDCl3 solution on a Bruker Ac 400 MHz spectrometer. Elemental analysis of the 
all the synthesized compounds was carried out on Elemental Vario EL III Carlo 
Erba 1108 model and the results are in agreements with the structures assigned. 
 
4.A.11.2 PREPARATION OF PYRAZOLE ALDEHYDE : GENERAL 
METHOD 
 
STEP – [1] PREPARATION OF ACETOPHENONE PHENYL HYDRAZONES 
 
 
Substituted acetophenone (0.1 mole) was dissolved in 50 ml of ethanol into 
250 ml round bottom flask. and Phenyl hydrazine (0.1 mole) was added to above flask 
along with 3-4 drops of glacial acetic acid. The reaction mixture was refluxed for 5-6 
hours. The progress and the completion of the reaction were checked by silica gel-G 
F254 thin layer chromatography using toluene : ethyl acetate (7 : 3) as a mobile phase. 
After the reaction to be completed, the reaction mixture was cooled to room 
temperature and the crystalline product was separated by filtration. The product was 
washed with ethanol and dried to give substituted acetone phenyl hydrazone in good 
yield which was pure enough to use as such for the next step. 
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Code No. MF MW (g/m) MP (°C) % Yield 
APH-01 C14H13N3O2 255 134-136 85 
APH-02 C14H13ClN2 244 ----- 80 
APH-03 C14H14N2 210 126-128 78 
APH-04 C14H13N3O2 255 106-108 79 
APH-05 C14H13ClN2 244 ----- 72 
APH-06 C15H16N2 224 ----- 72 
 
 
STEP – [2] PEPARATION OF PYRAZOLE ALDEHYDES  
 
25 ml of dry dimethylformamide was transferred into 250 ml flat bottom flask. 
3 ml of phosphorous oxychloride was added drop wise to above flask under stirring at 
0-5°C. After completion of the addition, the mixture was stirred at this temperature 
for 10-15 min. Acetophenone phenyl hydrazone (0.03 mole) freshly prepared was 
added to above mixture and the content was heated on water bath for 5-6 hours. The 
progress and the completion of the reaction were checked by silica gel-G F254 thin 
layer chromatography using toluene : ethyl acetate (7 : 3) as a mobile phase. After the 
reaction to be completed, the reaction mixture was cooled to room temperature and 
the content of the flask was poured on crushed ice to isolate the product. The 
separated product was filtered off and it was washed with cold water to remove 
acidity. It was dried at 65°C and recrystallized from the mixture of DMF-Methanol to 
give crystalline pyrazole aldehyde in good yield.  
Similarly other compounds are also prepared. 
 
TABLE-4.A.1 
Code No. MF MW (g/m) MP (°C) % Yield 
PA-01 C16H11N3O3 293 162-164 75 
PA-02 C16H11ClN2O 282 142-144 71 
PA-03 C16H12N2O 248 144-146 68 
PA-04 C16H11N3O3 293 176-178 72 
PA-05 C16H11ClN2O 282 140-142 71 
PA-06 C17H14N2O 262 152-154 70 
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4.A.11.3 PREPARATION OF 1-METHYL-3-((1, 3 (SUBSTITUTED)-
DIPHENYL-1H-PYRAZOL-4-YL)METHYLENE) QUINOLINE -
2,4-(1H,3H)-DIONES (SP-40-SP-45) : GENERAL METHODS 
 
[A] CONVENTIONAL METHOD 
 
N-methyl4-hydroxyquinolone (0.01 mole) was dissolved in 20 ml of 
dimethylformamide into 100 ml round bottom flask. Substituted pyrazole-4-
carboxaldehyde (0.01 mole) was added to the above flask along with few drops of 
piperidine. The reaction mixture was heated on water bath for 4-5 hours. The progress 
and the completion of the reaction were checked by silica gel-G F254 thin layer 
chromatography using hexane : ethyl acetate (6 : 4) as a mobile phase. After the 
reaction to be completed, the reaction mixture was cooled to room temperature and 
the product was separated by filtration. The product was washed with methanol and 
dried to give desired product in good yield which was recrystallized by DMF. 
Physical data of the synthesized end products are summarized in the Table No. 4.A.3.  
Similarly other compounds are also prepared. 
 
[B] MICROWAVE METHOD 
 
N-methyl4-hydroxyquinolone (0.01 mole) was dissolved into 20 ml of 
dimethylformamide into 100 ml microwave flask. Substituted pyrazole-4-
carboxaldehyde (0.01 mole) was added to the above flask along with few drops of 
piperidine. The reaction mixture was irradiated under microwave irradiation using 
Qpro-M microwave synthesizer for the desired time at 450 W. The progress and the 
completion of the reaction were checked at interval of every one min. by silica gel-G 
F254 thin layer chromatography using hexane : ethyl acetate (6 : 4) as a mobile phase. 
After the reaction to be completed, the reaction mixture was scratched into 30 ml of 
methanol. The separated product was filtered off and washed with methanol and it 
was dried to give desired product in good yield which was recrystallized by DMF. 
Physical data of the synthesized end products are summarized in the Table No. 4.A.3.  
Similarly other compounds are also prepared. 
 
 
 
Chapter – 4 Section-A                                                            A Rapid Microwave Assisted ….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     147 
COMPARATIVE RESULTS OF METHOD (A) AND METHOD (B) ARE 
SUMMARIZED AS UNDER. 
 
TABLE-4.A.2 
Code No. 
Reaction Condition % Yield 
Method (A) Method (B) Method 
(A) 
Method 
(B) Temp.  
(°C) 
Time  
(hrs.) 
Watt 
(W) 
Temp. 
(°C) 
Time 
(min.) 
SP – 40 150-160  4.5  450 110  3.0  68 85 
SP – 41 150-160  5.0  450 110  3.3 64 80 
SP – 42 150-160 4.8  450 110  3.1 70 83 
SP – 43 150-160 5.5  450 110  3.2 72 81 
SP – 44 150-160  5.3  450 110  3.0 66 79 
SP – 45 150-160 5.1 450 110  3.2 62 76 
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4.A.12     PHYSICAL DATA 
 
PHYSICAL DATA OF 1-METHYL-3-((1, 3 (SUBSTITUTED)-DIPHENYL-1H-
PYRAZOL-4-YL)METHYLENE) QUINOLINE -2,4-(1H,3H)-DIONES (SP-40 
TO SP-45) 
 
 
N
O
O
N
N
R
 
 
TABLE-4.A.3 
Sr. 
No. 
Code 
Name 
& No.
Substitutions 
Molecular 
Formula 
Molecular 
Weight 
M.P. 
0C 
Rf 
Value 
01 SP-40 4-NO2 C26H18N4O4 450 162-164 0.48 
02 SP-41 4-Cl C26H18ClN3O2 439 170-172 0.44 
03 SP-42 H C26H19N3O2 405 178-180 0.52 
04 SP-43 3-N02 C26H18N4O4 450 168-170 0.40 
05 SP-44 3-Cl C26H18ClN3O2 439 156-158 0.46 
06 SP-45 4-CH3 C27H21N3O2 419 174-176 0.44 
      
Rf value was calculated using solvent system, Hexane : Ethyl Acetate (6 : 4) 
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4.A.13    SPECTRAL DISCUSSION 
 
4.A.13.1    MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. SP-40 and SP-41 of Mass 
spectra are given on page no. 154 and 156. 
 
4.A.13.2    IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT IR 
8400 spectrophotometer using Diffused Reflectance Attachment (DRA) System using 
Potassium Bromide. 
In case of SP-40 to SP-45 of –CH stretching vib. of aromatic were found near 
3040 cm-1 . –CH stretching of assym were found near 2960 cm-1. –CH stretching of 
sym. were found near 2870 cm-1. Two Carbonyl stretching frequencies were obtained 
near 1700 cm-1. –CH deformation assym were found near 1460 cm-1. –CH 
deformation sym. were found near 1370 cm-1. SP-40 and SP-41 of IR spectra are 
given on page no. 154 and 156. 
 
4.A.13.3    1H NMR SPECTRA 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer. Sample solutions were made in DMSO solvent using 
tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons identified from H NMR spectrum and their chemical shift (δ 
ppm) were in the agreement of the structure of the molecule. J values were calculated 
to identify o, m and p coupling. In some cases, aromatic protons were obtained as 
multiplet. 1H NMR spectral interpretation can be discussed as under. 
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1H NMR OF 1-METHYL-3-((3-(4-NITROPHENYL)-1-PHENYL-1H-PYRAZOL-4-
YL)METHYLENE)QUINOLINE-2,4(1H,3H)-DIONE (SP-40) 
 
N
O
O
N
N
NO2H3C
1
2
3
4
5
6
7
8
9
10
11
12
1314
15
16
 
 
1. The Proton no. 1 of N-Methyl group gave a characteristic singlet at 2.13 δ 
ppm. 
2. Arylidine proton of Proton no. 2 became deshielded and gave a characteristic 
singlet at 6.43 δ ppm. The assignment of this proton is the most important for 
the structure elucidation and as it is evident here the successful assignment of 
this singlet has confirmed our structure. 
3. The Proton no. 3 and 6 of phenyl ring gave a doublet at 7.66 δ ppm – 7.68 δ 
ppm. and J value of this proton is 8.0 Hz. It suggests ortho coupling.  
4. The Proton no. 4 and 5 of phenyl ring gave a doublet at 7.79 δ ppm – 7.81 δ 
ppm. and J value of this proton is 8.0 Hz. It suggests ortho coupling. 
5. The Proton no. 13 and 16 of two proton gave a multiplet at 7.26 δ ppm – 7.33 
δ ppm. 
6. The Proton no. 8, 9 and 10 of three proton gave a multiplet at 7.36 δ ppm – 
7.47 δ ppm. 
7. The Proton no. 7 ,11 and 12 of three proton gave a multiplet at 8.06 δ ppm – 
8.12 δ ppm. 
8. The Proton no. 14 and 15 of two proton gave a multiplet at 7.57 δ ppm – 7.61 
δ ppm.  
Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound no. SP-40 has been confirmed for cis geometrical. Spectrum is given on  
page no. 155. 
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1H NMR OF 3-((3-(4-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOL-4-
YL)METHYLENE)-1-METHYLQUINOLINE-2,4(1H,3H)-DIONE (SP-41) 
 
N
O
O
N
N
ClH3C
1
2
3
4
5
6
7
8
9
10
11
12
1314
15
16
 
 
1. The Proton no. 1 of N-Methyl group gave a characteristic singlet at 2.13 δ 
ppm. 
2. Arylidine proton of Proton no. 2 became deshielded and gave a characteristic 
singlet at 6.37 δ ppm. The assignment of this proton is the most important for 
the structure elucidation and as it is evident here the successful assignment of 
this singlet has confirmed our structure. 
3. The Proton no. 3 and 6 of phenyl ring gave a doublet at 6.82 δ ppm – 6.84 δ 
ppm. and J value of this proton is 8.0 Hz. It suggests ortho coupling.  
4. The Proton no. 4 and 5 of phenyl ring gave a doublet at 7.17 δ ppm – 7.19 δ 
ppm. and J value of this proton is 8.0 Hz. It suggests ortho coupling. 
5. The Proton no. 13 and 16 of two proton gave a multiplet at 7.22 δ ppm – 7.26 
δ ppm. 
6. The Proton no. 8, 9 and 10 of three proton gave a multiplet at 7.40 δ ppm – 
7.44 δ ppm. 
7. The Proton no. 7 and 11 of two proton gave a multiplet at 7.61 δ ppm – 7.65 δ 
ppm. 
8. The Proton no. 14 and 15 of two proton gave a doublet at 7.75 δ ppm – 7.77 δ 
ppm. and J value of this proton is 8.0 Hz. It suggests ortho coupling. 
9. The Proton no. 12 of pyrazole ring gave a singlet at 8.00 δ ppm. 
Thus, by observing and assigning the peaks in the NMR spectrum and by 
the calculation of the J values for each of the above proton, the proposed structure for 
compound no. SP-41 has been confirmed for cis geometrical. Spectrum is given on  
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page no. 157. 
 
4.A.13.4 ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds. The spectral and elemental analysis data are given for individual 
compounds. 
 
4.A.14    ANALYTICAL DATA 
 
1-methyl–3-((3-(4-nitrophenyl)-1-phenyl-1H–pyrazol-4-yl)methylene)quinoline-2,4 
(1H,3H)-dione  (SP-40):   
IR (KBr, cm-1): 3032 (Ar-H, str.), 2946 (-CH str. Assym.), 2876 (-CH str. Sym.), 1692 
(>CO str.), 1624 (C=C alip.), 1540 (C=C, Ar.), 1451 (-CH def. Assym.), 1368 (-CH 
def. Sym.), 1122, 1095 (N-N str.), 754 (1,4-di sub); 1H NMR (400 MHz, DMSO): δ 
(ppm) 2.13 (3H, S), 6.43 (1H, S), 7.33 (2H, m,), 7.47 (3H, m), 7.61 (2H, m), 7.68 
(2H, d, J=8.0 Hz), 7.81 (2H, d, J=8.0 Hz), 8.12 (3H, m); MS m/z = 450 (M+); Anal. 
Calcd. for C26H18N4O4: C, 69.33; H, 4.03; N, 12.44; O, 14.21. Found: C, 69.30; H, 
4.01; N, 12.39; O, 14.20%. 
 
3-((3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1-methylquinoline-
2,4(1H,3H)-dione (SP-41):  
IR (KBr, cm-1): 3034 (Ar-H, str.), 2941 (-CH str. Assym.), 2866 (-CH str. Sym.), 1697 
(>CO str.), 1626 (C=C alip.), 1541 (C=C, Ar.), 1452 (-CH def. Assym.), 1371 (-CH 
def. Sym.), 1126, 1093 (N-N str.),  756 (1,4-di sub); 1H NMR (400 MHz, DMSO): δ 
(ppm) 2.13 (3H, S), 6.37 (1H, S), 6.84 (2H, d, J=8.0 Hz), 7.19 (2H, d, J=8.0 Hz), 7.26 
(2H, m), 7.44 (3H, m), 7.65 (2H, m), 7.77 (2H, d, J=8.0 Hz), 8.00 (1H, S); MS m/z = 
439 (M+), 441(M+2) ; Anal. Calcd. for C26H18ClN3O2: C, 70.99; H, 4.12; N, 9.55; O, 
7.27. Found: C, 70.93; H, 4.10; N, 9.55; O, 7.22%. 
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1-methyl-3-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)quinoline-2,4(1H,3H)-dione 
(SP-42):  
IR (KBr, cm-1): 3039 (Ar-H, str.), 2956 (-CH str. Assym.), 2874 (-CH str. Sym.), 1681  
(>CO str.), 1627 (C=C alip.), 1545 (C=C, Ar.), 1454 (-CH def. Assym.), 1371 (-CH 
def. Sym.), 1147, 1095 (N-N str.); MS m/z = 405 (M+); Anal. Calcd. for C26H19N3O2: 
C, 77.02; H, 4.72; N, 10.36; O, 7.89. Found: C, 77.00; H, 4.71; N, 10.33; O, 7.82%. 
 
1-methyl-3-((3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)quinoline-
2,4(1H,3H)-dione (SP-43):  
IR (KBr, cm-1): 3038 (Ar-H, str.), 2946 (-CH str. Assym.), 2864 (-CH str. Sym.), 1690 
(>CO str.), 1626 (C=C alip.), 1548 (C=C, Ar.), 1450 (-CH def. Assym.), 1371 (-CH 
def. Sym.), 1124, 1093 (N-N str.), 752 (1,4-di sub); MS m/z = 450 (M+); Anal. Calcd. 
for C26H18N4O4: C, 69.33; H, 4.03; N, 12.44; O, 14.21. Found: C, 69.30; H, 4.00; N, 
12.43; O, 14.19%.  
 
3-((3-(3-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1-methylquinoline-
2,4(1H,3H)-dione (SP-44):  
IR (KBr, cm-1): 3044 (Ar-H, str.), 2942 (-CH str. Assym.), 2863 (-CH str. Sym.), 1688 
(>CO str.), 1626 (C=C alip.), 1538 (C=C, Ar.), 1451 (-CH def. Assym.), 1371 (-CH 
def. Sym.), 1122, 1093 (N-N str.), 754 (1,4-di sub);  MS m/z = 439 (M+), 441(M+2); 
Anal. Calcd. for C26H18ClN3O2: C, 70.99; H, 4.12; N, 9.55; O, 7.27. Found: C, 70.94; 
H, 4.11; N, 9.52; O, 7.23%. 
 
1-methyl-3-((1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)methylene)quinoline-2,4(1H,3H)-
dione (SP-45):  
IR (KBr, cm-1): 3030 (Ar-H, str.), 2944 (-CH str. Assym.), 2868 (-CH str. Sym.), 1694 
(>CO str.), 1624 (C=C alip.), 1541 (C=C, Ar.), 1456 (-CH def. Assym.), 1370 (-CH 
def. Sym.), 1124, 1095 (N-N str.), 752 (1,4-di sub);  MS m/z = 419 (M+); Anal. Calcd. 
for C27H21N3O2: C, 77.31; H, 5.05; N, 10.02; O, 7.63. Found: C, 77.30; H, 5.01; N, 
10.00; O, 7.61%.   
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4.A.15    REPRESTANTIVE SPECTRA 
 
4.A.15.1 Mass Spectrum of SP-40   
 
 
 
4.A.15.2 IR Spectrum of SP-40 
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4.A.15.3 1H NMR Spectrum of SP-40 
 
 
  
  EXPANDED 1H-NMR SPECTRUM OF SP-40 
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4.A.15.4 Mass Spectrum of SP-41 
 
 
 
4.A.15.5 IR Spectrum of SP-41 
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4.A.15.6 1H NMR Spectrum of SP-41 
 
 
 
EXPANDED 1H-NMR SPECTRUM OF SP-41 
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4.B.1    COUMARINS 
 
Coumarin is a chemical compound (2H-chromen-2-one, 1-benzopyran-2-one, 
benzopyrone; C9H6O2); a toxin found in many plants, notably in high concentration in 
the tonka bean, vanilla grass, woodruff, mullein and bison grass. It has a sweet scent, 
readily recognised as the scent of newly-mown hayand has been used in perfumes 
since 1882. It has clinical medical value as the precursor for several anticoagulants, 
notably warfarin and is used as a gain medium in some dye lasers. 
 
 
 
 
 
 
 
 
    Fig. 4.1 
 
The isolation of coumarin was first reported by Vogel1 in 1820. He isolated 
coumarin from tonka beans, bearing the characteristic aroma of cutted grass. The 
name of coumarin originates2 from a Caribbean word “coumarou” for the tonka tree, 
which was known botanically at one time as Coumarouna odorta Aubl, coumarin is 
now the accepted trival name. Coumarin was first synthesized in 1868 on treatment of 
sodium salt of o-hyroxy benzaldehyde with acetic anhydride.3a,3b Compounds 
containing coumarin subunit possess a wide range of activities and show an 
interesting reactivity.4-7 This is consequence of the rich electronic structure of 
coumarin which offers abundant possibilities for diversified activity and reactivity of 
the system.  
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4.B.2      SYNTHESIS OF 4-HYDROXY COUMARINS 
 
Perkin3 synthesized coumarin and then several methods are reported for the 
synthesis of 4-hydroxy coumarins and their 4-hydroxy substituted derivatives namely: 
 
1 Anschutz method8 
2 Pauli Lockemann synthesis9 
3 Sonn's synthesis10 
4 Mentzer's synthesis11 
5 Robertson synthesis12 
6 Ziegler and Junek method13 
7 Garden's method14 
8 Shah, Bose and Shah's method15 
9 Kaneyuki method16 
10 Resplandy's method17 
11 Jain, Rohatagi and Sheshadri's method18 
12 Shah, Bhatt and Thakor's method19 
 
Shah and co-workers15, 19 have prepared 4-hydroxy coumarin derivatives in 
good yield by condentation of different phenols with malonic acid in the presence of 
zinc chloride and phosphorous oxychloride. The method is useful as single step 
preparation of 4-hydroxy coumarin derivatives substituted in benzenoid part. 
 
Recently many researchers20-51 have reported synthetic strategies for 4-
hydroxy coumarin. 
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4.B.3      CHROMANE DIONES 
 
Tautomeric form of 4-hydroxycoumarin was first established by J. Kolsa.52 He 
proposed that if 4-hydroxy coumarin is a 2, 4-dioxochroman than its –COCH2CO 
group should be reactive and easily condense with ester but show no reaction with 
diethylcarbonate, ethylcyanoacetate, methylacetoacetate, ethylacetoacetate and 
benzylacetoacetate in presence of sodium and sodium ethoxide. Thus it was 
concluded that 4-hydroxycoumarin enolises at the lactone carbonyl and exists mainly 
in coumarin tautomerism in which the enol form of coumarin is favored. (Fig. 4.2) 
 
O O
OH
O OH
O  
     Fig. 4.2 
 
Various methods are utilized to prepare 2, 4-chromandiones and 2, 3, 4-
chromantriones shows ketonic nature of 4-hydroxycoumarin and therefore they were 
thought of interest to investigate their chemical reactivity and other properties. So far, 
2, 4-chromandiones have been isolated as crystalline solids. Solid derivatives of 2, 3, 
4-chromantriones have been reported usually as derivatives of the 3-keto group. 
 
Extensive work has been reported on 2, 4-chromandiones and 2, 3, 4-
chromanetriones. They are regarded as analogues of 4-chromanones and 3, 4-
chromanediones respectively.53 (Fig. 4.3) 
 
O O
OH
O O
O
R1
R1 = O
R2 = Any Substituent
R1
R2
R1 = H
R2, R3 = Any substituent
R2 R3
 
Fig. 4.3 
A brief survey of literature on some 2, 4-chromandione and 2, 3, 4-
chromantrione derivatives is summarized. 
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4-hydroxycoumarins frequently react with aromatic aldehydes to give 3-
benzylidene-2, 4-chromandiones.54-57 (Fig. 4.4) 
 
O O
O
O O
OH
CHO
R2
+
R2
 
Fig. 4.4 
 
however, reactions using salicylaldehyde or its analogues multicyclic 
compounds were obtained either solely or in addition to salicylidene derivatives of 
type as shown in (Fig. 4.5).58 
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OH
CHO
OH
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O OO O
OOH
O
O
O
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+
 
Fig. 4.5 
 
The proportions of the products were dependent on reaction conditions used 
e.g. when salicylaldehyde and 4-hydroxycoumarin refluxed in ethanol; a dimeric type 
of structure in addition to benzylidene derivative was obtained.59 
When two moles of salicylaldehyde were reacted with 4-hydroxycoumarins, it 
gave appropriate benzylidene derivative only (Fig. 4.6). However, one mole of 
salicylaldehyde with two moles of 4-hydroxycoumarin gave the dicoumarinyl 
structure.60 (Fig. 4.7) 
O O
OH
CHO
OH
+2
O
O
O
OH  
Fig. 4.6 
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Fig. 4.7 
 
Similarly, reaction of 4-hydroxycoumarin with acetylated aldehydohexoses in 
ethanol for 24 hours gave substance shown in (Fig. 4.8).61 
 
O O
O
CH(CHOAc)4CH2OAc
 
Fig. 4.8 
 
Reaction between 4-hydroxycoumarin and hydroxylamine hydrochloride gave 
corresponding 2, 4-chromadione-4-oximes.62 (Fig. 4.9) 
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OH
+ NH2OH . HCl
O
O
N
O
OH
 
Fig. 4.9 
 
Reaction of chlorine with 4-hydroxycoumarins in suitable solvent or sulfuryl 
chloride led to the formation 3, 3-dichloro-2, 4-chromandiones.63-67 Halogenations of 
3-substituted 4-hydroxycoumarin afforded 3-chloro-2, 4-chromandiones. When 3, 3' 
methylenebis (4-hydroxycoumarin) was treated with sufuryl chloride, 3, 3' 
methylenebis (3-chloro-2, 4-chromandione) was isolated. (Fig. 4.10) 
 
Chapter-4 Section-B                                                                A Rapid Microwave Assisted….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     168 
O O
OH
Cl2+
SO2Cl2
O O
O
Cl
Cl
O O
OH
Cl2+
SO2Cl2
O O
O
R
Cl
R
O O
OH
O
OH
O
Cl2
O O
O
O
O
O
Cl
Cl
 
Fig. 4.10 
 
When 3-amino-4-hydroxycoumarin was reacted with nitrous acid, it gave 3-
diazo-2, 4-chromandiones. The same product was also obtained in 72% yield when 
sodium nitrite in dilute hydrochloric acid was added to 3-amino-4-
hydroxycoumarin.68 (Fig. 4.11) 
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O O
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O O
NH2
OH
HNO2
 
 
Fig. 4.11 
 
However, reaction of 4-hydroxycoumarin with aqueous sodium nitrite 
afforded 2, 3, 4-chromantrione-3-oxime which forms a silver salt.69 (Fig. 4.12)  
 
O O
O
N
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Fig. 4.12 
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4.B.4 MANNICH BASES FROM COUMARINS AND QUINOLONES 
 
Mannich reaction is a reaction between a molecule with an active hydrogen 
atom, an aldehyde or an amine yielding “Mannich bases”70 
4-hydroxy coumarin frequently reacts with aldehydes to give 3-benzylidene-
2,4-chromandiones. The conditions used were heating with acetic anhydride in 
presence of small amount of piperidine71, Ethanol at room temperature72 or at reflux73  
 
O O
OH
CHO
+
O O
O
CH
R
R
R = any substituent
 
 
Mannich74 has reported many primary amines like methylamine, ethylamine. 
Ethanolamine, β-phenylethylamine etc which are used for the formation of bases 
under Mannish reaction conditions.  
 
Robertson and Link75 prepared 3-substituted aminomethyl-4-
hydroxycoumarins by reaction between amine and formalin in absolute ethanol. To 
this solution, 4-hydroxycoumarin in ethanol was added and the product was obtained 
after cooling the reaction mixture.  
 
O
H
N R
O
R= Any substitution
OH
 
 
They also prepared 3,3’-methylenebis-4-hydroxycoumarin by reaction 
between secondary amine with 4-hydroxycoumarin against the expected product as 
Mannich bases. 
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Elderfield and Mehta76 prepared Mannich bases from 4-substituted-7-
hydroxycoumarin derivatives – which were converted to nitrogen mustard as potential 
anticancer agents.  
 
O O
R
Mannic Reaction
HO O O
R
HO
N
C2H4OH
C2H4OH
R= H, CH3, C2H5
 
 
A number merocyanine dyes of type (I) have been synthesized frpm 4-
hydroxy coumarin and 2-acetanilidovinylbenzothiazole methiodide and related 
compounds by refluxing for few minutes in acetic anhydride and triethylamine. 
Analogous coumpounds (II) have been prepared by treatment of 4-hydroxy coumarin 
with 2-(2-chloro propenyl)-3-ethylbenzothiazolonium chloride.77  
 
O O
O
N
X
(I) X= S,O
R= H, Br
O O
O
N
S
Et
(II)
R
R
R
 
 
Webster and McGolgin78 have prepared dimethylaminophenylpropylidene-2,4-
chromandione and it was used in the production of visible laser radiation.  
 
O O
O
(III)
R
N
 
 
4-hydroxy-6-phenyl-2-pyrone when condensed with triethyl orthoformate and 
aniline in ethanol, gave the compound of the type (IV), which was cleaved in 
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refluxing aqueous acetic acid-hydrochloride acid into 2-phenyl-4-pyrone in 62% 
yield.79  
 
O O
O
(IV)
H
N
 
 
Yasude and Hukuoka80 have reported many compounds of the type (V-X) 
which were claimed as UV absorbing agents, weather-resistant organic polymer 
compound and a cosmetic ingredient also (VI-X). It was also observed that these 
derivatives have an excellent UV absorbtion ability and a high light stability.  
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Stankovicova and co-workers have studied the skeletons of the compounds of 
the type (XXII). The semiemperical PM3 method has also been used for the 
calculation of the heats of formation and optimal structure of 4-chromones (XI). 
 
 
 
Chapter-4 Section-B                                                                A Rapid Microwave Assisted….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     172 
(XI)
O O
O
H
N
O
O
R2
 
 
Zhengming and co-workers81 have reported that when pyranones (XII) were 
refluxed with aqueous hydrochloride acid for 1 hour., afforded pyridine derivatives 
(XIII) with 46-72 percent yield.  
 
(XII)
O O
O
H
N
R
R= 4-Br, 4-Cl, 4-NO2, 4-CH3, 2-Cl, 2-NO2, 2,4-Dichloro
H
N
O
OHO
(XIII)
 
 
The equilibrium between Z and E isomers of the type (XIV, where X=S, Se) 
derived from 3-formyl-4-thio (seleno)coumarin resulting from the hindered rotation 
around the exocyclic carbon-carbon bond in the stable ketoamnie tautomeric forms 
have been studied by means of IR, 1D & 2D, NMR spectroscopy and also by ab initio 
and semi empirical calculation.82  
 
(XIV)
O O
X
H
N
R
 
 
Hamdi and co workers83 synthesized many new compounds N-(methylene-4-
oxo-coumarinyl) carbamates (XV) by the condensation of carbamates with 4-hydroxy 
coumarin in the presence of triethylorthoformate with good yields.  
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(XV)
O O
O
H
N
COOR
R= CH3, C2H5, C4H9, t-C4H9, CH2-Ph,CH2CH2OH
 
 
Further, when 4-hydroxy coumarin reacted with a-amino acids in the presence 
of excess triethylorthoformate gave the compounds of type (XVI) with good yield. 
The amino acids like glycine, alanine, leucine, phenyl alanine, tyrosine, tryptophan, 
L-DOPA, serine, cysteine, glutamic acid and glutamine were used.84  
 
(XVI)
O O
O
H
N
O O
OH
H2N
H
C C
R
OH
O
50-95%
4-hydroxy-2H-chromen-2-one
OH
O
R
 
 
It was also revealed that N-(methylene-4-oxo-coumarinyl) amines of the type 
(XVII) have been prepared by aliphatic and aromatic amines with 3-
ureidomethylenecoumarins. The compounds of the type (XVII) were prepared by the 
reactions of amines with 4-hydroxy coumarin and triethyl orthoformate with 40-90 % 
yield.85 
 
O O
O
H
N NH2
O
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It was also observed that the addition of the amine at site C3 of the unsaturated 
a-B-ketone system with elimination of urea indicated that the –NHR group is a poor 
leaving group. This reaction can also be carried out with substituted 3-
ureidomethylene coumarin with elimination of substituted urea. 
 
Numerous applications of methylene oxopyrone amines as an intermediate 
have been found from different literature and are summerised as below –  
 
a) Zeigler, E and coworkers 86 
 
O O
O O
O
O
H
N
O O
O
OH
O O
O
O
O O
R
R= CN, COOEt
4-hydroxypyrano[3,2-c]chromene-2,5-dione
Cl
(3E)-3-((4-chlorophenylamino)
methylene)pyrano[3,2-c]
chromene-2,4,5(3H)-trione
 
b) Butt, M.A. and coworkers 87, 88  
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O
H
N
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R2
R1
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O
O
O
O
R2
R1
R3
R3 = CN, COOC2H5  
 
c) Ziegler, E and coworkers 89,90,91,92  
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d) Peinhardt, et al93 
 
O O
S
H
N
Cl
O O
SH
O
S
O
O
COOEt
4-mercapto-2H-chromen-2-one (E)-3-((4-chlorophenylamino)
methylene)-4-thioxochroman-2-one
Cl
ethyl 4-(4-chlorophenyl)-2,5-dihydro-2,5-
dioxothiopyrano[3,2-c]chromene-3-carboxylate
 
discloses 4-hydroxy-2-oxo-3(1H)-quinoline carboxoamides and their 
analogues as herbicides.94 
 
H
N O
OH
H
N
R
O  
 
The authors synthesized a series of heterocycles including target compounds 
and found them to be active against gram positive, gram negative as well as yeast.95  
 
H
N O
OH
H
N
R1
R
R= Br, NH-NH2  
 
The authors screened a chemolibrary for drug like substances having the 
ability to activate reactive oxygen species production in murine phagocytes and 
identified the new molecules with potent neutrophil activating properties.96 
 
Chapter-4 Section-B                                                                A Rapid Microwave Assisted….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     176 
H
N O
OH
N CH2OH
CH2OH
HOH2C
3-((E)-(1,3-dihydroxy-2-(hydroxy
methyl)propan-2-ylimino)methyl)-
4-hydroxy-6-methylquinolin-2(1H)-one
 
 
The authors used CoMSIA and CoMFA to study three dimensional QSAR of 
21 compounds of 2, 4-quinolindione derivatives against wheat-leaf-rust.97 
 
N O
O
H
N
R
R= Et, CH3, OH  
 
The authors prepared a series of 3-(heteroarylaminomethylene) 
quinolonediones in 72-79% yields and studied their molluscidal and larvicidal 
activities.98 
 
N O
O
H
N
Hy
Hy= Heterocyclic Ring
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4.B.5 BIOLOGICAL ACTIVITIES  
 
Numerous biological activities have been associated with simple coumarins 
and its analogues. Among them, antimicrobial, antiviral, anticancer, enzyme 
inhibition, anti-inflammatory, antioxidant, anticoagulant and effect on central nervous 
system are most prominent. Coumarin nucleus possesses diversified biological 
activities that can be briefly summarized as under: 
 
1 Antimicrobial and Molluscicidal99-120 
2 Antiviral121-125 
3 Anticancer126-136 
4 As Enzyme Inhibition137-142 
5 Antioxidant143-146 
6 Anti-inflammatory147-151 
7 Anticoagulant and Cardiovascular152-155 
8 Effect on Central Nervous System156-158 
 
 4-hydroxycoumarin is a versatile scaffold and is being consistently used as a 
building block in organic chemistry as well as in heterocyclic chemistry for the 
synthesis of different heterocycles. The synthetic versatility of 4-hydroxycoumarin 
has led to the extensive use of this compound in organic synthesis. 4-hydroxy 
coumarin shows diversified chemical reactivity. Preparation of 3-acetyl-4-
hydroxycoumarinyl chalcones, condensation reaction of 4-hydroxycoumarin with 
aldehydes and use of 4-hydroxycoumarin as a β-keto ester in dihydropyrimidine 
synthesis have been discussed herein.  
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4.B.6      AIM OF CURRENT WORK 
 
4-hydroxycoumarins and aromatic aldehydes are known to produce 2, 4-
chromane diones (arylidine at C3 position) and coumarin dimers under reflux, with or 
without base. Thus, few new chromane diones were prepared using aldehydes. 
 
Besides this, microwave chemistry and especially microwave assisted organic 
synthesis has drawn a remarkable attention of all chemistry researchers towards its 
advantages. There are many reactions reported involving microwave assisted organic 
synthesis. Microwave chemistry is one of the best tools to carry out different reactions 
on desired molecules with lesser reaction time, lesser energy, easy work up and higher 
yields with better purity. In this chapter microwave assisted organic synthesis has 
been adopted to minimize the reaction time as compared to conventional heating and 
to optimize the results. 
 
Though the chemistry of the synthesized compounds is known, the compounds 
are reported herein for the first time. Biological importance of such important 
compounds is the rational behind the current work done in this chapter.  
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4.B.7      REACTION SCHEMES 
 
4.B.7.1 PREPARATION OF 8-METHYL-4-HYDROXYCOUMARIN 
 
 
CH3
OH O O
OH OH
Anhy. ZnCl2, POCl3
700 C
O O
OH
CH3
 
 
 
4.B.7.2 PREPARATION OF 3-SUBSTITUTED BENZYLIDENE-8-METHYL-
3H-CHROMENE-2, 4-DIONES 
 
 
O O
OH
CH3 CHO
R
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MW 400Watt
10-12min
O
O
O
R
CH3
Where R=3,4-di-OCH3, 4-CH3, 4-NO2 etc.
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4.B.8      PLAUSIBLE REACTION MECHANISM 
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4.B.9      EXPERIMENTAL 
 
4.B.9.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. All the reactions were 
carried out in Samsung MW83Y Microwave Oven which was locally modified for 
carrying out chemical reactions. IR spectra were recorded in Shimadzu FT-IR-8400 
instrument using KBr pellet method. Mass spectra were recorded on Shimadzu GC-
MS-QP-2010 model using Direct Injection Probe technique. 1H NMR was determined 
in CDCl3 solution on a Bruker Ac 400 MHz spectrometer. Elemental analysis of the 
all the synthesized compounds was carried out on Elemental Vario EL III Carlo 
Erba 1108 model and the results are in agreements with the structures assigned. 
 
4.B.9.2 PREPARATION OF 8-METHYL-4-HYDROXYCOUMARIN 
 
It was prepared according to the method reported by Shah et. al. a  
 
O-Cresol (0.1 mole) and malonic acid (10.4 gm; 0.1 moles) were added to a 
mixture of phosphorous oxychloride (40 ml) and anhydrous zinc chloride (30 gms) 
which was preheated to get rid of any moisture. The reaction mixture was heated on a 
water bath at 70 oC for 8-10 hours. It was cooled and decomposed with ice and water 
to afford buff-yellow coloured solid. 
The solid was then filtered and washed thoroughly with water. It was then 
triturated with 10% sodium carbonate solution and filtered. The filterate was slowly 
acidified with dilute HCl till the effervescence ceased. The product was filtered and 
dried and recrystallised with methanol.  
 
 
                                                 
a A. K. Shah, N. S. Bhatt and V. M. Thakor; Curr. Sci., 1984, 53(24), 1289. 
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4.B.9.3 PREPARATION OF 3-SUBSTITUTED BENZYLIDENE-8-
METHYL-3H-CHROMENE-2, 4-DIONES (SPC-01 TO SPC-20) : 
  GENERAL METHODS 
 
 [A] CONVENTIONAL METHOD 
 
8-Methyl 4-hydroxycoumarin (0.01 mole) was dissolved in 30 ml of methanol 
into 100 ml round bottom flask. Substituted Benzaldehydes (0.01 mole) was added to 
the above flask along with few drops of piperidine. The reaction mixture was heated 
on water bath for 4-5 hours. The progress and the completion of the reaction were 
checked by silica gel-G F254 thin layer chromatography using hexane: ethyl acetate (6: 
4) as a mobile phase. After the reaction to be completed, the reaction mixture was 
cooled to room temperature and the product was separated by filtration. The product 
was washed with methanol and dried to give desired product in good yield which was 
recrystallized by DMF. Physical data of the synthesized end products are summarized 
in the table.  
Similarly other compounds are also prepared.  
 
[B] MICROWAVE METHOD 
 
8-Methyl 4-hydroxycoumarin (0.01 mole) was dissolved into 20 ml of 
methanol into 100 ml microwave flask. Substituted Benzaldehydes (0.01 mole) was 
added to the above flask along with few drops of piperidine. The reaction mixture was 
irradiated under microwave irradiation using Qpro-M microwave synthesizer for the 
desired time at 400 Watt. The progress and the completion of the reaction were 
checked at interval of every one min. by silica gel-G F254 thin layer chromatography 
using hexane : ethyl acetate (6 : 4) as a mobile phase. After the reaction to be 
completed, the reaction mixture was scratched into 30 ml of methanol. The separated 
product was filtered off and washed with methanol and it was dried to give desired 
product in good yield which was recrystallized by DMF. Physical data of the 
synthesized end products are summarized in the table.  
Similarly other compounds are also prepared.  
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COMPARATIVE RESULTS OF METHOD (A) AND METHOD (B) ARE 
SUMMARIZED AS UNDER. 
 
TABLE-4.B.1 
Code 
No. 
Reaction Condition % Yield 
Method (A) Method (B) Method 
(A) 
Method 
(B) Temp.  
(°C) 
Time 
(hrs.) 
Watt 
(W) 
Temp. 
(°C) 
Time 
(min.) 
SPC-01 90-95  4.5  400 110  3.0  68 85 
SPC-02 90-95  5.0  400 110  3.3 64 80 
SPC-03 90-95  4.8  400 110  3.1 70 83 
SPC-04 90-95  5.5  400 110  3.2 72 81 
SPC-05 90-95  5.3  400 110  3.0 66 82 
SPC-06 90-95 5.0 400 110 3.4 70 86 
SPC-07 90-95 4.5 400 110 3.0 74 90 
SPC-08 90-95 5.2 400 110 3.2 68 88 
SPC-09 90-95 5.0 400 110 3.0 72 86 
SPC-10 90-95 4.8 400 110 3.1 76 84 
SPC-11 90-95 4.6 400 110 3.3 70 82 
SPC-12 90-95 4.8 400 110 3.7 64 88 
SPC-13 90-95 5.2 400 110 3.1 68 80 
SPC-14 90-95 5.5 400 110 4.2 76 84 
SPC-15 90-95 4.8 400 110 3.8 72 86 
SPC-16 90-95 4.6 400 110 3.6 70 82 
SPC-17 90-95 4.2 400 110 3.1 74 94 
SPC-18 90-95 5.2 400 110 3.0 78 86 
SPC-19 90-95 5.0 400 110 3.5 68 80 
SPC-20 90-95 4.7 400 110 3.3 76 88 
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4.B.10     PHYSICAL DATA 
 
PHYSICAL DATA OF 3-SUBSTITUTED BENZYLIDENE-8-METHYL-3H-
CHROMENE-2, 4-DIONES (SPC-01 TO SPC-20) 
 
O
O
O
R
 
 
    TABLE-4.B.2    
Sr. 
No. 
Code 
Name & 
No. 
Substitutions Molecular Formula 
Molecular 
Weight 
M.P. 
0C 
Rf  
Value
01 SPC-01 3,4-di-OCH3 C19H16O5 324 220-222 0.46 
02 SPC-02 4-CH3 C18H14O3 278 200-202 0.52 
03 SPC-03 4-Cl C17H11ClO3 298 212-214 0.44 
04 SPC-04 2-OH,4-OCH3 C18H14O5 310 180-182 0.48 
05 SPC-05 4-NO2 C17H11NO5 309 172-174 0.50 
06 SPC-06 2-CH3 C18H14O3 278 188-190 0.40 
07 SPC-07 2-NO2 C17H11NO5 309 164-166 0.44 
08 SPC-08 3-Cl C17H11ClO3 298 162-164 0.48 
09 SPC-09 4-OH C17H12O4 280 170-172 0.42 
10 SPC-10 2-OCH3 C18H14O4 294 178-180 0.46 
11 SPC-11 3,4-di-OH C17H12O5 296 184-186 0.42 
12 SPC-12 2-OH,5-OCH3 C18H14O5 310 192-194 0.54 
13 SPC-13 3-CH3 C18H14O3 278 190-192 0.50 
14 SPC-14 3-NO2 C17H11NO5 309 160-162 0.48 
15 SPC-15 2-Cl C17H11ClO3 298 166-168 0.40 
16 SPC-16 2-OH C17H12O4 280 172-174 0.46 
17 SPC-17 H C17H12O3 264 192-194 0.44 
18 SPC-18 3-OH C17H12O4 280 188-190 0.48 
19 SPC-19 4-Br C17H11BrO3 343 178-180 0.40 
20 SPC-20 4-F C17H11FO3 282 176-178 0.42 
 
        Rf value was calculated using solvent system, Hexane : Ethyl Acetate (6 : 4) 
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4.B.11    SPECTRAL DISCUSSION 
 
4.B.11.1 MASS SPECTRAL STUDY 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. SPC-02 and SPC-03 of Mass 
spectra are given on page no. 193 and 195. 
 
4.B.11.2 IR SPECTRAL STUDY 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT IR 
8400 spectrophotometer using Diffused Reflectance Attachment (DRA) System using 
Potassium Bromide. 
 
In case of SPC-01 to SPC-20 series of compounds, stretching and bending 
frequency for aromatic and stretching frequencies for methyl, methylene groups were 
found near 3050 cm-1, 1400-1640 cm-1, 2950 cm-1 and 2850 cm-1 respectively in all 
the compounds. Two Carbonyl stretching frequencies were obtained near 1700 cm-1 
and 1670 cm-1 in all the compounds. Frequencies for ether linkage were obtained near 
1050 cm-1 and in all the compounds. SPC-02 and SPC-03 of Mass spectra are given 
on page no. 193 and 195. 
 
4.B.11.3 1H NMR SPECTRAL STUDY 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer. Sample solutions were made in DMSO solvent using 
tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons identified from 1H NMR spectrum and their chemical shift (δ 
ppm) were in the agreement of the structure of the molecule. J values were calculated 
to identify o, m and p coupling. In some cases, aromatic protons were obtained as 
multiplet. 1H NMR spectral interpretation can be discussed as under. 
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1H NMR OF 3-(4-METHYLBENZYLIDENE)-8-METHYL-3H-CHROMENE-2, 4-
DIONE (SPC-02) 
 
O
O
O
H3C CH3
1
2
3
4
5
6 7
8
910
 
 
1. Proton no. 1 and 7 of total 6H gave a doublet at 2.47 δ ppm-2.50 δ ppm.  
2. Arylidine proton of Proton no. 10 became deshielded and gave a characteristic 
singlet at 6.07 δ ppm. The assignment of this proton is the most important for 
the structure elucidation and as it is evident here the successful assignment of 
this singlet has confirmed our structure. 
3. Aromatic ring proton no. 5, 6, 8 and 9 of four proton gave a multiplet at 7.09 δ 
ppm-7.14 δ ppm.  
4. Proton no. 2 and 3 of two proton gave a multiplet at 7.25 δ ppm-7.30 δ ppm. 
5. Proton no. 4 gave a dublet at 7.45 δ ppm - 7.47 δ ppm. and J value of this 
proton is 8.0 Hz. It suggests ortho coupling. 
 
  Thus, by observing and assigning the peaks in the NMR spectrum and 
by the calculation of the J values for each of the above proton, the proposed 
structure for compound no. SPC-02 has been confirmed for cis geometrical. 
Spectrum is given on page no. 194. 
 
 
 
 
 
 
Chapter-4 Section-B                                                                A Rapid Microwave Assisted….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     187 
1H NMR OF 3-(4-CHLOROBENZYLIDENE)-8-METHYL-3H-CHROMENE-2,4-
DIONE (SPC-03) 
 
1
2
3
4
5
6
7
89
O
O
O
H3C Cl
 
 
1. Proton no. 1 of three proton gave a characteristic singlet at 2.46 δ ppm. 
2. Arylidine proton of Proton no. 9 became deshielded and gave a characteristic 
singlet at 6.32 δ ppm. The assignment of this proton is the most important for 
the structure elucidation and as it is evident here the successful assignment of 
this singlet has confirmed our structure. 
3. Proton no. 6 and 7 gave a doublet at 7.18 δ ppm-7.20 δ ppm. and J value of 
this proton is 8.0 Hz. it suggests ortho coupling.It suggests an ortho coupling. 
4. Proton no. 5 and 8 gave a doublet at 7.46 δ ppm-7.48 δ ppm. and J value of 
this proton is 8.0Hz. It suggests ortho coupling.It suggests an ortho coupling. 
5. Proton no. 2 and 3 of two proton gave a multiplet at 7.24 δ ppm-7.28 δ ppm. 
6. Proton no.4 gave a doublet at 7.83 δ ppm-7.85 δ ppm. and J value of this 
proton is 8.0Hz. it suggests ortho coupling.It suggests an ortho coupling. 
 
  Thus, by observing and assigning the peaks in the NMR spectrum and 
by the calculation of the J values for each of the above proton, the proposed 
structure for compound no. SPC-03 has been confirmed for cis geometrical. 
Spectrum is given on page no. 196. 
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4.B.11.4  ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds. The spectral and elemental analysis data are given for individual 
compounds. 
 
4.B.12    ANALYTICAL DATA 
 
3-(3,4-dimethoxybenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-01):   
IR (KBr, cm-1): 3020 (-CH3 str.), 2866 (-CH2 str.), 1670 (>CO str.), 1604, 1572, 1510 
(Ar-H, ben), 1091 (C-O-C); MS m/z = 324 (M+); Anal. Calcd. for C19H16O5: C, 70.36; 
H, 4.97; O, 24.67. Found: C, 70.30; H, 4.94; O, 24.62. 
 
 3-(4-methylbenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-02):  
IR (KBr, cm-1): 3026 (-CH3 str.), 2866 (-CH2 str.), 1670 (>CO str.), 1602, 1573, 1508 
(Ar-H, ben), 1091 (C-O-C); 1H NMR (400 MHz, DMSO): δ (ppm) 2.50 (6H, d), 6.07 
(1H, S), 7.14 (4H, m,), 7.30 (2H, m), 7.47 (1H, m, J = 0.56 Hz); MS m/z = 278 (M+); 
Anal. Calcd. for C18H14O3: C, 77.68; H, 5.07; O, 17.25. Found: C, 77.60; H, 5.02; O, 
17.21. 
 
3-(4-chlorobenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-03):  
IR (KBr, cm-1): 3032 (-CH3 str.), 2918 (-CH2 str.), 1664 (>CO str.), 1602, 1570, 1489 
(Ar-H, ben), 1095 (C-O-C), 779 (C-Cl); 1H NMR (400 MHz, DMSO): δ (ppm) 2.46 
(3H, s), 6.32 (1H, s), 7.20 (2H, d, J = 8.56 Hz), 7.28 (2H, m), 7.48 (2H, d, J = 7.24 
Hz), 7.85 (1H, d, J=7.96 Hz); MS m/z = 298 (M+), 300 (M+2); Anal. Calcd. for 
C17H11ClO3: C, 68.35; H, 3.71; O, 16.07. Found: C, 68.31; H, 3.66; O, 16.01  
 
3-(2-hydroxy-4-methoxybenzylidene)-8-methyl-3H-chromene-2,4-dione   (SPC-04):            
IR (KBr, cm-1): 3014 (-CH3 str.), 2870 (-CH2 str.), 1674 (>CO str.), 1602, 1570, 1508 
(Ar-H, ben), 1091 (C-O-C); MS m/z = 310 (M+); Anal. Calcd. for C18H14O5: C, 69.6  
7; H, 4.55; O, 25.78. Found: C, 69.61; H, 4.50; O, 25.72. 
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3-(4-nitrobenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-05):  
IR (KBr, cm-1): 3016 (-CH3 str.), 2874 (-CH2 str.), 1670 (>CO str.), 1604, 1566, 1506 
(Ar-H, ben), 1094 (C-O-C); MS m/z = 309 (M+); Anal. Calcd. for C17H11NO5: C, 
66.02; H, 3.58; N, 4.53; O, 25.87. Found: C, 66.02; H, 3.50; N, 4.51; O, 25.82. 
 
3-(2-methylbenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-06):  
IR (KBr, cm-1): 3020 (-CH3 str.), 2872 (-CH2 str.), 1672 (>CO str.), 1603, 1571, 1508 
(Ar-H, ben), 1088 (C-O-C); MS m/z = 278 (M+); Anal. Calcd. for C18H14O3: C, 77.68; 
H, 5.07; O, 17.25. Found: C, 77.62; H, 5.01; O, 17.21.  
 
3-(2-nitrobenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-07):  
IR (KBr, cm-1): 3010 (-CH3 str.), 2866 (-CH2 str.), 1670 (>CO str.), 1601, 1567, 1512 
(Ar-H, ben), 1090 (C-O-C); MS m/z = 309 (M+); Anal. Calcd. for C17H11NO5: C, 
66.02; H, 3.58; N, 4.53; O, 25.87. Found: C, 66.00; H, 3.53; N, 4.50; O, 25.84.  
 
3-(3-chlorobenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-08):  
IR (KBr, cm-1): 3024 (-CH3 str.), 2877 (-CH2 str.), 1670 (>CO str.), 1611, 1572, 1511 
(Ar-H, ben), 1092 (C-O-C); MS m/z = 298 (M+), 300 (M+2); Anal. Calcd. for 
C17H11ClO3: C, 68.35; H, 3.71; O, 16.07. Found: C, 68.31; H, 3.70; O, 16.04.  
 
3-(4-hydroxybenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-9):  
IR (KBr, cm-1): 3024 (-CH3 str.), 2860 (-CH2 str.), 1664 (>CO str.), 1606, 1560, 1508 
(Ar-H, ben), 1090 (C-O-C); MS m/z = 280 (M+); Anal. Calcd. for C17H12O4: C, 72.85; 
H, 4.32; O, 22.83. Found: C, 72.82; H, 4.30; O, 22.80. 
 
3-(2-methoxybenzylidene)-8-methyl-3H-chromene-2,4-dione(SPC-10):             
IR (KBr, cm-1): 3018 (-CH3 str.), 2876 (-CH2 str.), 1671 (>CO str.), 1612, 1572, 1508 
(Ar-H, ben), 1088 (C-O-C); MS m/z = 294 (M+); Anal. Calcd. for C18H14O4: C, 73.46;  
H, 4.79; O, 21.75. Found: C, 73.42; H, 4.71; O, 21.71. 
 
3-(3,4-dihydroxybenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-11):  
IR (KBr, cm-1): 3022(-CH3 str.), 2878 (-CH2 str.), 1670 (>CO str.), 1601, 1573, 1511 
(Ar-H, ben), 1093 (C-O-C); MS m/z = 296 (M+); Anal. Calcd. for C17H12O5: C, 68.92; 
H, 4.08; O, 27.00. Found: C, 68.88; H, 4.02; O, 27.02.  
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3-(2-hydroxy-5-methoxybenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-12):  
IR (KBr, cm-1): 3015 (-CH3 str.), 2873 (-CH2 str.), 1671 (>CO str.), 1602, 1572, 1508 
(Ar-H, ben), 1095 (C-O-C); MS m/z = 310 (M+); Anal. Calcd. for C18H14O5: C, 69.67; 
H, 4.55; O, 25.78. Found: C, 69.63; H, 4.51; O, 25.74.  
 
3-(3-methylbenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-13):  
IR (KBr, cm-1): 3012 (-CH3 str.), 2870 (-CH2 str.), 1672 (>CO str.), 1602, 1571, 1507 
(Ar-H, ben), 1093 (C-O-C); MS m/z = 278 (M+); Anal. Calcd. for C18H14O3: C, 77.68; 
H, 5.07; O, 17.25. Found: C, 77.62; H, 5.02; O, 17.20.  
 
3-(3-nitrobenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-14):  
IR (KBr, cm-1): 3023 (-CH3 str.), 2871 (-CH2 str.), 1675 (>CO str.), 1602, 1571, 1511 
(Ar-H, ben), 1091 (C-O-C); MS m/z = 309 (M+); Anal. Calcd. for C17H11NO5: C, 
66.02; H, 3.58; N, 4.53; O, 25.87. Found: C, 66.00; H, 3.54; N, 4.51; O, 25.83.  
 
3-(2-chlorobenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-15):  
IR (KBr, cm-1): 3011 (-CH3 str.), 2873 (-CH2 str.), 1676 (>CO str.), 1601, 1570, 1518 
(Ar-H, ben), 1095 (C-O-C); MS m/z = 298 (M+), 300 (M+2); Anal. Calcd. for 
C17H11ClO3: C, 68.35; H, 3.71; O, 16.07. Found: C, 68.30; H, 3.62; O, 16.04.  
 
3-(2-hydroxybenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-16):  
IR (KBr, cm-1): 3020 (-CH3), 2877 (-CH2), 1671 (>CO), 1610, 1574, 1506 (Ar-H, 
ben), 1090 (C-O-C); MS m/z = 280 (M+); Anal. Calcd. for C17H12O4: C, 72.85; H, 
4.32; O, 22.83. Found: C, 72.81; H, 4.30; O, 22.81. 
 
3-benzylidene-8-methyl-3H-chromene-2,4-dione (SPC-17):  
IR (KBr, cm-1): 3010 (-CH3 str.), 2874 (-CH2 str.), 1674 (>CO str.), 1606, 1570, 1509 
(Ar-H, ben), 1090 (C-O-C); MS m/z = 264 (M+); Anal. Calcd. for C17H12O3: C, 77.26; 
H, 4.58; O, 18.16. Found: C, 77.24; H, 4.52; O, 18.14. 
 
3-(3-hydroxybenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-18):  
IR (KBr, cm-1): 3017 (-CH3 str.), 2874 (-CH2 str.), 1670 (>CO str.), 1611, 1570, 1505  
(Ar-H, ben), 1088 (C-O-C); MS m/z = 280 (M+); Anal. Calcd. for C17H12O4: C, 72.85; 
H, 4.32; O, 22.83. Found: C, 72.81; H, 4.30; O, 22.81.  
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3-(4-bromobenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-19):  
IR (KBr, cm-1): 3012 (-CH3 str.), 2875 (-CH2 str.), 1674 (>CO str.), 1603, 1576, 1508 
(Ar-H, ben), 1091 (C-O-C); MS m/z = 343 (M+), 345 (M+2); Anal. Calcd. for 
C17H11BrO3: C, 59.50; H, 3.23; O, 13.99. Found: C, 59.46; H, 3.20; O, 13.96.  
 
3-(4-fluorobenzylidene)-8-methyl-3H-chromene-2,4-dione (SPC-20):  
IR (KBr, cm-1): 3016 (-CH3 str.), 2875 (-CH2 str.), 1666 (>CO str.), 1603, 1568, 1509 
(Ar-H, ben), 1088 (C-O-C); MS m/z = 282 (M+), 284 (M+2); Anal. Calcd. for 
C17H11FO3: C, 72.34; H, 3.93; O, 17.00. Found: C, 72.32; H, 3.90; O, 17.04.  
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4.B.13    RESULTS AND DISCUSSION 
 
This chapter is mostly related to modification in the previous work done by 
our group as well as others but the scaffolds reported here are new. Earlier 4-
hydroxycoumarin and N-methyl 4-hydroxy quinolone derivatives were known to be 
prepared by conventional method. Moreover, microwave assisted method was also 
employed to compare both the methods in order to acquire best results. Microwave 
assisted method found much faster than the conventional one and % yield found to be 
higher than conventional but the purity was similar in both the methods. 
 
It is very well known that C3 position of 4-hydroxycoumarin and N-methyl 4- 
hydroxy quinolone is highly reactive. In section-A N-methyl 4-hydroxy quinolone 
and different pyrazole aldehydes were refluxed in methanol under alkaline condition. 
In section-B, 4-hydroxycoumarin and different aldehydes were refluxed in methanol 
under alkaline condition, in order to prepare coumarin and quinolone dimers, but the 
N-methyl 4-hydroxyquinolone tautomarize into 4(3H)-dione and due to the in situ 
generation of active methylene group it gave arylidine at C3-position. 
 
 
4.B.14    CONCLUSION 
 
4-hydroxycoumarin and N-methyl-4-hydroxy quinolone is a versatile scaffold 
and is being consistently used as a building block in organic chemistry as well as in 
heterocyclic chemistry for the synthesis of different heterocycles. The synthetic 
versatility of 4-hydroxycoumarin and N-methyl-4-hydroxy quinolone has led to the 
extensive use of this compound in organic synthesis. It was of interest to study the 
biological activities of newly synthesized coumarin and quinolone derivatives. 
These types of the compounds were synthesized using Microwave assisted 
method which was found to be much faster than the conventional and the % yield was 
found to be higher than conventional methods. 
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4.B.15   REPRESENTATIVE SPECTRA  
 
4.B.15.1 Mass Spectrum of SPC-02 
 
 
 
4.B.15.2 IR Spectrum of SPC-02 
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4.B.15.3 1H NMR Spectrum of SPC-02 
 
 
 
 EXPANDED 1H-NMR SPECTRUM OF SPC-02 
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4.B.15.4 Mass Spectrum of SPC-03 
 
 
 
4.B.15.5 IR Spectrum of SPC-03 
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4.B.15.6 1H NMR Spectrum of SPC-03 
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5.A.1 INTRODUCTION 
       
        Quinolones are a very important family of antibacterial agents that are widely 
prescribed for the treatment of infections in humans. Since their discovery in the early 
1960s, the quinolone group of antibacterial has generated considerable clinical and 
scientific interest. Two major groups of compounds have been developed from the 
basic molecule: quinolones and naphthyridones. The 4-pyridone-3-carboxylic acid 
associated with a 5, 6-fused aromatic ring is the common chemical feature of 
bactericidal quinolones. In the resulting bicyclic ring, the 1-, 5-, 6-, 7-and 8-positions 
are the major targets of chemical variation. Manipulations of the basic molecule, 
including replacing hydrogen with fluorine at position 6, substituting a cyclic amine 
residue at position 7 and adding new residues at position 1 of the quinolone ring, have 
led to improved breadth and potency of antibacterial activity and pharmacokinetics. 
One of the most significant developments has been the improved anti-Gram-positive 
activity of the newer compounds, such as moxifloxacin and garenoxacin. However, 
some of these structural changes have been found to correlate with specific adverse 
effects: the addition of fluorine or chlorine at position 8 being associated with photo 
reactivity, e.g. sparfloxacin; and the substitution of an amine or a methyl group at 
position 5 having a potential role in QTc prolongation, e.g. sparfloxacin and 
grepafloxacin. The clinical utility of this expanding class of antimicrobial agentsand 
the lower propensity for the development of resistance with the newer quinolones will 
need to be continually monitored in the changing therapeutic environment. Antibiotic 
drug choice will remain difficult in the presence of increasing resistance, but 
introduction of the new quinolones has created a new and exciting era in antimicrobial 
chemotherapy. 
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5.A.2 SYNTHESIS OF BROMOBUTOXY QUINOLONE 
 
N
H
O OH
Br
Br
N
H
O O
Br
3,4-dihydro-7-hydroxyquinolin-
2(1H)-one
1,4-dibromobutane
7-(4-bromobutoxy)-3,4-dihydroquinolin-
2(1H)-one
K2CO3
water
 
 
 
5.A.3 ARIPIPRAZOLE 
 
Aripiprazole (Abilify, Abilify Discmelt) is an atypical antipsychotic and 
antidepressant used in the treatment of schizophrenia, bipolar disorder and clinical 
depression. It was approved by the Food and Drug Administration (FDA) for 
schizophrenia on November 15, 2002, for acute manic and mixed episodes associated 
with bipolar disorder on October 1, 2004and as an adjunct for major depressive 
disorder on November 20, 2007. Aripiprazole was developed by Otsuka in Japanand 
in the United States, Otsuka America markets it jointly with Bristol-Myers Squibb. 
 
5.A.3.1 PHARMACEUTICAL INFORMATION 
 
Drug Substance: 
Proper name:     Aripiprazole 
Chemicalname:7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-
dihydrocarbostyril. 
Molecular formula: C23H27Cl2N3O2 
Molecular mass: 448.38 
Structural formula: 
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N
H
OO
N
N
Cl
Cl
 
 
Physicochemical properties:  Aripiprazole is a white crystalline powder. Aripiprazole 
is practically insoluble in water. The pKa was determined to be 7.6 (in 20% ethanol 
solution). 
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5.A.4 MECHANISM OF ACTION OF ARIPIPRAZOLE 
 
The mechanism of action of aripiprazole, as with other drugs having efficacy 
in schizophrenia and bipolar disorder is unknown. However, it has been proposed that 
the efficacy of aripiprazole may be mediated through a combination of partial agonist 
activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors; 
however, the clinical relevance of these interactions has not been established. Actions 
at receptors other than D2, 5-HT1Aand 5-HT2A may explain some of the other 
clinical effects of aripiprazole (eg, the orthostatic hypotension observed with 
aripiprazole may be explained by its antagonist activity at adrenergic alpha1 
receptors). The clinical relevance of these receptor interactions with aripiprazole is 
unknown. 
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5.A.5 SYNTHESIS OF ARIPIPRAZOLE 
 
Representative procedure for the synthesis of 7-{4-[4-(2,3-dichlorophenyl) 
piperazin-1-yl]butoxy}-1,2,3,4-tetrahydro quinolin-2-one To a suspension of 7-(4-
bromobutoxy)-1,2,3,4-tetrahydrochinolin-2-one (1) (29.8 g; 0.1 M) and 1-(2,3-
dichlorophenyl)piprazine hydrochloride (2) (29.4 g; 0.1 M) in 300 mL of technical 
ethanol, powdered anhydrous sodium carbonate (23.3 g; 0.2 M) was added. The 
mixture was refluxed for 12 h. The resulting solid was filtered, taken up in technical 
ethanol (50 mL) and refluxed for 10 min. The insoluble inorganic residue was filtered 
off and the two obtained filtrates were combined, refluxed and then left at the room 
temperature for crystallization for 12 h. The crystalline aripiprazole (3) was filtered 
and dried to give 42.2 g (yield 85 %) of final product (HPLC purity 99.32 %). 
 
N
H
O OH
Br
Br N
H
O O
Br
3,4-dihydro-7-hydroxyquinolin-
2(1H)-one
1,4-dibromobutane 7-(4-bromobutoxy)-3,4-dihydroquinolin-
2(1H)-one
K2CO3
water
Cl
Cl
N
HN
sodium iodide
Acetonitrile
Ethanol
N
H
O O
N
N
Cl
Cl
7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-
dihydroquinolin-2(1H)-one
 
Aripiprazole(7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydro 
carbostyril) belongs to the group of new antipsychotics (like, for example, olanzapine, 
quetiapine, risperidone, amisulpride). It is used in the treatment of schizophrenia, 
bipolar mania and some dementia related psychosis symptoms1. The drug was 
invented initially by the Otsuka Pharmaceutical Co., Ltd., Tokyo [OPC-145972,3] and 
co-marketed with Bristol-Myers Squibb [AbilifyTM, BMS-3370394].Aripiprazole can 
form several inclusion compounds containing polar and protic species.5 In a search for 
optimal conditions to obtain crystals of aripiprazole solvate with ethanol suitable for 
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pharmaceutical technology, a series of experiments has been recently performed.6, 7 In 
order to get the product of pharmaceutical quality it was necessary to optimize 
synthetic process, maximizing reaction yield and minimizing the level of potential 
impurities and unconsumed substrates. This lead to the application of theoretical 
methodology supporting the reaction response hypersurface.8-10 Theoretical approach 
using statistical methods was shown to be very useful in analytical methods 
validation11 as well as in prediction of biological activity.12 
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5.A.6 PHARMACOLOGY OF ARIPIPRAZOLE 
 
Aripiprazole's mechanism of action is different from those of the other FDA-
approved atypical antipsychotics (e.g., clozapine, olanzapine, quetiapine, ziprasidone 
and risperidone). Rather than antagonizing the D2 receptor, aripiprazole acts as a D2 
partial agonist.13, 14 Aripiprazole is also a partial agonist at the 5-HT1A receptor and 
like the other atypical antipsychotics displays an antagonist profile at the 5-HT2A 
receptor.15,16  it also antagonizes the 5-HT77 receptor and acts as a partial agonist at 
the 5-HT2C receptor, both with high affinity. The latter action may underlie the 
minimal weight gain seen in the course of therapy.17 Aripiprazole has moderate 
affinity for histamine and α-adrenergic receptors and for the serotonin transporter and 
no appreciable affinity for cholinergic muscarinic receptors.18 D2 and D3 receptor 
occupancy levels are high, with average levels ranging between ~71% at 2 mg/day to 
~96% at 40 mg/day.19,20 most atypical antipsychotics bind preferentially to 
extrastriatal receptors, but aripiprazole appears to be less preferential in this regard, as 
binding rates are high throughout the brain.21 Recently, it has been demonstrated that 
in 5-HT7 receptor knockout mice, Aripiprazole does not reduce immobility time in the 
forced swim test (FST)and actually increases it.22,23 This implicates 5-HT7 antagonism 
as playing a major role in aripiprazole's antidepressant effects, similarly to 
amisulpride.22,23,24 
 
5.A.7 BIOLOGICAL ASPECTS 
 
Antidepressant drugs are medicines that relieve symptoms of depressive 
disorders. An antidepressant is a psychiatric medication used to alleviate mood 
disorders, such as major depression and dysthymia. Drugs including the monoamine 
oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), tetracyclic 
antidepressants (TeCAs), selective serotonin reuptake inhibitors (SSRIs)and 
serotonin-nor epinephrine reuptake inhibitors (SNRIs) are most commonly associated 
with the term. These medications are among those most commonly prescribed by 
psychiatrists and other physicians and their effectiveness and adverse effects are the 
subject of many studies and competing claims. Many drugs produce an antidepressant 
effect, but restrictions on their use have caused controversy and off-label prescription 
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a risk, despite claims of superior efficacy. Most typical antidepressants have a delayed 
onset of action (2–6 weeks) and are usually administered for anywhere from months 
to years. Despite the name, antidepressants are often used to treat other conditions, 
such as anxiety disorders, obsessive compulsive disorder, eating disorders, chronic 
painand some hormone-mediated disorders such as dysmenorrhea. Alone or together 
with anticonvulsants (e.g., Tegretol or Depakote), these medications can be used to 
treat attention-deficit hyperactivity disorder (ADHD) and substance abuse by 
addressing underlying depression. Also, antidepressants have been used sometimes to 
treat snoring and migraines. Other medications that are not usually called 
antidepressants, including antipsychotics in low doses and benzodiazepines, may be 
used to manage depression, although benzodiazepines may cause physical dependence 
if treatment is not properly monitored by a doctor. Stopping benzodiazepine (or SSRI) 
treatment abruptly can cause unpleasant withdrawal symptoms. An extract of the herb 
St John's Wort is commonly used as an antidepressant, although it is labeled as a 
dietary supplement in some countries. The term antidepressant is sometimes applied 
to any therapy (e.g., psychotherapy, electro-convulsive therapy, acupuncture) or 
process (e.g., sleep disruption, increased light levels, regular exercise) found to 
improve a clinically depressed mood. Inert placebos can have significant 
antidepressant effectsand so to establish a substance as an "antidepressant" in a 
clinical trial it is necessary to show superior efficacy to placebo.  
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5.A.8 AIM OF CURRENT WORK 
 
Owing to the above mentioned uses of Aripiprazole as the atypical 
antipsychotic drug, our main aim and plan was to synthesize some new chemical 
entities which are structural analogues of Aripiprazole which could also be screened 
to find out whether they would be able to mimic the biological activity of 
Aripiprazole. 
 
5.A.9 REACTION SCHEMES 
 
PREPARATION OF 7-(4-(SUBSTITUTED AMINO) BUTOXY)-3, 4-DIHYDRO 
QUINOLIN-2-(1H)-ONES 
 
H
N O
NH
R2
R1 K2CO3 DMF
RT
Br HN ON
R1
R2
 
 
5.A.10 PLAUSIBLE REACTION MECHANISM 
 
SPAPI Series
N
H
O Br
+
R1
N
R2
H
.. Br--
N
H
O N+
R1
R2
H
H+-
N
H
O N
R1
R2
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5.A.11 EXPERIMENTAL 
 
5.A.11.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. Formation of all 
compounds was purified by using flash chromatography. IR spectra were recorded 
in Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass spectra were 
recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection Probe 
technique. 1H NMR was determined in DMSO-d6 solution on a Bruker Ac 400 MHz 
spectrometer. Elemental analysis of the all the synthesized compounds was carried 
out on Elemental Vario EL III Carlo Erba 1108 model and the results are in 
agreements with the structures assigned. 
 
5.A.11.2 GENERAL PROCEDURE FOR PREPARATION OF 7-(4-
(SUBSTITUTED AMINO) BUTOXY)-3, 4-DIHYDRO QUINOLIN-2-
(1H)-ONES 
 
Bromobutoxy Quinolone (0.01 mole) was charged into 250 ml round bottom 
flask. 10 ml of dimethylformamide was added to dissolve it. Then add in to 0.03 mole 
of potassium carbonate as a catalyst. And add into Different secondary amines (0.01 
mole) at RT. the reaction mixture was stirred at RT overnight. The progress and the 
completion of the reaction were checked by silica gel-G F254 thin layer 
chromatography using hexane: ethyl acetate (3: 7) as a mobile phase. After the 
reaction to completed mixture poured into crushed ice, to get acquire the product. 
Finally, it was purified by Flash chromatography using hexane and ethyl acetate as 
eluents.  
Similarly other compounds are also prepared. 
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5.A.12 PHYSICAL DATA  
 
PHYSICAL DATA OF STUDIES ON 7-(4-(SUBSTITUTED AMINO) 
BUTOXY)-3, 4-DIHYDRO QUINOLIN-2-(1H)-ONES (SPAPI-01 TO SPAPI-12) 
 
HN
O
O
NR1
R2
 
TABLE-5.A.1 
Sr. 
No. 
Code 
Name & 
No. 
Substitutions Molecular Formula 
Molecular 
Weight 
BP 
 0C 
Rf 
Value
01 SPAPI-01 
O
H
N
C17H24N2O3 304 184-186 0.41 
02 SPAPI-02 
N
H
N
C18H27N3O2 317 166-168 0.45 
03 SPAPI-03 
N
H
N
C19H29N3O2 331 156-158 0.42 
04 SPAPI-04 N
H
N
C23H29N3O2 379 122-126 0.40 
05 SPAPI-05 N
H
N
C24H31N3O2 394 202-204 0.51 
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06 SPAPI-06 
NH
CH3
C20H24N2O2 324 165-169 0.44 
07 SPAPI-07 NHH3C
H3C
H3C CH3
C19H30N2O2 318 174-176 0.46 
08 SPAPI-08 
N
H
H
N
C17H25N3O2 303 134-138 0.50 
09 SPAPI-09 
H
N
C18H26N2O2 302 164-166 0.39 
10 SPAPI-10 
HN
C19H30N2O2 318 114-118 0.42 
11 SPAPI-11 
NH
C21H26N2O2 338 186-188 0.46 
12 SPAPI-12 
NH
C17H24N2O2 288 194-196 0.48 
 
Rf value was calculated using solvent system, Hexane : Ethyl Acetate (3: 7) 
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5.A.13 SPECTRAL DISCUSSION 
 
5.A.13.1 MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-MS 
QP-2010 model using direct injection probe technique. The molecular ion peak was 
found in agreement with molecular weight of the respective compound. SPAPI-01 and 
SPAPI-03 of Mass spectra are given on page no. 223 and 225. 
 
5.A.13.2 IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT IR 
8400 spectrophotometer using Diffused Reflectance Attachment (DRA) System using 
Potassium Bromide.  
 
-N-H stretching frequency was observed near 3400 cm-1 in case of SPAPI-01 
to SPAPI-12. There are carbonyl groups present in all the compounds in the region of 
1680 cm-1. C-H stretching frequencies were observed between 2810 cm-1 and 3000 
cm-1, N-H bending frequency were observed near 1600 cm-1, CN stretching 
frequencies were observed near 1200  cm-1, -C-O-C- stretching observed between 
1150 cm-1 and 1060 cm-1. SPAPI-01 and SPAPI-03 of IR spectra are given on page 
no. 223 and 225. 
 
5.A.13.3 1H NMR SPECTRA 
 
1H spectra of the synthesized compounds were recorded on Bruker Avance II 
400 spectrometer. Sample solutions were made in CDCl3/DMSO-d6 solvent using 
tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons identified from proton NMR spectrum and their chemical shift (δ 
ppm) were in the agreement of the structure of the molecule. J values were calculated 
to identify o, m and p coupling. 1H NMR spectral interpretation can be discussed as 
under. 
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1H NMR OF 7-(4-MORPHOLINOBUTOXY)-3,4-DIHYDROQUINOLIN-2(1H)-
ONE (SPAPI-01) 
 
HN
O
O
N
O
1
2
3
45
6
7
8
910
11
12
13
14
 
 
1. The Proton no.1 of -NH group gave a characteristic singlet at 8.65 δ ppm. 
2. Another four protons of piprazine methylene groups which attached with N 
atom of proton no. 11 and 14 and proton no. 10 of butyl chain which is 
attached with N atom and proton no. 2 of dihydroquinolone. All these eight 
protons are deshielded due to the nitrogen atmosphere. All these protons gave 
a multiplet at 2.41 δ ppm – 2.55 δ ppm. 
3. Proton no. 3 of dihydroquinolone of two protons gave a multiplet at 2.82 δ 
ppm. 
4. Another two protons of piprazine methylene group of proton no. 12 and 13 
which becomes deshielded due to the oxygen atom. These entire four proton 
gave a multiplet at 3.67 δ ppm. 
5. Proton no. 8 and 9 of butyl chain of four proton gave a multiplet at 1.62 δ 
ppm-1.72 δ ppm. 
6. Proton no. 7 of butyl chain which is attached with oxygen atom and it gave a 
multiplet at 3.88 δ ppm. 
7. Proton no. 4 and 6 of aromatic ring of of two proton gave a multiplet at 6.30 δ 
ppm-6.44 δ ppm. 
8. Proton no. 5 of aromatic ring of proton gave a multiplet at 6.97 δ ppm. 
 
Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound no. SPAPI-01 has been confirmed. Spectrum is given on page no. 224. 
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1H NMR OF 7-(4-(4-ETHYLPIPERAZIN-1-YL)BUTOXY)-3,4-DIHYDROQUINOLIN-
2(1H)-ONE (SPAPI-03)  
 
HN
O
O
N
N
1
2
3
45
67
8
910
11
12
13
14
15
16
 
 
1. The Proton no.1 of -NH group gave a characteristic singlet at 9.38 δ ppm. 
2. Another eight protons of piprazine methylene groups which attached with N 
atom on same atmosphere of proton no. 11, 12, 13, 14, proton 10 of butyl 
chain and proton no.15 these all are attached with N atom, All these twelve 
protons are deshielded due to the nitrogen atmosphere. All these protons gave 
a multiplet at 2.85 δ ppm – 2.97 δ ppm. 
3. Proton no. 8 of butyl chain of two protons gave a multiplet at 1.92 δ ppm. 
4. Proton no. 9 of butyl chain of two protons gave a multiplet at 1.25 δ ppm. 
5. Proton no. 2 and 3 of dihydroquinolone of four protons gave a multiplet at 
2.54 δ ppm-2.60 δ ppm. 
6. Proton no. 7 of butyl chain which is attached with oxygen atom and it gave a 
multiplet at 3.91 δ ppm – 3.98 δ ppm. 
7. Proton no. 16 of methyl group gave a triplet at 0.87 δ ppm. 
8. Proton no. 4 and 6 of aromatic ring of of two proton gave a multiplet at 6.42 δ 
ppm-6.49 δ ppm. 
9. Proton no. 5 of aromatic ring of proton gave a doublet at 7.00 δ ppm-7.02 δ 
ppm. and J value of this proton are 8.0 Hz. So, it suggests ortho coupling. 
 
Thus, by observing and assigning the peaks in the NMR spectrum and by the 
calculation of the J values for each of the above proton, the proposed structure for 
compound no. SPAPI-03 has been confirmed. Spectrum is given on page no. 226. 
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5.A.13.4 ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds. The spectral and elemental analysis data are given for individual 
compounds.  
 
 
5.A.14 ANALYTICAL DATA 
 
7-(4-morpholinobutoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-01):  
Yield: 78%, IR (KBr, cm-1): 3431 (-NH stretching), 3028 (-CH3 asym str.), 2941 (-
CH2 asym. str.), 2862 (-CH3 sym. Str.), 2767 (-CH2 sym. Str.), 1678 (>C=O), 1624 (-
NH bending), 1467 (-CH3 asym bending deformation), 1379 (-CH3 sym bending 
deformation), 1192 (-CN str.), 1111(-C-O-C- str.);  1H NMR (400 MHz, CDCl3): δ 
(ppm) 1.72 (4H, m), 2.55 (8H, m), 2.82 (2H, m), 3.67 (4H, m), 3.88 (2H, m), 6.44 
(2H, m), 6.97 (1H, m), 8.65 (1H, s), MS m/z = 304 (M+); Anal. Calcd. for 
C17H24N2O3: C, 67.08; H, 7.95; N, 9.20; O, 15.77. Found: C, 67.01; H, 7.93; N, 9.15; 
O, 15.72%. 
 
7-(4-(4-methylpiperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-02): 
Yield: 80%,  IR (KBr, cm-1): 3437 (N-H stretching), 3030 (-CH3 asym str.), 2946 (-
CH2 asym. str.), 2864 (CH3 sym. Str.), 2761 (CH2 sym. Str.), 1672 (-C=O), 1622 (N-H 
bending), 1461 (-CH3 asym bending deformation), 1371 (-CH3 sym bending 
deformation), 1194 (-CN str.), 1116(-C-O-C- str.); MS m/z = 317 (M+); Anal. Calcd. 
for C18H27N3O2: C, 68.11; H, 8.57; N, 13.24; O, 10.08. Found: C, 68.06; H, 8.54; N, 
13.22; O, 10.03%. 
 
7-(4-(4-ethylpiperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-03): 
Yield: 82%, IR (KBr, cm-1): 3439 (N-H stretching), 3057 (-CH3 asym str.), 2953 (-
CH2 asym. str.), 2893 (CH3 sym. Str.), 2858 (CH2 sym. Str.), 1689 (-C=O), 1626 (N-H 
bending), 1448 (-CH3 asym bending deformation), 1375 (-CH3 sym bending 
deformation), 1170 (-CN str.), 1132 (-C-O-C- str.); 1H NMR (400 MHz, DMSO): δ 
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(ppm) 0.87 (3H, s), 1.25 (2H, m), 1.92 (2H, m), 2.60 (4H, m), 2.97 (12H, m), 3.98 
(2H, m), 6.49 (2H, m), 7.02 (1H, d, J=8.0 Hz), 9.38 (1H, s), MS m/z = 331 (M+); 
Anal. Calcd. for C19H29N3O2: C, 68.85; H, 8.82; N, 12.68; O, 9.65. Found: C, 68.82; 
H, 8.80; N, 12.64; O, 9.61%. 
 
7-(4-(4-phenylpiperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-04): 
Yield: 74%, IR (KBr, cm-1): 3440 (N-H stretching), 3006 (-CH3 asym str.), 2938 (-
CH2 asym. str.), 2865 (CH3 sym. Str.), 2761 (CH2 sym. Str.), 1671 (-C=O), 1630 (N-H 
bending), 1461 (-CH3 asym bending deformation), 1368 (-CH3 sym bending 
deformation), 1188 (-CN str.), 1115(-C-O-C- str.);  MS m/z = 379 (M+); Anal. Calcd. 
for C23H29N3O2: C, 72.79; H, 7.70; N, 11.07; O, 8.43. Found: C, 72.74; H, 7.66; N, 
11.05; O, 8.41%. 
 
7-(4-(4-benzylpiperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-05): 
Yield: 70%, IR (KBr, cm-1): 3436 (N-H stretching), 3021 (-CH3 asym str.), 2948 (-
CH2 asym. str.), 2864 (CH3 sym. Str.), 2760 (CH2 sym. Str.), 1671 (-C=O), 1621 (N-H 
bending), 1476 (-CH3 asym bending deformation), 1371 (-CH3 sym bending 
deformation), 1193 (-CN str.), 1110(-C-O-C- str.); MS m/z = 394 (M+); Anal. Calcd. 
for C24H31N3O2: C, 73.25; H, 7.94; N, 10.68; O, 8.13. Found: C, 73.23; H, 7.91; N, 
10.63; O, 8.10%. 
 
7-(4-(methyl(phenyl)amino)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-06): 
Yield: 68%, IR (KBr, cm-1): 3421 (N-H stretching), 3022 (-CH3 asym str.), 2931 (-
CH2 asym. str.), 2872 (CH3 sym. Str.), 2867 (CH2 sym. Str.), 1674 (-C=O), 1622 (N-H 
bending), 1465 (-CH3 asym bending deformation), 1371 (-CH3 sym bending 
deformation), 1182 (-CN str.), 1109 (-C-O-C- str.); MS m/z = 324 (M+); Anal. Calcd. 
for C20H24N2O2: C, 74.04; H, 7.46; N, 8.64; O, 9.86. Found: C, 74.01; H, 7.43; N, 
8.61; O, 9.83%. 
 
7-(4-(diisopropylamino)butoxy)-3,4-dihydroquinolin-2(1H)-one (SPAPI -07):  
Yield: 74%,  IR (KBr, cm-1): 3442 (N-H stretching), 3012 (-CH3 asym str.), 2935 (-
CH2 asym. str.), 2866 (CH3 sym. Str.), 2856 (CH2 sym. Str.), 1688 (-C=O), 1620 (N-H 
bending), 1462 (-CH3 asym bending deformation), 1376 (-CH3 sym bending 
deformation), 1186 (-CN str.), 1117 (-C-O-C- str.);  MS m/z = 318 (M+); Anal. Calcd. 
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for C19H30N2O2: C, 71.66; H, 9.50; N, 8.80; O, 10.05. Found: C, 71.62; H, 9.48; N, 
8.76; O, 10.03%. 
 
7-(4-(piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-08):  
Yield: 78%, IR (KBr, cm-1): 3438 (N-H stretching), 3025 (-CH3 asym str.), 2936 (-
CH2 asym. str.), 2856 (CH3 sym. Str.), 2787 (CH2 sym. Str.), 1677 (-C=O), 1622 (N-H 
bending), 1463 (-CH3 asym bending deformation), 1371 (-CH3 sym bending 
deformation), 1191 (-CN str.), 1114 (-C-O-C- str.); MS m/z = 303 (M+); Anal. Calcd. 
for C17H25N3O2: C, 67.30; H, 8.31; N, 13.85; O, 10.55. Found: C, 67.28; H, 8.30; N, 
13.82; O, 10.53%. 
 
7-(4-(piperidin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-09):  
Yield: 66%, IR (KBr, cm-1): 3447 (N-H stretching), 3018 (-CH3 asym str.), 2940 (-
CH2 asym. str.), 2872 (CH3 sym. Str.), 2867 (CH2 sym. Str.), 1672 (-C=O), 1621 (N-H 
bending), 1469 (-CH3 asym bending deformation), 1389 (-CH3 sym bending 
deformation), 1190 (-CN str.), 1104 (-C-O-C- str.); MS m/z = 302 (M+); Anal. Calcd. 
for C18H26N2O2: C, 71.49; H, 8.67; N, 9.26; O, 10.58. Found: C, 71.45; H, 8.65; N, 
9.23; O, 10.56%. 
 
7-(4-(dipropylamino)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-10):  
Yield: 72%, IR (KBr, cm-1): 3445 (N-H stretching), 3011 (-CH3 asym str.), 2966 (-
CH2 asym. str.), 2864 (CH3 sym. Str.), 2854 (CH2 sym. Str.), 1678 (-C=O), 1634 (N-H 
bending), 1468 (-CH3 asym bending deformation), 1373 (-CH3 sym bending 
deformation), 1182 (-CN str.), 1119 (-C-O-C- str.);  MS m/z = 318 (M+); Anal. Calcd. 
for C19H30N2O2: C, 71.66; H, 9.50; N, 8.80; O, 10.05. Found: C, 71.63; H, 9.44; N, 
8.79; O, 10.03%. 
 
7-(4-(ethyl(phenyl)amino)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-11): 
Yield: 76%,     IR (KBr, cm-1): 3427 (N-H stretching), 3022 (-CH3 asym str.), 2936 (-
CH2 asym. str.), 2872 (CH3 sym. Str.), 2860 (CH2 sym. Str.), 1672 (-C=O), 1625 (N-H 
bending), 1462 (-CH3 asym bending deformation), 1371 (-CH3 sym bending 
deformation), 1187 (-CN str.), 1117 (-C-O-C- str.);  MS m/z = 338 (M+); Anal. Calcd. 
for C21H26N2O2: C, 74.52; H, 7.74; N, 8.28; O, 9.45. Found: C, 74.50; H, 7.72; N, 
8.24; O, 9.42%. 
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7-(4-(pyrrolidin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one(SPAPI-12):  
Yield: 70%, IR (KBr, cm-1): 3451 (N-H stretching), 3010 (-CH3 asym str.), 2924 (-
CH2 asym. str.), 2878 (CH3 sym. Str.), 2844 (CH2 sym. Str.), 1676 (-C=O), 1620 (N-H 
bending), 1463 (-CH3 asym bending deformation), 1377 (-CH3 sym bending 
deformation), 1184 (-CN str.), 1102 (-C-O-C- str.); MS m/z = 288 (M+); Anal. Calcd. 
for C17H24N2O2: C, 70.80; H, 8.39; N, 9.71; O, 11.10. Found: C, 70.77; H, 8.35; N, 
9.70; O, 11.08%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter – 5 Section-A                                                    Studies on 7-(4-(substituted amino)….. 
Department of Chemistry, Saurashtra University, Rajkot-360 005                                        223 
5.A.15 REPRESENTATIVE SPECTRA  
 
5.A.15.1 Mass Spectrum of SPAPI-01 
 
5.A.15.2 IR Spectrum of SPAPI-01 
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5.A.15.3 1H NMR Spectrum of SPAPI-01 
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5.A.15.4 Mass Spectrum of SPAPI-03 
  
5.A.15.5     IR Spectrum of SPAPI-03 
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5.A.15.6 1H NMR Spectrum of SPAPI-03 
 
 
EXPANDED 1H-NMR SPECTRUM OF SPAPI-03 
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5.B.1  INDOLE SYSTEM 
 
Indole (2, 3-benzopyrrole, ketole, 1-benzazole; C8H7N) is an aromatic 
heterocyclic organic compound. It has a bicyclic structure, consisting of a six-
membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. 
The participation of the nitrogen lone electron pair in the aromatic ring means that 
indole is not a base, and it does not behave like a simple amine.  
 
Indole is a solid at room temperature. Indole can be produced by bacteria as a 
degradation product of the amino acid tryptophan. It occurs naturally in human feces 
and has an intense fecal odor. At very low concentrations, however, it has a flowery 
smell, and is a constituent of many flower scents (such as orange blossoms) and 
perfumes. It also occurs in coal tar.  
 
N
H
1
2
345
6
7
 
 
Fig. A.1 
 
Many researchers have described synthesis of indole and its derivatives along 
with its applications in literature. 1-47 
 
 
5.B.2  PHYSICAL PROPERTIES OF INDOLE 
 
Indole is a white colored solid, melting at 52-54°C and boiling at 253-254 °C. 
0.19 gm of indole is soluble in 100 ml of hot water. Indole is soluble in alcohol, ethyl 
acetate etc. Indole is having planar molecular shape, 1.22 g/cm3 density and 2.11 D 
dipole moment in benzene. All indole derivatives show certain family resemblances to 
indole 4, but striking changes can be brought about by substitution of groups in the 
pyrrole ring. Thus, the fecal-like odor of skatole is the most pronounced of all the 
methyl indoles, less pronounced for the 2-methylindole and the 2, 3-dimethyl indole; 
1-methylindole, on the other hand, resembles methyl aniline in odor. Introduction of 
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carboxyl groups or phenolic hydroxyl groups causes elimination of the odor, and the 
naphtha indoles are also without odor.  
All the common indole derivatives, like indole, form well-defined crystalline 
picrates, yellow to red in color. Formation of picrates is usually a suitable procedure 
for identification and purification. 
 
5.B.3  SYNTHESIS OF INDOLES 
 
NH
R''
R'
5mole-% in Br3
Toluene
reflux 0.5-20h
N
R''
R'
R
R'-H, Bn, Ac
     EtCO2
R''- Ar, alkyl
R
 
 
Indium-catalyzed cyclization of 2-ethynylanilines produced various oly functionalized 
indole derivatives in good yields for substrates having an alkyl or aryl group on the 
terminal alkyne. In contrast, substrates with a tri methyl silyl group or without 
substituent on the triple bond afforded poly substituted quinoline derivatives in good 
yields via an intermolecular dimerization.48 
 
R
CO2Me
N3
3-5 mol-%
Rh2(OCOC3F7)4
Toluene
40 or 60oC, 16h
N
H
CO2MeR
 
 
Rhodium (II) perfluorobutyrate-mediated decomposition of vinyl azides 
allows rapid access to a variety of complex, functionalized N-heterocycles in 
two steps from commercially available starting materials.49 
EWG
R''
NHR R'
1.3eq. PhI(O2CCF3)2(PIFA)
(added over 30 min)
CH2Cl2, RT, 30 min N
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R
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Various N-arylated and N-alkylated indoles and pyrrole-fused aromatic compounds 
were synthesized by a phenyliodine bis(trifluoroacetate) (PIFA)-mediated 
intramolecular cyclization.50 
 
5.B.4 MECHANISM OF THE FISCHER INDOLE SYNTHESIS 
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5.B.5 SOME INDOLE NATURAL PRODUCTS  
 
The indole nucleus is found to be present in a varied group of products of 
natural occurance in both the animal and vegetable kingdom. 51, 52, 53 Most of these 
product show marked physiological activity and some are extremely complex in 
nature. 
 
N
H
COOH
Heteroauxin (indole-3-acetic acid)
Fig. 2         
N
H
COOH
NH2
Tryptophen
Fig. 3  
 
Tryptophan is one of the essential amino acids, isolated from natural sources 
exists as the levo isomer. 
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Bufotenine has a pronounced effect upon blood pressure.54 
 
Gramine (donaxine)
N
H
N
CH3
CH3
Fig. 7  
 
Indoles are probably the most widely distributed heterocyclic compounds in nature. 
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5.B.6 BIOLOGICAL IMPORTANCE  
 
The Indole derivatives display a wide range of biological activities.  This is 
exemplified by the amino acid tryptophan, the hormones serotonin and melatonin, the 
anti-inflammatory drug indo methacin, the psychotropic drug LSD and the anti-tumor 
agent vinblastine.55 
In animals serotonin is a very important neurotransmitter in the central 
nervous system and also plays a vital role in the cardiovascular and gastrointestinal 
system. Many indole derivatives are used as pharmaceuticals and highly selective 
medicines which are in current use. 
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 Sumatriptan is used for the treatment of migraine.    
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Ondansetron is used for the suppression of the nausea and vomiting caused by the 
cancer chemotherapy and radiotherapy. Indoles are also good plant growth hormones. 
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5.B.7 INDOLES AS ANTICANCER AGENTS 
 
Interest in the synthesis of novel indole-based heterocycles has increased in 
recent years due the prevalence of indoles in biologically-active natural products such 
as a fumitremorgin class and the significance of the indole moiety in clinical 
chemotherapeutics like ellipticine. Many MDR cell lines which are found to be 
resistant to many present pharmacological agents, proved as non-resistant to many of 
synthetic indole derivatives. Therefore indole derivatives have gained much attention 
in the field of discovering potent and effective anticancer agents. 
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5.B.8  MANNICH REACTION ON INDOLE 2- CARBOXYLIC 
ACID 
 
Abonia et. al.56 in their effort to synthesize pyrroloquinolines, synthesized 1-
(benzotriazol-1(2)-ylmethyl)indolines for which they carried out Mannich reaction on 
2-methyl indoline using benzotriazole as a secondary amine, formaldehyde and 
diethyl ether as a solvent and stirred for 30 minutes at room temperature. This 
Mannich base was reacted with un activated and electron-rich alkenes in the presence 
of p-toluenesulfonic acid catalyst to give pyrroloquinolines but the pharmacological 
importance of the synthesized molecules was not reported. 
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5.B.9 AIM OF CURRENT WORK  
 
Since last few years, our group is involved in the synthesis of nitrogen 
containing heterocycles viz. pyrrole, indole, 2-methyl indole, dihydro pyridine, 
dihydropyrimidine, 4-hydroxy quinolones etc. Where, pyrrole, indole,57a 
dihydropyridine57b, dihydropyrimidine57c, 4-hydroxy quinolone57d and 2-methyl 
indole showed good anti tubercular57e, anti diabetic, anti cancer57f and multi drug 
resistance reversal57g activity. Looking to the interesting biological profile showed by 
indole, 2-methyl indole and indole 2-Carboxylic acid from the literature survey and 
development of a simple preparation method for 2-methyl indole by our group we 
decided to prepare indole 2-Carboxylic acid and to explore the chemistry involving 
indole 2-Carboxylic acid moiety. 
 
Recently 57h Mannich reaction has been carried out on N1 position in indole 2-
Carboxylic acid using formaldehyde. Looking to the reactivity of N1 position for 
Mannich reaction, the secondary nitrogen is more active than C3 while in 2-methyl 
indole, Mannich reaction goes on both N1 and C3 positions depending upon the 
reaction condition. 
 
Mannich bases can be synthesized by Mannich reaction on nitrogen of 
secondary amine having hydrogen atom with pronounced activity using simplified 
methodology and easy work up and this inspired us to develop some new N-
substituted indole 2-Carboxylic acid derivatives by Mannich reaction. Literature also 
revealed that secondary amines viz. morpholine, piperidine, pyrrolidine, piperazine 
derivatives and other secondary amines like dimethylamine, diethylamine etc. and 
secondary aromatic amines have not been used yet that is why we used secondary 
amines to acquire Mannich bases having desired scaffolds. These interesting Mannich 
bases derived from indole 2-Carboxylic acid are not only structurally novel but the 
biological evaluation is reported here for the first time. Biological importance of such 
an important scaffold is the rational behind the current work done in this chapter.  
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5.B.10 REACTION SCHEMES 
 
5.B.10.1 PREPARATION OF INDOLE 2-CARBOXYLIC ACID 
 
STEP – 1 
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5.B.10.2 PREPARATION OF 1-(SUBSTITUTED METHYL)-1H-INDOLE-2-
CARBOXYLIC ACID N-MANNICH BASES 
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5.B.11 PLAUSIBLE REACTION MECHANISM 
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5.B.12 EXPERIMENTAL 
 
5.B.12.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. IR spectra were recorded 
in Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass spectra were 
recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection Probe 
technique. 1H NMR was determined in DMSO-d6 solution on a Bruker Ac 400 MHz 
spectrometer. Elemental analysis of the all the synthesized compounds was carried 
out on Elemental Vario EL III Carlo Erba 1108 model and the results are in 
agreements with the structures assigned. 
 
5.B.12.2 PREPARATION OF INDOLE 2-CARBOXYLIC ACID 
 
STEP – 1 PREPARATION OF ACETONE PHENYL HYDRAZONE 
 
25 ml of phenyl hydrazine was added drop wise to a magnetically stirred 
solution of 20 ml of acetone. After the completion of the addition, 5 ml of acetone 
was added to the reaction mixture and the reaction mixture was heated on the water 
bath to remove the excess of the acetone. Afterwards the reaction mixture was cooled 
to room temperature and it was made anhydrous by means of anhydrous sodium 
sulphate or anhydrous calcium chloride. The solution was filtered to give the dark 
yellow solution of phenyl hydrazone. Yield - 80 %, BP - 140-142°C (141-142°Ca) 
 
STEP – 2 PREPARATION OF 2-METHYL INDOLE 
 
30 gm of acetone phenyl hydrazone was added drop wise to a beaker 
containing 75 gm of poly phosphoric acid with constant stirring. The reaction mixture 
was heated on water bath for 2-3 hours, where the orange colored solution became 
dark red-brown. After that the temperature of the reaction mixture was raised to 
                                                 
a H. M. Kissman, D. W. Farnsworth and B. Witkop; J. Am. Chem. Soc., 1952, 74, 3948. 
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120°C and then it was cooled to room temperature. After that 400 ml of distilled water 
was added to the reaction mixture to decompose the polyphosphoric acid, the whole 
content was steam distilled to acquire the 2-Methyl Indole as white colored shining 
crystals. Yield - 79 %, MP - 58-59°C (56-57°Cb) 
 
STEP-3 PREPARATION OF INDOLE 2-CARBOXYLIC ACID 
 
Take 2-methyl indole (0.01 mole) into 100 ml RBF then add into 10 ml of 
water and 5 gm of K2Cr2O7 then add 10 ml of H2SO4 drop wise with stirring in approx 
20-25min. after addition allow the reaction mixture to cool down at rt. then check the 
TLC using hexane : ethyl acetate (9: 1) as a mobile phase. then reaction mixture 
Poured into crushed ice filter the separated product. Transfer the solid material in to 
beaker and add 5%H2SO4.digest the content on water bath for 20-25 min. allow the 
reaction mixture  to cool at RT. filter the separated product wash with water. Dissolve 
the solid material into 5%NaOH solution. Shake well and filter it, wash with water. 
Collect the filtrate and acidify with 15% H2SO4 solution. so indole 2-carboxylic acid 
precipitate out by acid base treatment. filter it and wash with water. Crystalline with 
suitable organic solvent. 
 
5.B.12.3 PREPARATION OF 1-(SUBSTITUTED METHYL)-1H-INDOLE-2-
CARBOXYLIC ACIDS (SP-20 TO SP-32)  
GENERAL METHOD 
 
It was prepared according to the method described by Abonia et. Al56.  indole 
2-Carboxylic acid (0.01 mole) was charged into 50 ml erlenmeyer flask and 
formaldehyde (0.015 mole) (37-41% w/w solution) and 10 ml diethyl ether were 
added into above flask and the mixture was magnetically stirred for some time at 
room temperature under acidic condition. and an appropriate secondary amine (0.01 
mole) was added drop wise into above reaction mixture. Stirring was continued for 
further half an hour at room temperature. The progress and the completion of the 
reaction were checked by silica gel-G F254 thin layer chromatography using hexane : 
ethyl acetate (9: 1) as a mobile phase. After the reaction to be completed, the reaction 
                                                 
b C. F. H. Allen and J. Vanallan; Organic Syntheses, 1955, Coll. Vol. 3, p. 597. 
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mixture was extracted using ethyl acetate (30 ml×3). The combined organic layer was 
washed using water (20 ml × 2). The organic layer was dried over anhydrous sodium 
sulphate and the solvent was removed under reduced pressure to acquire the product. 
Similarly other compounds are also prepared.  
Physical data of the synthesized end products are summarized in the Table No. 5.B.1.  
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5.B.13 PHYSICAL DATA  
 
PHYSICAL DATA OF 1-(SUBSTITUTED METHYL)-1H-INDOLE-2-CARBOXYLIC 
ACIDS (SP-20 TO SP-32) 
 
N
N
COOH
R1
R2  
TABLE-5.B.1 
Sr. 
No. 
Code 
Name 
& No. 
Substitutions Molecular Formula 
Molecular 
Weight 
MP 
0C 
Rf 
Value
01 SP-20 
O
H
N
C14H16N2O3 260 184-186 0.41 
02 SP-21 N
H
N
C20H21N3O2 335 166-168 0.45 
03 SP-23 
N
H
N
C16H21N3O2 287 156-158 0.42 
04 SP-24 
N
H
N
C15H19N3O2 273 122-126 0.40 
05 SP-25 
NH
C15H18N2O2 258 202-204 0.51 
06 SP-26 N
H
N
C21H23N3O2 349 165-169 0.44 
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07 SP-27 
NH
NH
C14H17N3O2 259 174-176 0.46 
08 SP-28 
NH
CH3
CH3 C14H18N2O2 246 134-138 0.50 
09 SP-29 
NH
CH3
CH3
C16H22N2O2 274 164-166 0.39 
10 SP-30 
NH
CH3
CH3
CH3
CH3
C16H22N2O2 274 114-118 0.42 
11 SP-31 
NH
C14H16N2O2 244 186-188 0.46 
12 SP-32 
NH
CH3
C17H16N2O2 280 194-196 0.48 
 
    Rf value was calculated using solvent system, Hexane : Ethyl Acetate (9: 1) 
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5.B.14 SPECTRAL DISCUSSION 
 
5.B.14.1 MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-MS 
QP-2010 model using direct injection probe technique. The molecular ion peak was 
found in agreement with molecular weight of the respective compound. SP-24 and 
SP-25 of Mass spectra are given on page no. 251 and 253. 
 
5.B.14.2 IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT-IR 
8400 spectrophotometer using Diffused Reflectance Attachment (DRA) system using 
Potassium Bromide.  
 
In case of SP-20 to SP-32, there is no characteristic peak obtained in the spectra. In 
case of SP-21 to SP-26 secondary amine of piperazine gave stretching frequency in 
the region of 3310 to 3530 cm-1 and bending vibrations in the region of 1550 to 1650 
cm-1. Aliphatic C-N vibrations are found near 1220 cm-1. SP-24 and SP-25 of IR 
spectra are given on page no. 251 and 253. 
 
5.B.14.3 1H NMR SPECTRA 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer. Making a solution of samples in DMSO-d6 solvent 
using tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons identified from NMR spectrum and their chemical shift (δ ppm) 
were in the agreement of the structure of the molecule. J values were calculated to 
identify o, m and p coupling. In some cases, aromatic protons were obtained as 
multiplet. 1H  NMR spectral interpretation can be discussed as under. 
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1H NMR OF 1-((4-METHYLPIPERAZIN-1-YL)METHYL)-1H-INDOLE-2-
CARBOXYLIC ACID (SP-24) 
 
N N
COOH
N 1
2
3
4 56
7
8
9
10 11
12
 
 
1. The most deshielded proton no. 12 of hydroxyl group gave a characteristic 
singlet at 11.28 δ ppm and as it is bonded to the electronegative oxygen atom 
the singlet is shifted to downfield significantly.  
2. The proton no.1 of methyl group gave a characteristic singlet at 2.40 δ ppm it 
became deshielded due to attached with nitrogen atom. 
3. The proton no. 2, 3, 4 and 5 it clearly shows 8H gave a multiplet at 3.14 δ ppm 
– 3.47 δ ppm. All eight protons became deshielded due to attached with 
nitrogen atom on both side. 
4. The proton no. 6 of methylene proton gave a characteristic singlet at 4.21 δ 
ppm. The assignment of this proton is the most important for the structure 
elucidation and as it is evident here the successful assignment of this singlet 
has confirmed our structure. 
5. The proton no. 7 of aromatic region gave a characteristic singlet at 7.70 δ ppm. 
6. The proton no. 8 of aromatic protons gave triplet at 7.08 δ ppm -7.11 δ ppm. 
 7. The Proton no. 11 of aromatic gave a triplet at 7.21 δ ppm-7.24 δ ppm. 
 8. The Proton no. 9 of aromatic ring gave a doublet at 7.49 δ ppm -7.51 δ ppm 
and J value of proton no. 9 is 8.0 Hz it clearly suggesting a ortho-coupled with 
another proton. 
9.  The Proton no. 10 of aromatic ring gave a doublet at 7.55 δ ppm -7.57 δ ppm 
and J value of proton no. 10 is 8.0 Hz it clearly suggesting a ortho-coupled 
with another proton. 
 
Thus, by observing and assigning the peaks in the NMR spectrum and 
by the calculation of the J values for each of the above proton, the proposed 
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structure for compound no. SP-24 has been confirmed. Spectrum is given on 
page no. 252. 
 
1H NMR OF 1-((PIPERIDIN-1-YL) METHYL)-1H-INDOLE-2-CARBOXYLIC 
ACID (SP-25) 
 
N N
COOH 2
3
4
56
7
8
9
10 11
12
1
 
 
1. The proton no.1, 2 and 5 of piprazine six protons gave a multiplet at 1.78 δ 
ppm -1.87 δ ppm. it  clearly shows in expanded spectra. 
2. The proton no. 3 and 4 of piprazine four proton which is attached with 
nitrogen atom gave a multiplet at 2.59 δ ppm-3.42 δ ppm. it became a 
deshielded due to the nitrogen atom. 
 3. The proton no. 6 of methylene group gave a characteristic singlet at 4.25 δ 
ppm. The assignment of this proton is the most important for the structure 
elucidation and as it is evident here the successful assignment of this singlet 
has confirmed our structure. 
4. The proton no. 7 of aromatic region gave a characteristic singlet at 7.68 δ ppm. 
5.  The proton no. 8 of aromatic proton gave triplet at 7.07 δ ppm -7.11 δ ppm. 
6. The proton no. 11 of aromatic proton gave triplet at 7.19 δ ppm -7.23 δ ppm. 
7. The Proton no. 9 and 10 of two aromatic protons gave a triplet at 7.50 δ ppm -
7.54 δ ppm.  
8. The most deshielded proton no.12 of hydroxyl group gave a characteristic 
singlet at 11.17 δ ppm and as it is bonded to the electronegative oxygen atom 
the singlet is shifted to downfield significantly.  
 
Thus, by observing and assigning the peaks in the NMR spectrum and 
by the calculation of the J values for each of the above proton, the proposed 
structure for compound no. SP-25 has been confirmed. Spectrum is given on 
page no. 254. 
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5.B.14.4 ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds. The spectral and elemental analysis data are given for individual 
compounds. 
 
5.B.15 ANALYTICAL DATA 
 
1-(morpholinomethyl)-1H-indole-2-carboxylic acid (SP-20): 
Yield: 72%, IR (KBr, cm-1): 3240 (-OH bonded), 2990 (–CH3 stretching), 2780 (-CH2 
stretching), 1692 (-C=O stretching), 1547, 1468, (Ar-C-C- skleton), 1151 (C-N 
stretching), 748 (-C-H oop bending); MS m/z = 260 (M+); Anal. Calcd. for 
C14H16N2O3: C, 64.60; H, 6.20; N, 10.76; O, 18.44. Found: C, 64.52; H, 6.18; N, 
10.70; O, 18.41%. 
 
1-((4-phenylpiperazin-1-yl)methyl)-1H-indole-2-carboxylic acid (SP-21): 
Yield: 80%,  IR (KBr, cm-1): 3520 (secondary amine of piprazine stretching), 3254 (-
OH bonded), 2987 (–CH3 stretching), 2758 (-CH2 stretching), 1694 (-C=O stretching), 
1545, 1478, (Ar-C-C skleton), 1182 (C-N stretching), 746 (-C-H oop bending); MS 
m/z = 335 (M+); Anal. Calcd. for C20H21N3O2: C, 71.62; H, 6.31; N, 12.53; O, 9.54. 
Found: C, 71.61; H, 6.30; N, 12.51; O, 9.52%. 
 
1-((4-ethylpiperazin-1-yl)methyl)-1H-indole-2-carboxylic acid (SP-23):  
 Yield: 91%, IR (KBr, cm-1): 3478 (secondary amine of piprazine stretching), 3242 (-
OH bonded), 2977 (–CH3 stretching), 2774 (-CH2 stretching), 1694 (-C=O stretching), 
1535, 1459, (Ar-C-C skleton), 1188 (C-N stretching), 739 (-C-H oop bending); MS 
m/z = 287 (M+); Anal. Calcd. for C16H21N3O2: C, 66.88; H, 7.37; N, 14.62; O, 11.14. 
Found: C, 66.77; H, 7.31; N, 14.61; O, 11.11%. 
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1-((4-methylpiperazin-1-yl)methyl)-1H-indole-2-carboxylic acid (SP-24): 
 Yield: 94%, IR (KBr, cm-1): 3524 (secondary amine of piprazine stretching),  3250 (-
OH bonded), 3005 (–CH3 stretching), 2766 (-CH2 stretching), 1680 (-C=O stretching), 
1535, 1469, (Ar. C-C skleton), 860 (-C-H oop bending); 1H NMR (400 MHz, DMSO-
d6): δ (ppm) 2.40 (3H, s), 3.47 (8H, m), 4.21 (2H, s), 7.11 (1H, t), 7.24 (1H, t), 7.51 
(1H, d, J=8.0 Hz), 7.57 (1H, d, J=8.0 Hz), 7.70 (1H, s), 11.28 (1H, s); MS m/z = 273 
(M+); Anal. Calcd. for C15H19N3O2: C, 65.91; H, 7.01; N, 15.37; O, 11.71. Found: C, 
65.90; H, 7.00; N, 15.34; O, 11.66%. 
 
1-((piperidin-1-yl)methyl)-1H-indole-2-carboxylic acid (SP-25): 
Yield: 90%, IR (KBr, cm-1): 3435 (secondary amine of piprazine stretching), 3190 (-
OH bonded), 2966 (–CH3 stretching), 2796 (-CH2 stretching), 1790 (-C=O stretching), 
1533, 1475 (Ar-C-C skleton), 887 (-C-H oop bending); 1H NMR (400 MHz, DMSO-
d6): δ (ppm) 1.87 (6H, m), 2.70 (2H, m), 3.42 (2H, m), 4.25 (2H, s), 7.11 (1H, t), 7.23 
(1H, t), 7.54 (2H, t), 7.68 (1H, s), 11.17 (1H, s); MS m/z = 258 (M+); Anal. Calcd. for 
C15H18N2O2: C, 69.74; H, 7.02; N, 10.84; O, 12.39. Found: C, 69.71; H, 7.01; N, 
10.80; O, 12.30%. 
 
1-((4-benzylpiperazin-1-yl)methyl)-1H-indole-2-carboxylic acid (SP-26): 
 Yield: 84%, IR (KBr, cm-1): 3466 (secondary amine of piprazine stretching), 3238 (-
OH bonded), 2987 (–CH3 stretching), 2778 (-CH2 stretching), 1698 (-C=O stretching), 
1535, 1469, (Ar-C-C skleton), 1166 (C-N stretching), 745 (-C-H oop bending); MS 
m/z = 349 (M+); Anal. Calcd. for C21H23N3O2: C, 72.18; H, 6.63; N, 12.03; O, 9.16;. 
Found: C, 72.11; H, 6.61; N, 12.02; O, 9.10%. 
 
1-((piperazin-1-yl)methyl)-1H-indole-2-carboxylic acid (SP-27): 
 Yield: 86%, IR (KBr, cm-1): 3262 (-OH bonded), 2992 (–CH3 stretching), 2794 (-
CH2 stretching), 1691 (-C=O stretching), 1535, 1477, (Ar-C-C skleton), 1201 (C-N 
stretching), 750 (-C-H oop bending); MS m/z = 259 (M+); Anal. Calcd. for 
C14H17N3O2: C, 64.85; H, 6.61; N, 16.20; O, 12.34. Found: C, 64.82; H, 6.61; N, 
16.20; O, 12.26%. 
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1-((diethylamino)methyl)-1H-indole-2-carboxylic acid (SP-28): 
Yield: 81%, IR (KBr, cm-1): 3241 (-OH bonded), 2955 (–CH3 stretching), 2776 (-CH2  
stretching), 1680 (-C=O stretching), 1545, 1469, (Ar-C-C skleton), 1146 (C-N 
stretching), 738 (-C-H oop bending); MS m/z = 246 (M+); Anal. Calcd. for 
C14H18N2O2: C, 68.27; H, 7.37; N, 11.37; O, 12.99. Found: C, 68.22; H, 7.30; N, 
11.30; O, 12.92%. 
 
 1-((diisopropylamino)methyl)-1H-indole-2-carboxylic acid (SP-29): 
Yield: 90%, IR (KBr, cm-1): 3262 (-OH bonded), 2988 (–CH3 stretching), 2788 (-CH2 
stretching), 1684 (-C=O stretching), 1535, 1477, (Ar-C-C skleton), 1174 (C-N 
stretching), 751 (-C-H oop bending); MS m/z = 274 (M+); Anal. Calcd. for 
C16H22N2O2: C, 70.04; H, 8.08; N, 10.21; O, 11.66. Found: C, 70.00; H, 8.02; N, 
10.21; O, 11.63%. 
 
1-((dipropylamino)methyl)-1H-indole-2-carboxylic acid (SP-30): 
Yield: 84%, IR (KBr, cm-1): 3244 (-OH bonded), 2991 (–CH3 stretching), 2766 (-CH2 
stretching), 1694 (-C=O stretching), 1537, 1469, (Ar-C-C skleton), 1147 (C-N 
stretching), 753 (-C-H oop bending); MS m/z = 274 (M+); Anal. Calcd. for 
C16H22N2O2. C, 70.04; H, 8.08; N, 10.21; O, 11.66. Found: C, 70.01; H, 8.02; N, 
10.17; O, 11.63%. 
 
1-((pyrrolidin-1-yl)methyl)-1H-indole-2-carboxylic acid (SP-31): 
 Yield: 90%, IR (KBr, cm-1): 3258 (-OH bonded), 2997 (–CH3 stretching), 2769 (-
CH2 stretching), 1694 (-C=O stretching), 1535, 1469, (Ar-C-C skleton), 1161 (C-N 
stretching), 748 (-C-H oop bending); MS m/z = 244 (M+); Anal. Calcd. for 
C14H16N2O2: C, 68.83; H, 6.60; N, 11.47; O, 13.10. Found: C, 68.74; H, 6.61; N, 
11.46; O, 13.15%. 
 
 1-((methyl (phenyl) amino) methyl)-1H-indole-2-carboxylic acid (SP-32):  
Yield: 84%, IR (KBr, cm-1): 3254 (-OH bonded), 2997 (–CH3 stretching), 2781 (-CH2 
stretching), 1689 (-C=O stretching), 1535, 1469, (Ar-C-C skleton), 1144 (C-N 
stretching), 734 (-C-H oop bending); MS m/z = 280 (M+); Anal. Calcd. for 
C17H16N2O2: C, 72.84; H, 5.75; N, 9.99; O, 11.42. Found: C, 72.80; H, 5.71; N, 9.88;  
O, 11.40%. 
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5.B.16 RESULTS AND DISCUSSION 
 
 In Section-A, many mimics of Aripiprazole were prepared as a ‘Core’ moiety. 
In Section-B, known methods were adopted for the preparation of 2-methyl 
indole as well as indole 2-carboxylic acid with slight modifications in the previously 
reported methods. 
Earlier reported method for the preparation of N-Mannich bases of indole 2-
carboxylic acid where they used benzotriazole was used as secondary amine and 
formaldehyde (37-41% w/w solution). They mixed all the three reagents in 
diethylether and stirred the reaction mixture at the room temperature and obtained 
solid product. Thus it may be concluded that the physical state of the product may 
depend upon the secondary amine used.  
 
 
5.B.17 CONCLUSION 
 
In Section-A, New chemical entities were prepared to obtain a small library of 
Aripiprazole mimics. 
 
While in Section B, the Mannich base of indole 2-carboxylic acid were 
prepared to obtain several drug like important molecules having various secondary 
amines namely, morpholine, piprazine, N-methyl piprazine, N-ethyl piprazine, etc. 
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5.B.18 REPRESENTATIVE SPECTRA  
 
5.B.18.1 Mass Spectrum of SP-024 
 
 
  
5.B.18.2 IR Spectrum of SP-024 
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5.B.18.3 1H NMR Spectrum of SP-024 
 
 
EXPANDED 1H-NMR SPECTRUM OF SP-024 
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5.B.18.4 Mass Spectrum of SP-025 
 
5.B.18.5 IR Spectrum of SP-025 
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5.B.18.6 1H NMR Spectrum of SP-025 
 
 
 
EXPANDED 1H-NMR SPECTRUM OF SP-025 
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EXPANDED 1H-NMR SPECTRUM OF SP-025 
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6.1 INTRODUCTION TO CHROMATOGRAPHY 
 
In 1906, the Russian botanist M.S. Tswett reported separation of different 
colored constituents of extract of green leaves into a series of colored bands by 
allowing a solvent to percolate through column bed of powdered calcium carbonate1. 
He termed this technique as ‘chromatography’ from the Greek words meaning ‘color 
(chroma)’ and ‘writing (graphy)’. As a matter of above fact, chromatography owes its 
origin to the efforts of him. Tswett’s this technique was virtually unnoticed in the 
literature until the early 1940s, when the well-known paper of Martin and Synge was 
published2. They reported the discovery of liquid-liquid partition chromatography, 
both on columns and on paper. They also provided a theoretical frame work for the 
basic chromatographic process and they received the Nobel Prize in chemistry in 1952 
for their work. The next major step that led to progress in this field was the 
development of gas-liquid chromatography by James and Martin3. The success of 
modern chromatography is greatly due to the excellent extensive treatment of 
chromatographic theory by Giddings in 1965 through his book entitled Dynamics of 
Chromatography4. Afterwards, a number of well-known scientists whose 
contributions are too numerous to be recounted here and their work has led to the 
development of modern liquid chromatography, which is often called high-pressure or 
high performance liquid chromatography. This technique is also called as HPLC, or 
simply LC. 
 
Classification of Chromatographic Methods 
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6.2 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY5, 6 
 
Based on the preceding discussion, chromatography can be simply defined as: 
‘Chromatography is the technique in which the components of a mixture are separated 
based upon the rates at which they are distributed through two phases, one of which 
does not move (stationary phase) and the other that moves (mobile phase) .’ When 
mobile phase is liquid, this technique is known as ‘liquid chromatography.’ Liquid 
chromatography (LC) is a method of chromatographic separation based on the 
difference in the distribution of species between two non miscible phases, in which 
the mobile phase is a liquid which percolates through a stationary phase contained in a 
column. It is mainly based on mechanisms of adsorption, mass distribution, ion 
exchange, size exclusion or stereo chemical interaction. Early liquid chromatography 
is carried out in long glass columns with wide diameter. Now days with the help of 
advent of latest technology, the particle diameters were reduced as small as to below 
10 µm with replacement of glass columns to steel ones. The flow rate of the mobile 
phase was improved by applying high pressure to the column using pumps and hence 
the performance was improved. This development led to be mostly called as ‘high-
performance liquid chromatography’ or ‘high-pressure liquid chromatography’ 
(HPLC). 
 
HPLC is most widely used analytical separation technique that offers major 
improvements over the old chromatography. The technique is more popular because it 
is non-destructive and may be applied to thermally liable compounds (unlike GC). 
HPLC is ideally suitable for the separation of macromolecules and ionic species of 
biomedical interest, liable natural products and diverse less stable and/or high 
molecular weight compounds. The majority of difficult separations are often more 
readily attained by HPLC because both phases used in HPLC participate in the 
chromatographic process (as opposed to only one in GC) to increase more selective 
interactions with the sample molecule. Short, small-bore columns containing densely 
packed particles of stationary phase provide for the rapid exchange of compounds 
between the mobile and stationary phases. A large variety of unique column packing 
(stationary phase) provide a wide range of selectivity to separation through HPLC. 
HPLC also offers wide choice of detection methods as numbers of unique detectors  
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are available. 
 
INSTRUMENTATION OF HPLC 
A schematic instrumentation of HPLC is given through figure-1 as under: 
Figure-1: A schematic instrumentation of HPLC equipment 
 
 
 
 
A liquid chromatography consists of a reservoir containing the mobile phase, a pump 
to force the mobile phase through the system at high pressure, an injector to introduce 
the sample into the mobile phase, a chromatographic column (a column temperature 
controller may be also used) to attain retention, a detector to detect analyze response 
and a data collection device such as a computer, integrator, or recorder. Further, in 
some cases, degasser with vacuum pump and pre-column facility can implement in 
the modern HPLC; represented as figure-2: 
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Figure-2: Designing of HPLC path  
 
 
 
A brief introduction of HPLC components is given as under 
 
Pumping Systems 
HPLC pumping system delivers measured amounts of mobile phase from the 
solvent reservoirs to the column through high-pressure tubing and fittings. Operating 
pressures up to 5000 psi or higher, with delivery rates up to about 10 ml/minute is 
typical. Pumps used for quantitative analysis should be constructed of materials that 
inert to corrosive mobile phase components and be capable of delivering the mobile 
phase at a constant rate with minimal fluctuations over extended periods of time. 
Modern systems consist of microprocessor controlled metering pumps that can be 
programmed to deliver either constant (isocratic) flow of mobile phase or vary the 
ratio of mobile phase components, as is required for gradient run. Advanced pumping 
system is equipped with a degasser to remove dissolved air and other gases from the 
solvent through solvent delivery system. 
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Injectors 
After dissolution in mobile phase or suitable diluent, compounds to be 
chromatographed are injected into the mobile phase, either manually by syringe/loop 
injectors or automatically by auto sampler. Autosampler consist of a carousel or rack 
to hold sample vials with tops that have a pierce able septum or stopper and an 
injection device to transfer sample from the vials to a loop from which it is loaded 
into the chromatograph. Autosampler can be programmed to control sample volume, 
the number of injections, the interval between injections and rinse cycles.  
 
Columns7-15 
The column is usually made up of stainless steel to withst and high pressure. 
Columns used for analytical separations usually have 10-30 cm length and 4-10 mm 
inside diameter containing stationary phase having particle diameter of 3-10 µm. 
Particles may range up to 50 µm or more for preparative columns. Stationary phases 
for modern, reverse-phase liquid chromatography typically consist of an organic 
phase chemically bound to silica or other materials. Small particles thinly coated with 
organic phase provide for low mass transfer resistance and, hence, rapid transfer of 
compounds between the stationary and mobile phases. Columns may be heated to 
give more efficient separations, but only rarely are they used at temperatures above 
60° C. Unmodified silica, porous graphite or polar chemically modified silica, e.g. 
cyano propyl or diol, used as the stationary phase for normal-phase liquid 
chromatography. Most of separations for reversed-phase liquid chromatography are 
based upon partition mechanisms that utilize chemically modified silica as the 
stationary phase and polar solvents as the mobile phase. The surface of the support, 
e.g. the silanol groups of silica, is reacted with various saline reagents to produce 
covalently bound silyl derivatives covering a varying number of active sites on the 
surface of the support. The nature of the bonded phase is an important parameter for 
determining the separation properties of the chromatographic system. 
 
Detectors16-21 
UV/Vis spectrophotometers, including diode array detectors, are the most 
commonly employed detectors. Fluorescence spectrophotometers, differential 
refractometers, electrochemical detectors, mass spectrometers, light scattering 
detectors, radioactivity detectors or other special detectors may also be used. 
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Detector consists of a flow-through cell mounted at the end of the column. A 
beam of UV radiation passes through the flow cell and into the detector. As 
compounds elute from the column, they pass through the cell and absorb the radiation, 
resulting in measurable energy level changes. Fixed (mercury lamp), variable 
(deuterium or high-pressure xenon lamp) and multi-wavelength detectors are widely 
available. Modern variable wavelength detectors can be programmed to change 
wavelength while an analysis is in progress. Multi wavelength detectors measure 
absorbance at two or more wavelengths simultaneously. In diode array multi-
wavelength detectors, continuous radiation is passed through the sample cell and then 
resolved into its constituent wavelengths, which are individually detected by the 
photodiode array. These detectors acquire absorbance data over the entire UV-visible 
range, thus providing the analyst with chromatograms at multiple, selectable 
wavelengths, spectra of the eluting peaks and also peak purity. 
  
Data Collection Devices 
 Modern data stations receive and store detector output and print out 
chromatograms complete with peak heights, peak areas, sample identification and 
method variables. They are also used to program the liquid chromatograph, 
controlling most of variables and providing for long periods of unattended operation. 
 
Mode of HPLC 
Various modes of HPLC utilized to separate compounds are classified as follows: 
1) Adsorption chromatography 
2) Normal-phase chromatography 
3) Reversed-phase chromatography 
4) Ion-pair chromatography 
5) Ion-exchange chromatography 
6) Size exclusion chromatography 
 
Adsorption chromatography 
 Adsorption chromatography uses polar stationary phases with relatively non 
polar mobile phases. Separations in adsorption chromatography result to a great extent 
from the interaction of sample polar functional groups with discrete adsorption sites 
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on the stationary phase. Adsorption chromatography is usually considered appropriate 
for the separation of nonionic molecules that are soluble in organic solvents. 
 
Normal-phase chromatography 
 In HPLC, if stationary phase is more polar than the mobile phase, it is termed 
as normal-phase liquid chromatography. Polar bonded phases that have a diol, cyano, 
diethyl amino, amino, or diamino functional groups are used as stationary phase in 
normal-phase chromatography. Due to lower affinity of non polar compounds to the 
stationary phases used, non polar compounds are elute first while polar compounds 
are retained for longer time. Normal-phase chromatography is widely applied for 
chiral separations. 
 
Reversed-phase chromatography 
In HPLC, if stationary phase is less polar than the mobile phase, it is termed as 
reversed-phase liquid chromatography. In this technique, C-18, C-8, Phenyl and 
cyano-propyl functional groups that chemically bonded to micro porous silica 
particles are used as stationary phase. Retention in reversed phase chromatography 
occurs by nonspecific hydrophobic interactions of the solute with stationary phase. 
The ubiquitous application of reversed-phase chromatography arise from the fact that 
practically all organic molecules have hydrophobic regions in their structures and 
effectively interact with the stationary phase. It is estimated that over 65% (possibly 
as high as 90%) of all HPLC separations are executed in the reversed-phase mode. 
The rationale for this includes the simplicity, versatility and scope of the reversed-
phase method.22 
 
Ion-pair chromatography 
 Ionic or partially ionic compounds can be chromatographed on reversed phase 
columns by using ion-pairing reagents. These reagents are typically long chain alkyl 
anions or cations that, when used in dilute concentrations, can increase the retention 
of analyte ions. C-5 to C-10 alkyl sulfonates are commonly used for cationic 
compounds while C-5 to C-8 alkyl ammonium salts are generally used in the cases of 
anionic solutes. 
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Ion-exchange chromatography 
 Ion-exchange chromatography is an adaptable technique used primarily for the 
separation of ionic or easily ionizable species. The stationary phase is characterized 
by the presence of charged centers having exchangeable counter ions. Both anions 
and cations can be separated by choosing the suitable ion-exchange medium. Ion-
exchange chromatography employs the dynamic interactions between charged solute 
ions and stationary phases that have oppositely charged groups. 
 
Size exclusion chromatography 
 Size exclusion chromatography separates molecules according to their 
molecular mass. In Size exclusion chromatography, column is filled with material 
having precisely controlled pore sizes and the sample is simply screened or filtered 
according to its solvated molecular size. Largest molecules are eluted first and the 
smallest molecules last. This method is generally used when a mixture contains 
compounds with a molecular mass difference of at least 10%. This mode can be 
further subdivided into gel permeation chromatography (with organic solvents) and 
gel filtration chromatography (with aqueous solvents). 
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6.4 AIM OF CURRENT WORK 
 
The prime and specific objective of the work is to develop simple and Rapid 
Liquid Chromatographic Method of Newly Synthesized Compounds Like, 
Benzofuran derivatives, Valproic acid  derivatives, Quinolone derivatives, Coumarin 
derivatives and Indole derivatives for the quantification and Purity Determination by 
High-performance liquid chromatographic method. 
 
6.5 EXPERIMENTAL 
 
Instrument: 
Liquid chromatography was performed using Waters equipments with TM-
600 quaternary  pump, Waters 2489 UV-Visible detector, Waters 600 Controller, 
waters inline degasser AF and manual injector with 20 µl loop. The equipment was 
connected to multi-instrument data acquisition and data processing system (Empower 
2.1 software). 
 
Reagents: 
Methanol (HPLC grade) 
3.2 pH Phosphate Buffer 
Water (Milli-Q) 
 
Blank : 
Diluent was used as blank. 
 
Sample Preparation: 
Weigh accurately 10 mg of different newly synthesized compounds in to 100 ml 
volumetric flask. Add 60 ml of diluent into the flask and sonicate of 30 minutes with 
normal hand-shaking. Cool the flask to room temperature and dilute to volume with 
diluent. Filter 10 ml of this solution through 0.45 µm nylon syringe filter. The 
concentration obtained is 100 µg/ml. 
All samples were prepared as per above mentioned sample preparation method. 
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6.5 CHROMATOGRAMS 
 
Chromatographic condition: 
Sample Code : SBF-01 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
N
N
O
O
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Chromatographic condition: 
Sample Code : SBF-02 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
N
N
O
O
H3C
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Chromatographic condition: 
Sample Code : SPSC-01 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
O
N
H
NH
O
N N CH3
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Chromatographic condition: 
Sample Code : SPSC-02 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
O
N
H
NH
O
N N CH2
CH3
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Chromatographic condition: 
Sample Code : SPA-01 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
O
N
H
N
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Chromatographic condition: 
Sample Code : SPA-02 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
O
N
H
N
Cl
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Chromatographic condition: 
Sample Code : SPAM-01 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
O
NH
HN O
Cl
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Chromatographic condition: 
Sample Code : SPAM-02 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
O
NH
HN O
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Chromatographic condition: 
Sample Code : SP-40 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
N
O
O
N
N
NO2
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Chromatographic condition: 
Sample Code : SP-41 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
N
O
O
N
N
Cl
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Chromatographic condition: 
Sample Code : SPC-02 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
O
O
O
H3C CH3
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Chromatographic condition: 
Sample Code : SPC-03 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
O
O
O
H3C Cl
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Chromatographic condition: 
Sample Code : SPAPI-01 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
HN
O
O
N
O
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Chromatographic condition: 
Sample Code : SPAPI-03 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
HN
O
O
N
N
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Chromatographic condition: 
Sample Code : SP-24 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
N N
COOH
N
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Chromatographic condition: 
Sample Code : SP-25 
Mobile phase :- 3.2 pH Phosphate Buffer : Methanol (10 : 90) 
Column :- YMC Pack HPLC column (C-8, 150 mm x 4.6mm id x 5micron) 
Column Temperature: ambient  
Flow rate :- 1.0 ml/min 
Detection :- 300 nm 
Injection volume :- 20 µl 
Diluent :- Mobile phase 
N N
COOH
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6.6 RESULTS AND DISCUSSION 
 
Benzofuran derivatives, Valproic acid derivatives, Quinolone derivatives, 
Coumarin derivatives and Indole derivatives have been analyzed on HPLC (Waters 
600). Method developed for the all compound was quite, simple and rapid. 
Chromatography for all compounds found good with adequate sensitivity and Purity. 
For all compounds, Chromatographic method was carried out on Column-YMC Pack 
HPLC column (C-8, 150 mm x 4.6mm id x 5micron), Mobile phase - 3.2 pH 
Phosphate Buffer : Methanol (10 : 90), Column Temperature - ambient, Flow rate - 
1.0 ml/min, Injection volume - 20 µl, Detection- 300 nm.  
 
6.7 CONCLUSION 
 
The Above Chromatographic data and observation during experiment suggest 
that the proposed analytical method is highly appropriate for the said objective, which 
further confirm by the purity results of newly synthesized bioactive molecules are 
between 94% – 100 %, which was subsequently bear out by other  analytical data like 
NMR, Mass, Infra Red and Elemental analysis mentioned in the relevant chapter.  
Chapter-6                                                                                         Purity Determination of ….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     285 
6.8 REFERENCES 
1. Tswett, M. S.; Ber. Duet. Botan. Ges. 1906, 24:316 and 384.  
2. Martin, A.J.P., Synge B.L.M.; Biochem. J. 1941, 35:1358. 
3. James A.T., Martin A.J.P.; Biochem. J. 1952, 50:679.  
4. Giddings J.C.; Dynamics of Chromatography, Part I, Marcel Dekker, New 
York, 1965. 
5. Snyder, L. R., Kirkl and J.J., Glajch J.L.; Practical HPLC Method 
Development, 2nd edition, John Wiley & Sons, Inc., NJ. 
6. Satinder, Ahuja; Chromatography and Separation Science, Academic Press, 
SanDiego, CA, 2003, page 153.  
7. Majors; R.E., LC/GC, 1991, 9, 686. 
8. Kalghatgi, K., Horvath, C.; J. Chromatogr., 1988, 443, 343. 
9. Unger, K. K., Giesche, H.; Ger. Pat. 1985, DE-3543 143.2.  
10. Afeyan, N. B., Gorden, N. F., Mazsaroff, I., Varady, L., Fulton, S.P., Yang, 
Y.B., Regnier, F.E.; J. Chromatogr., 1990, 519, 1. 
11. Kirkland, J. J., Van Straten, M.A., Claessens, H. A.; J. Chromatogr. A., 1995, 
691, 3. 
12. Snyder, L. R., Stadalius, M. A.; in High-Performance Liquid Chromatography: 
Advance and Perspectives, Vol.4, C. Horvath, ed., page 294-295, Academic 
Press, San Diego, CA, 1986. 
13. Kirkland, J. J.; J. Chromatogr. Sci., 1993, 31, 493. 
14. Kirkland, K. M., McCombs, D. A., Wirth, M. J., Fatunmbi, H. O., Anal. and 
Kirkland, J. J.; J. Chromatogr. A, 1994, 660, 327. 
15. Wirth, M. J., Fatunmbi, H. O.; Anal. Chem., 1993, 65, 822. 
16. van der Wal, S., Snyder, L.R.; J. Chromatogr., 1983, 225, 463. 
17. A Practical Guide to HPLC Detection, Academic Press, San Diego, CA, 1983. 
18. Poole, C. F., Schutte, S. A.; Contemporary Practice of Chromatography, 1984, 
page 375, Elsevier, Amsterdam. 
19. Krull, I. S.; in Chromatography and Separation Chemistry: Advances 
andDevelopments, Ahuja, S., ed.; ACS Symposium Series 297, page 137, 
ACS, Washington, DC, 1986. 
 
Chapter-6                                                                                         Purity Determination of ….. 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     286 
20. Li, G., Szulc, M. E., Fischer, D. H., Krull, I. S.; in Electrochemical Detection 
inLiquid Chromatography and Capillary Electrophoresis, Kissinger P.T., ed., 
Chromatography Science Series, Marcel Dekker, New York, 1997. 
21. Kissinger, P. T., Heineman, W. R., eds., Laboratory Techniques in 
ElectroanalyticalChemistry, Chaptor 20, Marcel Dekker, New York, 1984. 
22. Krstulovic, A. M., Brown, P. R.; Reversed-Phase High Performance 
LiquidChromatography : Theory, Practice and Biomedical Applications, 
Wiley, NewYork, 1982. 
 
 
 
 
 
 
CHAPTER - 7
BIOLOGICAL ACTIVITY
STUDY OF
NEWLY SYNTHESIZED
COMPOUNDS
Chapter-7                                                Biological activity of Newly Synthesized compounds.  
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     287 
7.1 MULTIDRUG RESISTANCE (MDR) 
 
The membrane efflux protein P-glycoprotein, a member of the ATP binding 
cassette (ABC) family, recognizes and transports structurally, chemically, and 
pharmacologically diverse hydrophobic compounds, giving rise to a phenomenon 
known as multidrug resistance (MDR).  
 
7. 2 NOVEL MDR MODIFIERS AND REVERSING AGENTS  
 
7.2.1 Cancer and the Current Status in World 
With more than 10 million new cases every year, cancer has become one of 
the most devastating diseases worldwide. The disease burden is immense, not only for 
affected individuals but also for their relatives and friends. At the community level, 
cancer has posed considerable challenges for the health care systems in poor and rich 
countries alike. World Cancer Report (WCR) of 2007 provides a unique global view 
of cancer. It documents the frequency of cancer in different countries and trends in 
cancer incidence and mortality as well as describing the known causes of human 
cancer1. 
Table-7.1: The estimated numbers of new cases and deaths for each common 
cancer type2, 3:  
 
Cancer Type Estimated New Cases Estimated Deaths 
Bladder 67,160 13,750 
Breast (Female -- Male) 178,480 -- 2,030 40,460 -- 450  
Colon and Rectal (Combined) 153,760 52,180 
Endometrial 39,080 7,400 
Kidney (Renal Cell) Cancer  43,512  10,957  
Leukemia (All) 44,240 21,790 
Lung (Including Bronchus) 213,380 160,390 
Melanoma 59,940 8,110 
Non-Hodgkin's Lymphoma 63,190 18,660 
Pancreatic 37,170 33,370 
Prostate 218,890 27,050 
Skin (Non-melanoma) >1,000,000 <2,000 
Thyroid 33,550 1,530  
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7.2.2 Role of ABC Transporters 
Cancer chemotherapy is the treatment of choice in many malignant diseases. A 
major form of resistance against a variety of the antineoplastic agents currently used 
involves the function of a group of membrane proteins that extrude cytotoxic 
molecules, thus keeping intracellular drug concentration below a cell-killing 
threshold. Multidrug transporters belong to the superfamily of ATP Binding Cassette 
(ABC) proteins, present in organisms from bacteria to humans. The medical 
significance of ABC proteins exceeds their role in cancer chemotherapy resistance; 
the transport function of several members was found to hinder the effective therapy of 
anticancer agents for many other widespread diseases (e.g. malaria, AIDS), and 
inherited diseases were also linked to mutations in these genes. The transport activity 
of ABC proteins has an important effect in general pharmacology, that is, in 
modulating the absorption, distribution and excretion of numerous pharmacological 
cancer agents.4  
 
These substrate molecules exhibit a wide variety of chemical structures. Some ABC 
proteins facilitate the transport of inorganic ions, whereas others pump various 
organic compounds, including lipids, bile acids, glutathione and glucuronide 
conjugates, or even short peptides. Most ABC family proteins utilize the energy of 
ATP hydrolysis for this transport activity (active transporters), but some ABC 
transporters form specific membrane channels.4  
 
7.2.3 Structure of ABC Proteins 
The typical structure of an ABC protein consists of membrane-embedded 
transmembrane domains (TMD) and ATP binding domains. Typically, the 
transmembrane regions anchor the protein to the membrane and form a pore through 
which the transport of a surprisingly large variety of substrates occurs. The 
cytoplasmic nucleotide binding domains provide the molecular compartment, where 
the energy of ATP is released. It is not known how the energy is conveyed from the 
ABC domains to the site of the transport and the precise mechanism of transport also 
remains elusive.4  
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7.2.4 Role of Resistance in Cancer-The Players 
Numerous clinical data revealed that the multidrug resistance (MDR) phenotype in 
tumors is associated with the overexpression of certain ABC transporters, termed as 
MDR proteins. The P-glycoprotein (Pgp, MDR1, ABCB1)-mediated MDR was the 
first discovered5-7 and probably still is the most widely observed mechanism in 
clinical MDR.8-11 Soon after the cloning and characterization of MDR1, it became 
evident that other efflux-pumps may also play a significant role in the transport-
associated drug resistance. There are two other ABC transporters, which have been 
definitively demonstrated to participate in the MDR of tumors: the MDR protein 1 
(MRP1, ABCC1), and the mitoxantrone resistance protein11-15 (MXR/BCRP, 
ABCG2). Furthermore, other human ABC proteins capable of actively transporting 
various compounds out of cells may also be their players in selected cases of MDR. 
These include ABCB4 (MDR3) and ABCB11 (sister Pgp or BSEP), two proteins 
residing predominantly in the liver with a function involved in the secretion of 
phosphatidyl choline and bile acids, respectively.16-18 MDR3 has been already shown 
to transport certain drugs as well.19 In addition to MRP1, five homologues (MRP2-
MRP6) have been cloned. Overexpression of MRP2 (an organic anion transporter 
which can also extrude hydrophobic compounds) was definitively shown to confer 
cancer MDR.13,20 MRP3, an organic conjugate transporter, and MRP5, a nucleoside 
transporter, are also candidate proteins for causing certain forms of drug resistance.13  
 
7.3 BASIC MECHANISM OF MDR IN CANCER  
 
The generally accepted mechanism of MDR is that the MDR proteins actively 
expel the cytotoxic drugs from tumor cells, maintaining the anticancer drug level 
below a cell-killing concentration. Drug extrusion mediated by these primary active 
transporters is driven by the energy of ATP hydrolysis. The most intriguing 
characteristic distinguishing the MDR proteins from other mammalian transporters is 
their wide substrate specificity. Unlike other selective (classical) transport proteins, 
multidrug transporters have been recognized and handled as a wide range of 
substrates. This wide substrate specificity explains the cross-resistance to several 
chemically unrelated compounds, the characteristic feature found in the MDR 
phenotype.8-11  
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Different tumors with MDR protein overexpression (e.g. hepatomas, lung or colon 
carcinomas) often show primary (or intrinsic) resistance to cancer chemotherapy. In 
addition, cancer chemotherapy itself might induce the overexpression of these 
proteins, so that the MDR clones become less sensitive to chemotherapy (secondary 
drug resistance). Treatment failure due to MDR is also found in connection with 
conditions other than cancer, including some autoimmune disorders and infectious 
diseases.21-23  
 
7.3.1 Nomenclature, Basic Structure and Membrane Topology of MDR 
Proteins 
The ABC superfamily is one of the largest families in proteins. The most 
recent annotation of the human genome sequence revealed 48 genes for ABC 
proteins. The ABC proteins were grouped into seven sub-classes, ranging from 
ABCA to ABCG24-28 based on genomic organization, order of domains and sequence 
homology. The phylogenetic tree of the ABC transporters involved in cancer MDR is 
presented in Figure 1. A thick line and a circle label the three definite players, while 
the close relatives, which may have a role in drug resistance, are also indicated on this 
evolutionary diagram. 
 
 
Figure-1. Phylogenic tree of the MDR- related ABC transporters. The thick lines 
represent the proteins definitively involved in multi-drug resistance. 
(Reproduced from reference-4) 
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All ABC proteins contain at least three characteristic peptide sequences: the Walker A 
and B motifs and the so-called ABC-signature sequence. Whereas the Walker motifs 
are present in several classes of ATP binding proteins, the presence of the signature 
region is diagnostic for the ABC proteins. It is generally accepted that the minimum 
functional unit requirement for an ABC transporter is the presence of two 
transmembrane domains (TMDs) and two ATP Binding Cassette (ABC) units. These 
may be present within one polypeptide chain ("full transporters"), or within a 
membrane-bound homo- or heterodimer of "half transporters".8-11,27,28 There are no 
high-resolution structural data presently available for any mammalian ABC 
transporter; therefore computer modeling and laborious biochemical experiments are 
necessary to elucidate the position and orientation of membrane spanning segments 
and other domains within the polypeptide chain. Figure 2 presents the most plausible 
membrane topology models for the key MDR-ABC transporters. As shown in Figure 
2, Pgp-MDR1 (ABCB1) is a "full transporter" with six TM helices in both TMDs of 
the protein, each followed by an ABC domain. A similar membrane topology has 
been predicted for ABCB4 (MDR3), and ABCB11 (sister Pgp) as well.24-28  
 
MRPs belong to the ABCC-subfamily, comprising eleven members in the human 
genome. Most of these proteins (ABCC1-6) have been identified as active, ATP-
dependent membrane transporters for various anticancer agents and organic anions.12-
14, 17 In contrast to these active transporters, the cystic fibrosis transmembrane 
conductance regulator, ABCC7 (CFTR) is a regulated chloride channel, while 
ABCC8 (SUR1) and ABCC9 (SUR2) are called sulfonylurea receptors and best 
described as intracellular ATP sensors, regulating the permeability of specific K+ 
channels. Nothing is currently known about the function of ABCC10 and ABCC11.11, 
13, 27, 28  
 
The predicted membrane topology of MRP1 is shown in Figure 2. According to 
current notion, in addition to an MDR1-like core, MRP1 contains an additional N-
terminal segment of about 280 amino acids. A major part of this region is membrane-
embedded with five transmembrane helices (TMH0), while a small cytoplasmic loop 
of about 80 amino acids (L0) connects this area to the core region.29-32 Recent studies 
revealed that the TMD0 domain of ABCC1 does not play a crucial role in either the 
transport activity or the proper routing of the protein. However, the presence of the 
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membrane-associated cytoplasmic L0 region (together with the core region) is 
necessary for both the transport activity and the proper intracellular routing of the 
protein. These studies indicate that the L0 region forms a distinct structural and 
functional domain, which interacts with the membrane and the core region of the 
MRP1 transporter.33 
 
 
Figure-2. Membrane topology models for the MDR-related ABC transporters. Green Bars represents 
predicted transmembrane helices, the purple circles represents the ABC domains, the gold 
tree are glycosylation sites at the extra cellular surface. (Reproduced from reference-4) 
 
The third ABC protein believed to play a role in clinical MDR, ABCG2 
(MXR/BCRP) is a half transporter15, 34, with a unique domain arrangement, where the 
ABC is located at the N-terminus (Figure-2). This protein performs an active 
extrusion of hydrophobic, positively charged molecules from the cells in an N-
glycosylated mature form, and in contrast to many other ABC half-transporters is 
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probably localized in the plasma membrane. Recently, it has been shown that the 
human ABCG2 MDR protein forms an active homodimer for its transport function.35, 
36  
There is no high-resolution three-dimensional structure available for any of the 
mammalian ABC transporters, thus the structural background of the MDR molecular 
mechanism is currently unresolved. A low-resolution structure of the MDR137 
indicates that the protein is embedded into the membrane as a cylinder with a large 
central pore, which is closed at the inner (cytoplasmic) face of the membrane. This 
structure also included an opening of this cylinder to the lipid phase.  
 
The structure of a bacterial ABC transporter, MsbA of E. coli, has recently 
been determined by X-ray crystallography.38 MsbA is a half-transporter with a TMD-
ABC domain arrangement, organized as a homodimer. The structure reveals that each 
MsbA subunit contains a transmembrane domain with six transmembrane helices, an 
ABC-domain, and an "intracellular domain" which is composed of the three 
intracellular loops connecting the transmembrane segments to the ABC-domain. One 
of the most important conclusions of the MsbA structure is that the membrane-
spanning segments of the polypeptide are indeed α-helices. The organization and 
interactions of these peptide domains will probably be a valuable foundation towards 
elucidating the structures of mammalian multidrug transporter ABC proteins.  
 
7.3.2 Substrate Specificity of MDR-ABC Transporter 
The three major MDR proteins are highly promiscuous transporters; they share the 
ability of recognizing and translocating a large number of structurally diverse, mainly 
hydrophobic compounds. In addition to their overlapping substrate specificity, each 
transporter can handle unique compounds.  
 
Pgp is a transporter for large hydrophobic, either uncharged or slightly positively 
charged compounds, while the MRP family primarily transports hydrophobic anionic 
conjugates and extrudes hydrophobic uncharged anticancer drugs. The MRP1-related 
uncharged drug transport is quite an enigma, and is somehow linked to the transport 
or allosteric effect of cellular free reduced glutathione13. The exact spectrum of the 
MXR (ABCG2) transported substrates has not yet been explored in detail, and these 
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studies are complicated by the variable substrate-mutants of MXR observed in the 
most recent studies.39  
 
In order to put the MDR substrates in their medical and pharmacological 
context, we present some of the key molecules in separate figures. Figure 3A shows 
anticancer drugs, which are, unfortunately for the patients, also MDR substrates. 
Figure 3B shows the chemical MDR modulators used experimentally or in clinical 
trials, while Figure 3C compiles the best-known MDR substrates used for functional 
diagnosis of the proteins.8-11, 40-43 
 
3A:  MDR-substrate anticancer agents. Abbreviations: VCR: vincristine, VP-16: etoposide, STER: 
steroids, TAM: tamoxiphen, TKI-INHIB: tyrosin kinase inhibitors e.g. STI-571, DOX: 
doxorubicine or adriamycin, DNR: daunorubicin, , EPIR: epirubicin, MX: mitoxantrone, 
TOPOT: topotecan, iridotecan, BISANT: bisanthrone, COLCH: colchicin, ACT-D: actinomycin 
D, MYTOM: mytomycin, TX: methotrexate, CPHAM: cyclophosphamide, CHLB: 
chlorambucil, CARM: carmustine, LCV: leucovorin, HUR: hydroxy urea, CISPL: cisplatin, 
TAXOL: paclitaxel. (Reproduced from reference-4) 
 
3B:  MDR-Modulating agents. Abbreviations: CSA: cyclosporin A, VERAP: verapamil STAURO: 
staurosporine, ECON: econazole, PRAZ: prazosine, FTC: fumitremorgin C, PROB: 
probenecide, BBR: benzbromarone, SUPYR: sulfinpyrazone, INDOM: indomethacin, GENIS: 
genistein, PGA2: prostaglandin A2, CCCP: chlorocarbonyl cyanide phenylhydrazine. 
(Reproduced from reference- 4) 
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3C: Fluorescent Compounds for the functional detection of multi drug resistance. Abbreviations: CA-
AM: calcein AM, FL-3-AM: fluo-3AM, Pot. Dyes: potentiomeric dyes, RH123: rhodamine123, 
HST: Hoechst dye No. 33342, GS-N-PM: N-Pyrenemaleimide glutathione conjugate, BOD-
VER: BODIPY verapamil, BOD-PRAS: BODIPY prazosin, MX: mitoxantrone, LYS: 
LysoTracker dye. (Reproduced from reference-4) 
Figure-3. Venn-diagram for selected compounds interacting with the key MDR-related ABC 
transporters. 
 
7.3.3 Cellular and Tissue Distribution of MDR-ABC Transporter 
The tissue distribution of the MDR-ABC proteins is as varied as their substrate 
specificity. MRP1 is almost ubiquitously expressed, while the expression of Pgp is 
more restricted to tissues involved in absorption and secretion.8-11 High level MDR1 
expression has also been shown in certain pharmacological barriers of the body, such 
as the blood-brain barrier (BBB) and the choroid plexus.44,45 It has been reported that 
MXR is highly expressed in the placenta, liver, and most interestingly, in various stem 
cells.34-46 All multidrug transporters are localized predominantly in the plasma 
membrane. In polarized cells, Pgp-MDR1 is localized in the apical (luminal) 
membrane surface (e.g. in the epithelial cells of the intestine and the proximal tubules 
of kidney, or in the biliary canalicular membrane of hepatocytes).47-49 In contrast, 
MRP1 expression in polarized cells is restricted to the basolateral membrane. The 
expression of MRP2, MDR3, and of Sister Pgp (BSEP) is predominant in the 
canalicular membrane of hepatocytes, while MRP3 and MRP5 are expressed in the 
basolateral membranes of these cells (Figure 4). MRP2 is also highly expressed in the 
apical membranes of kidney proximal tubules. In polarized cells, the MXR expression 
was reported to be mostly apical.50 
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Figure-4. Multi-drug transporters in the human liver hepatocytes. Abbreviations: TJ, tight junction. 
(Reproduced from reference- 4) 
 
7.3.4 Molecular Mechanism of the Multidrug Pumps 
Drug transport by MDR proteins requires the energy of ATP-hydrolysis, controlled by 
drug interaction, and closely coupled to the actual drug translocation. Interaction with 
the drug-substrate significantly enhances the basal ATPase activity of the multidrug 
transporters, that is, the transported drug-substrates increase the rate of ATP 
cleavage.51-53 The schematic pictures of the proposed molecular mechanisms of the 
MDR1 and MRP1 proteins, as depicted in Figure-5.  
 
The site(s) in multidrug transporters interacting with the drug-substrates are 
probably encoded in the transmembrane domains. Detailed mutagenesis studies of 
MDR1 and photochemical labeling with the reactive drug-derivatives revealed that 
transmembrane helices 5 and 6 (in the N-proximal transmembrane domain), helices 11 
and 12 (in the C-proximal transmembrane domain), as well as the short cytoplasmic 
loops connecting these helices, are involved in the formation of an extended drug-
binding site(s).54 There are strong indications that the hydrophobic substrates of 
MDR1 are recognized within the membrane bilayer or in its vicinity, and this type of 
recognition makes the MDR1 protein a highly effective pump, preventing the cellular 
entry of toxic compounds.55 In the case of MRP1 a similar picture has emerged. 
Recent studies have explored some parts of the transmembrane domains involved in- 
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-drug interactions.56 
 
 
5A:  MDR1-P-glycoprotein (substrates are recognized in, or near to the membrane lipid phase). 
Abbreviations: hD: hydrophobic drugs, PL: Phospholipids. (Reproduced from reference- 4) 
 
 
5B:  MRP1. Both hydrophobic drugs and anionic conjugates, such as glutathione, are transported. 
The transport of some hydrophobic drugs may be coupled to reduced gluthatione (GSH) as GS-
X molecules. (Reproduced from reference- 4) 
 
               Figure-5. Possible model for the molecular mechanism of multidrug transporters 
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Based on the three-dimensional structures of bacterial ABC-units, the nucleotide 
binding sites appear as shallow, more or less open grooves, forming atypical active 
sites. The close interaction of the two ABC units' likely results in the formation of a 
fully competent catalytic site. The regions connecting the ABC units to the 
transmembrane domains have an active key role in the transfer of conformational 
information within the protein, and the ABC signature region may have a special 
function in this regard.57  
 
The transport and ATPase cycle of the MDR proteins is blocked by vanadate, 
a phosphate-mimicking inhibitory anion, which stabilizes a transition state 
intermediate of the ATPase cycle. An occluded nucleotide in the catalytic sites is 
locked within the ABC protiens in this interaction. Similar to their ATPase activity, 
the rate of the vanadate-dependent nucleotide occlusion in MDR-ABC proteins is 
greatly accelerated by the transported drug-substrates.58 It has recently been shown, 
that in the case of MDR1 the MDR1*MgADP*Vi complex exhibits a dramatically 
reduced binding affinity for the transported drug substrate, as compared to the 
MDR1*MgATP complex.59 This observation suggests that the hydrolytic step triggers 
conformational changes, which reduce drug binding to the binding site (and 
presumably makes drug binding to another site favorable, from which the drug can be 
released to the extracellular space).  
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7.4 PROTOCOL FOR THE MDR SCREENING 
 
Cell cultures  
L5178Y mouse T-cell lymphoma cells (ECACC cat. no. 87111908, U.S. FDA, 
Silver Spring, MD, USA) were transfected with pHa MDR1/A retrovirus, as described 
previously.60, 61 The MDR1-expressing cell line was selected by culturing the infected 
cells with 60 ng/ml colchicine to maintain the expression of the MDR phenotype. 
L5178Y (parental, PAR) mouse T-cell lymphoma cells and the human mdr1-
transfected subline (MDR) were cultured at 37oC in McCoy's 5A medium 
supplemented with 10% heat-inactivated horse serum, L-glutamine and antibiotics. 
The mouse lymphoma cell lines were maintained in a 5% CO2 atmosphere at 37oC. 
A 2780cis cell line (ECACC cat. no. 93112517, Salisbury, UK) has been 
developed by chronic exposure of the parental cisplatin-sensitive A2780 human ovary 
cancer cell line to increasing concentrations of cisplatin62,63. This cell line was 
cultured in RPMI 1640 medium supplemented with 10 % heat-inactivated foetal 
bovine serum, L-glutamine and antibiotics. In order to retain resistance, cisplatin has 
to be added to the medium every 2-3 passages in 1 µM final concentration. The 
A2780cis cell line was maintained in a 5% CO2 atmosphere at 37oC. 
Assay for antiproliferative effect 
The effects of increasing concentrations of the drugs on cell growth were tested in 
96-well flat-bottomed microtitre plates in one parallel. The compounds were diluted 
in two-steps from a starting concentration of 50 µg/ml in a final volume of 150 µl, and 
DMSO was used as a control. A total of 6×103 cells in 50 µl of medium were then 
added to each well, with the exception of the medium control wells. The culture plates 
were further incubated at 37°C for 72 h, at the end of which 15 µl of MTT solution 
(thiazolyl blue solved in PBS to a final concentration of 5 mg/ml) were added to each 
well. After further incubation at 37°C for 4 h, 100 µl of sodium dodecyl sulphate 
(SDS) solution (10%) were measured into each well and the plates were further 
incubated at 37°C overnight. The cell growth was determined by measuring the 
optical density (OD) at 550 nm (ref. 630 nm) with a Multiscan EX ELISA reader 
(Thermo Labsystems, Cheshire, WA, USA). Inhibition of cell growth was determined 
as a percentage according to the formula: 
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⎥⎦
⎤⎢⎣
⎡ ×−
−− 100100
controlmediumODcontrolcellOD
controlmediumODcellstreatedOD
 
 
Assay for reversal of MDR in tumor cells 
The cells were adjusted to a density of 2×106 cells/ml, resuspended in serum-free 
McCoy’s 5A medium and distributed in 0.5 ml aliquots into Eppendorf centrifuge 
tubes. The tested compounds were added at different final concentrations (2.0 and 20 
µg/ml), and the samples were incubated for 10 min at room temperature. Indicator 
rhodamine 123 (R123) (Sigma-Aldrich Kft, Budapest, Hungary) was added to each 
sample to a final concentration of 10 µg/ml and the cells were incubated for a further 
20 min at 37°C, washed twice and resuspended in 0.5 ml phosphate-buffered saline 
(PBS) for analysis. The fluorescence of the cell population was measured with a 
FACStar Plus flow cytometer (Beckton, Dickinson and Company, Franklin Lakes, NJ, 
USA). Verapamil (EGIS Pharmaceuticals PLC, Budapest, Hungary) was used as a 
positive control in the R123 exclusion experiments at final concentration of 22 µM. 
The percentage mean fluorescence intensity was calculated for the treated MDR/PAR 
and A2780cis cell lines as compared with the untreated cells. Fluorescent activity 
ratio (FAR) was calculated via the following equation, on the basis of the measured 
fluorescence values: 
controlparentaltreatedparental
controlMDRtreatedMDRFAR =
 
 
The results presented are obtained from a representative flow cytometric experiment 
in which 1×105 individual cells of the population were evaluated for the amount of 
R123 retained are first presented by the FACS Star Plus flow cytometer as histograms 
and the data were converted to FAR units that define fluorescence intensity, standard 
deviation, peak channel in the total and in the gated populations. 
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7.5 MDR REVERSAL ACTIVITY STUDY 
  
TABLE-7.2 - FLUORESCENT ACTIVITIES OF NEWLY SYNTHESIZED 
COMPOUNDS  
 
 Samples final cc. dye FSC SSC FL-1 
FAR 
* 
Peak 
Ch 
1 
 
PAR - R123 477,39 162,62 1039,43 - 1027
2 PAR - R123 471,28 165,01 1029,18 - 1197
3  MDR - R123 521,70 190,17 40,75 - 40 
 MDR mean  493,72 R123 32,34 - 30 
4  
Verapamil
1 mg/ml 
(2,2 mM) 
5,2 
µM R123 516,66 188,56 236,90 7.33 149 
5 
 
SBF-01 
(0.5mg/ml)
2 
µg/ml R123 522,30 194,59 352,14 10.89 289 
6 20 µg/ml R123 521,94 194,16 608,08 18.80 557 
7 
 
SBF-02 
(0.5mg/ml)
2 
µg/ml R123 504,28 187,59 147,16 4.55 79 
8 20 µg/ml R123 518,36 198,85 245,41 7.59 201 
9 
 
SBF-03 
(0.5mg/ml)
2 
µg/ml R123 506,78 186,23 536,56 16.59 429 
10 20 µg/ml R123 511,44 153,98 491,02 15.18 414 
 
N
N
O
O
N
N
O
O
H3C
N
N
O
O
O2N
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11 
 
SBF-04 
(0.5mg/ml)
2 
µg/ml R123 503,27 186,01 867,73 26.83 749
12 20 µg/ml R123 506,21 169,73 934,62 29.90 842
13 
 
SBF-05 
(0.5mg/ml)
2 
µg/ml R123 495,45 187,53 432,99 13.39 358
14 20 µg/ml R123 497,24 192,26 648,69 20.06 609
15 
 
SBF-06 
(0.5 g/ml) 
2 
µg/ml R123 494,27 189,19 225,53 6.97 156
16 20 µg/ml R123 500,82 203,13 269,80 8.34 187
17 
 
SBF-07 
(0.5mg/ml)
2 
µg/ml R123 468,48 179,83 469,62 14.51 417
18 20 µg/ml R123 494,92 148,31 520,81 16.10 406
N
N
O
O
H3CO OCH3
N
N
O
O
F
N
N
O
O
Cl
N
N
O
O
Cl
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19 
 
SBF-08 
(0.5mg/ml)
2 
µg/ml R123 480,18 179,57 770,70 23.83 743
20 20 µg/ml R123 487,55 169,41 865,82 26.77 784
 
 
 
 
21 
 
 
 
 
 
SBF-11 
(0.5mg/ml)
 
 
 
2 
µg/ml
 
 
 
R123
 
 
 
471,87
 
 
 
183,87 
 
 
 
192,83 
 
 
 
5.96 
 
 
 
194
22 20 µg/ml R123 475,43 200,91 218,84 6.77 268
23 
 
DMSO 4% R123 468,46 176,40 22,18 0.69 19 
24 MDR - R123 465,74 177,60 23,92 - 20 
 
FAR* : Fluorescence Activity Ratio 
N
N
O
O
H3CO
N
N
O
O Cl
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TABLE-7.3 - IC50 VALUE OF NEWLY SYNTHESIZED COMPOUNDS 
CHAPTER-2  
COMPOUND CODE STRUCTURE IC50 
SBF-01 
 
7.58 
 
SBF-02 
 
16.602 
 
SBF-03 
 
4.866 
 
SBF-04 
 
6.888 
 
SBF-05 
 
9.936 
 
 
 
N
N
O
O
N
N
O
O
H3C
N
N
O
O
O2N
N
N
O
O
H3CO OCH3
N
N
O
O
F
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SBF-06 
 
5.134 
 
SBF-07 
 
6.219 
 
SBF-08 
 
4.569 
 
SBF-11 
 
13.632 
 
SBF-12 
 
8.496 
 
SBF-13 
 
5.743 
 
 
 
 
N
N
O
O
Cl
N
N
O
O
Cl
N
N
O
O
H3CO
N
N
O
O Cl
N
N
O
O Cl
Cl
N
N
O
O Cl
H3CO
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SBF-14 
 
34.125 
 
SBF-15 
 
44.79 
 
SBF-16 
 
6.29 
 
SBF-21 
 
11.765 
 
SBF-22 
 
>50 
 
SBF-23 
 
22.997 
 
N
N
O
O Cl
O2N
N
N
O
O Cl
Cl
N
N
O
O Cl
H3CO
H3CO
N
N
O
O F
N
N
O
O F
Cl
N
N
O
O F
H3CO
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SBF-24 
 
>50 
 
SBF-25 
 
45.193 
 
SBF-26 
 
>50 
 
SBF-27 
 
>50 
 
SBF-28 
 
>50 
 
N
N
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O F
O2N
N
N
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TABLE-7.4 – IC50 VALUE OF NEWLY SYNTHESIZED COMPOUNDS 
CHAPTER-3 (SECTION-A) 
 
COMPOUND CODE STRUCTURE IC50 
SPSC-01 
 
>50 
SPSC-02 
 
>50 
SPSC-03 
 
>50 
SPSC-04 
 
>50 
SPSC-05 
 
>50 
SPSC-06 
 
>50 
SPSC-07 
 
>50 
SPSC-08 
 
>50 
 
 
O
N
H
NH
O
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N
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H
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TABLE-7.5 – IC50 VALUE OF NEWLY    SYNTHESIZED COMPOUNDS 
CHAPTER-3 (SECTION-B) 
 
COMPOUND CODE STRUCTURE IC50 
SPA-01 
 
 
>50 
SPA-02 
 
>50 
SPA-03 
 
1.569 
 
SPA-04 
 
2.077 
 
SPA-05 
 
3.792 
 
SPA-06 
 
30.981 
 
SPA-07 
 
>50 
 
SPA-08 
 
21.222 
 
SPA-09 
 
1.83 
 
SPA-10 
 
>50 
 
O
N
H
N
O
N
H
N CH3
Cl
O
N
H
N
CH3
O
N
H
N
OH
O
N
H
N
OCH3
O
N
H
N
NO2
O
N
H
N
F
O
N
H
N
OCH3
O
N
H
N
NO2
O
N
H
N
Cl
Chapter-7                                                Biological activity of Newly Synthesized compounds.  
Department of Chemistry, Saurashtra University, Rajkot – 360 005                                     310 
TABLE-7.6 – IC50 VALUE OF NEWLY SYNTHESIZED COMPOUNDS 
CHAPTER-3 (SECTION-C) 
 
COMPOUND CODE STRUCTURE IC50 
SPAM-01 
 
>50 
 
SPAM-02 
 
>50 
 
SPAM-03 
 
>50 
 
SPAM-04 
 
12.123 
 
 
O
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TABLE-7.7 – IC50 VALUE OF NEWLY SYNTHESIZED COMPOUNDS  
CHAPTER-4 (SECTION-B) 
 
COMPOUND CODE STRUCTURE IC50 
SPC-01 
 
>50 
 
SPC-02 
 
>50 
 
SPC-03 
 
12.881 
 
SPC-04 
 
17.754 
 
SPC-05 
 
>50 
 
SPC-06 
 
8.307 
 
SPC-07 
 
35.577 
 
SPC-08 
 
30.679 
 
SPC-09 
 
>50 
 
SPC-10 
 
22.535 
 
SPC-12 
 
5.353 
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7.6 RESULTS AND DISCUSSION 
 
MDR reversal assay has gained importance in view of many cancerous cells 
developing multiple drug resistance (MDR) due to incorporation of MDR-1 gene 
coding of P-gp, a glycoprotein involved in MDR. The glycoprotein P-gp is driven by 
ATP and is responsible for efflux of drug from the cancerous cells leading to MDR. 
Therefore, MDR reversal agents are being exploited as potential anticancer agents.64,65 
Herein fluorescence activities shows that SBF-02, SBF-06 and SBF-11 from the 
synthesized compounds shown to be moderately active. This means that the above 
stated compounds were moderately effective in reversal of MDR efflux pump activity 
and rests of the compounds are poorly active.  
While antiproliferative activities in terms of IC50 shows that molecules like 
SBF-03, SBF-08, SPA-03, SPA-04, SPA-05, SPA-09 among the synthesized 
compounds seems to be moderately active and molecules like SBF-01, SBF-02, SBF-
04, SBF-05, SBF-06, SBF-07, SBF-11, SBF-12, SBF-13, SBF-14, SBF-15, SBF-16, 
SBF-21, SBF-23, SBF-25, SPA-06, SPA-08, SPAM-04, SPC-03, SPC-04, SPC-06, 
SPC-07, SPC-08, SPC-10 and SPC-12 seems to be poorly active. 
 
7.7 CONCLUSION 
  
Among the synthesize compounds, three compounds which are benzofuran 
analogous have shown good MDR reversal activity against cancer cell lines described 
in the protocol.  
 While atleast six compounds have shown good antiproliferative activity where 
in SBF-03 and SBF-08 are benzofuran analogues, while the others SPA-03, SPA-04, 
SPA-05 and SPA-09 are novel valproic acid analogues first time reported for such 
activity.  
Please refer Table 7.8 and Table 7.9. 
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Thus, Following molecules are identified for MDR reversal activity. 
TABLE-7.8 
Sr. No. Series Code Structure 
1 SBF SBF-02
 
2 SBF SBF-06
 
3 SPA SBF-11
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Following molecules are showing good antiproliferative activity. 
TABLE-7.9 
Sr. No. Series Code Structure 
1 SBF SBF-03
 
2 SBF SBF-08
 
3 SPA SPA-03
 
4 SPA SPA-04
 
5 SPA SPA-05
 
6 SPA SPA-09
 
 
 
Pyrazole bearing Benzofuran derivatives and hydrazides from valproic acid 
are good ‘scaffold’ for antiproliferative activity. 
On the basis of the above interesting results, new synthetic programmes can be 
develop to more active molecules.  
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SUMMARY 
 
The work represented in the thesis entitled “Synthesis and Characterization 
of Pharmacologically Active compounds” is divided into seven chapters which can 
be summarized as under. 
 
 Chapter-1 covers an introduction to Medicinal Chemistry depicting drug 
discovery Pathways and brief history of evolution of heterocycles as drug molecules. 
 
 Chapter-2 deals with the introduction of oxygen heterocycle – Benzofuran-2-
Carboxylic acid ester and various chalcones. It deals with synthesis of 24 new 
molecules derived from Benzofuran and chalcones to arrive at variously 
functionalized pyrazoles. The chapter covers Reaction mechanism, IR, 1H NMR, 
Mass spectral and other Physical data to support the structure elucidation. 
 
 Chapter-3 Section – A is an effort to modify known antiepileptic drug 
Valproic acid to convert into various analogs, in order to explore other biological 
activities. Total 12 compounds are synthesized. 
In Section – B, reactions between Valproic acid hydrazide and substituted 
acetophenone afforded to give 10 novel derivatives. The microwave assisted methods 
was used. 
In Section – C, The condensation products are obtained having important 
amide linkage between Valproic acid and aroyl nucleus. Another 10 compounds are 
obtained in this section.              
All compounds are characterized by spectral and elemental analysis. 
 
 Chapter-4 is subdivided into two sections. 
In Section – A is preparation of several pyrazole bearing arylidine derivatives 
appended at N-methyl 4-hydroxy 2-quinolone. 
In Section – B is again novel arylidine derivatives obtained from 8-methyl-4-
hydroxy coumarin and various aldehydes. 
The synthesis was carried out using microwave assisted as well as conventional 
method. Total 26 compounds were synthesized and characterized by IR, 1H NMR,  
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Mass spectra and elemental analysis. 
 
Chapter-5 Section – A deals with hybridized analogs of known drug 
Aripiprazole. The core structure motif was utilized to obtain 12 molecules which were 
adequately characterized. 
In Section – B, twelve new Mannich base were prepared using secondary 
amines and indole-2-carboxylic acid. The structural elucidations of all compounds 
were carried out. 
 
Chapter-6 is an effort to develop analytical method for purity check of newly 
synthesized compounds, mentioned in the five chapters earlier. In all sixteen HPLC 
assay determination are given along with the experimental condition and protocols. 
  
Chapter-7 is revolved to the biological activity. The MDR reverting activity 
against resistant cancer cell lines was carried out and the anti proliferative study was 
also done on several newly synthesized molecules.  
In all 55 compounds were screened. three new compounds were shown to the 
posses moderate MDR reversal activity, while six new compounds are showing good 
anti proliferative activity. 
 
In entire thesis, total 106 compounds were prepared and more than half of 
them are screened. The remaining compounds are also under study.   
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